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 L. lactis subsp. lactis จ านวน 6 สายพนัธ์ุถูกเลือกจากแหล่งเก็บสะสมเช้ือจุลินทรีย ์
Génoferment culture เม่ือน าจุลินทรียน้ี์มาตรวจหาความหลากหลายของชนิดยอ่ยของจุลินทรียใ์น
กลุ่มเดียวกนัท่ีระดบัฟีโนไทป์ดว้ยการน าไปเพาะเล้ียงในน ้ านมดิบท่ีกรองเอาส่วนไขมนัออก และ
ในอาหารเล้ียงเช้ือชนิดต่างๆ เช่น อาหารสังเคราะห์ (chemically defined medium; CDM) อาหาร 
complex medium (M17) และอาหารสังเคราะห์ดดัแปลง (M13) จากการทดลอง พบวา่ เช้ือจุลินทรีย์
ทั้ง 6 สายพนัธ์ุเจริญเติบโตไดดี้ใน UF-cheese model โดยมีอตัราการเจริญเติบโตอยูร่ะหวา่ง 0.78 
และ 0.88 ต่อชัว่โมง และมีค่าความเป็นกรดสูง นอกจากน้ี ยงัพบวา่แบคทีเรียทุกสายพนัธ์ุมีอตัรา
การเจริญจ าเพาะในอาหารสังเคราะห์ CDM สูงกว่าในอาหาร M17 เช่นเดียวกบัท่ีไม่พบการ
เจริญเติบโตของแบคทีเรียในอาหาร M13 จากนั้นแบคทีเรียทั้ง 6 สายพนัธ์ุ ถูกน าไปตรวจหาแกน
ของจีโนมดว้ยวิธี array-based comparative genomic hybridization (CGH) และค านวณหาค่า
อตัราส่วนของความหนาแน่นระหว่างแบคทีเรียท่ีทดสอบกบัแบคทีเรียแลคติก สายพนัธ์ุ IL1403 
เพื่อหาความแตกต่างของจีโนมในระหว่างสายพนัธ์ุท่ีทดสอบ จากการทดลองแสดงให้เห็นว่า L. 
lactis subsp. lactis ทั้ง 6 สายพนัธ์ุ มีความเหมือนกนัมากในระหวา่งล าดบัเบสโดยมีส่วนของแกนจี
โนม (dairy core genome) ใหญ่ท่ีมีจ  านวนจีนมากถึง 1,915 จีนเหมือนกนัในทุกสายพนัธ์ุ อยา่งไรก็
ตาม มีเพียงล าดบัเบสของแบคทีเรียสายพนัธ์ุ LD61 ท่ีมีความใกลชิ้ดกนักบัล าดบัเบสของแบคทีเรีย
สายพนัธ์ุ IL1403 มากกว่าสายพนัธ์ุอ่ืน นอกจากนั้นแกนจีโนมของแบคทีเรียทั้งหมดถูกน ามา
ทดสอบความแตกต่างของการแสดงออกของจีนด้วยไมโครแอเรย์ของดีเอ็นเอ และน าผลการ
ทดสอบท่ีไดม้าจดักลุ่มดว้ยวิธีการ hierarchical clustering เพื่อหาความสัมพนัธ์กนัของแบคทีเรีย
สายพนัธ์ุต่างๆ ซ่ึงจากภาพแสดงความสัมพนัธ์ของแบคทีเรียแต่ละสายพนัธ์ุแสดงให้เห็นว่า
แบคทีเรียสายพนัธ์ุ LD55 มีความใกลชิ้ดกนักบัแบคทีเรียสายพนัธ์ุ UCMA571 ในทางตรงกนัขา้ม
แบคทีเรียสายพนัธ์ุ LL08 มีความแตกต่างจากแบคทีเรียสายพนัธ์ุอ่ืนๆ มากท่ีสุด และเม่ือตรวจหา
จ านวนของจีนท่ีแสดงออกแตกต่างกนัในแต่ละสายพนัธ์ุ พบวา่มีจีนท่ีแตกต่างกนัมากถึง 968 จีนซ่ึง
ถูกควบคุมอยา่งนอ้ยในสายพนัธ์ุใดสายพนัธ์ุหน่ึงในหา้สายพนัธ์ุโดยเปรียบเทียบกบัสายพนัธ์ุ LD61 
และความแตกต่างของจีนท่ีพบมากในแบคทีเรียทั้ง 5 สายพนัธ์ุนั้นพบวา่เก่ียวขอ้งกบัเมตาบอลิซึม 
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LACTOCOCCUS LACTIS/GENOMIC/TRANSCRIPTOMIC APPROACH 
 
 Six strains of L. lactis subsp. lactis were selected from the Génoferment 
culture collection. Intra-subspecies diversity at the phenotypic levels was detected by 
growing these strains in skimmed raw milk ultrafiltration (UF) retentate and in 
different media: the synthetic chemically defined medium (CDM), complex medium 
(M17), and modified synthetic medium (M13). It was found that all the six strains 
were highly grown in the UF-cheese model with values of the growth rate ranging 
between 0.78 and 0.88 h
-1
 and were also grown under highly acid condition. The 
higher specific growth rate was also detected in all the strains on CDM medium than 
in M17 medium whereas none of these strains were able to grow on M13 medium. 
The core genome of these strains was determined by using arrary-based comparative 
genomic hybridization (CGH). Afterwards, the ratios of intensities were calculated 
between the tested strain and the IL1403 for the genomic divergences between the 
strains. It revealed that the six L. lactis subsp. lactis strains had strong similarities 
between the sequences by sharing of a large dairy core genome of 1,915 genes. 
However, the sequence of LD61 strain was very close to the sequence of the IL1403 
strain compared with the other five strains. The differential transcriptomic analysis for 
the core genome of these strains was examined with DNA arrays and was then 
classified by a hierarchical clustering for the relationships of the different strains. The 
  
 
 
 
 
 
 
strain dendrogram showed the strains grouping between the LD55 and UCMA571 
strains. In contrast, LL08 strain was the most divergent strain compared with the other 
four strains. The number of genes differentially expressed was determined for each 
strain. It was found that the total of 968 different genes was differentially regulated in 
at least one of the five strains compared with the LD61 strain. The strong divergence 
of the five strains compared with LD61 strain was observed within many regulated 
categories distributed all over the metabolism. In addition, the physiological 
characteristics of these strains were also determined by comparing the nitrogenous 
bases and the branched chain amino acids (BCAAs) requirements. The slightly grow 
of these strains was observed in different kinds of CDM medium with the nitrogenous 
base and the BCAAs compared with the classic CDM medium.  
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CHAPTER I 
INTRODUCTION 
 
 Lactococcus lactis is a member of the lactic acid bacteria and produces lactic 
acid from sugars. It is found in environment including plant and animal habitats 
(Teuber et al., 2006). L. lactis is one of the main microbes in the food application and 
widely used as a starter cultures for the production of cheese products and milk 
fermentations. Owing to several metabolic properties such as degradation of casein, 
acidification by lactic acid synthesis, and production of flavor compounds and 
exopolysaccharides (EPS) which are used in situ to improve the textural 
characteristics of fermented dairy products (Dabour et al., 2005), these microbes are 
promising candidates for innovative applications. Many important functions in 
fermentation are encoded on many conjugative plasmids contained in these bacteria 
(Mills et al., 2006). 
Microbial genomes are highly flexible and genetic adaptation through gene 
(in)-activation or DNA exchange as adaptive responses to challenge environments is 
important sources of intraspecies diversity (Van Hylckama Vlieg et al., 2006). 
Generally, Lactococcus lactis is continuously exposed to stress conditions generated 
by either in natural ecological niches including plants, animals, gastrointestinal tracts 
(Drouault et al., 1999) or during industrial processes. It encounters a wide range of 
different conditions such as extremes in temperature, pH, acid or osmotic pressure, 
and suboptimal growth. The bacterial response to stress conditionsis very complex and 
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can be regulated at all steps of gene expression such as transcription and translation 
efficiency, or the stability of mRNAs (Redon et al., 2005) or the allosteric regulation 
of the enzymes. Hence, it is important to know how the observed phenotype is related 
to the global regulation of gene expression during growth. 
 The development of microarray, enables the whole transcripts profile, i.e. the 
expression levels of thousands of genes simultaneously in different samples or 
conditions, to be examined. The coordinately regulated genes are also identified. 
Transcriptomic analysis can also be used for strain comparison at the functional level. 
Recently, the complete genome sequence of L. lactis subsp. lactis IL1403 has become 
available (Bolotin et al., 2001) and lead to  intraspecies comparative genomic as well 
as functional genomics studies. There are gained a lot of understanding in 
physiological processes and regulatory networks operating of lactococci. Moreover, 
for a deeper understanding, these genomics studies can be correlated with the 
phenotypic behavior of the strains (Klaenhammer et al., 2007). Recently, genome-
wide transcriptomic analysis of Lactic Acid Bacteria (LAB) was performed during the 
cell response and adaptation of L. lactis strains which led all the gene expression 
changes due to various stresses to be quantified. 
 Hence, this study was carried out to determine the biodiversity of dairy strains of 
Lactococcus lactis subsp. lactis using comparative genomic and transcriptomic 
approaches with microarrays. In our experiments, six strains of L. lactis subsp. lactis 
were studied for phenotypic aspects, in which the influence of different compounds 
within the media on growth was determined by comparative genome hybridization 
(CGH) for genomic characteristics and transcriptomic approach for gene expression.  
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Research objectives 
    1. To determine the physiological characteristics of six strains of Lactococcus 
lactis subsp. lactis. 
       2. To determine the genomic characteristics of the L. lactis strains by using 
comparative genomic hybridization (CGH). 
  3. To determine the correlation between genes expression and its function of L. 
lactis strains using transcriptomic analysis.   
   
  
 
 
 
 
 
 
CHAPTER II 
LITERATURE REVIEW 
 
2.1 Lactic acid bacteria 
         The lactic acid bacteria (LAB) are a group of Gram-positive, facultative 
anaerobes, non-spore-forming bacteria, which produce lactic acid as the major end-
product during the fermentation of carbohydrates. They have a cocci or rod shape and 
generally lack catalase activity. Cultures of LAB can be either mesophilic with 
optimal growth at approximately 26-30 
o
C or thermophilic (optimal growth at 
approximately 42
 o
C) (Marth and Steele, 2001). LAB can be sub-classified into 7 
phylogenetic classes: Lactococcus, Lactobacillus, Enterococcus, Pediococcus, 
Streptococcus, Leuconostoc and Oenococcus (óSullivan et al., 2009). Generally, LAB 
are associated with nutrient-rich habitats containing simple sugars. They are found 
naturally in a variety of environmental habitats, including dairy, meat, vegetable, 
cereal and plant environments, where fermentation can occur (Klaenhammer et al, 
2005) but some are also members of the normal flora of the mouth, intestine and 
vagina of mammals (Salminen and Wright, 1998). 
2.1.1 Type of lactic acid fermentation 
          Lactic acid fermentation can be divided into two major types (Salminen 
and Wright, 1998). 
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     2.1.1.1 Homolactic fermentation  
                               Homolactic fermentation is a metabolic process in which 
glycolysis (Embden-Meyerhof-Parnas pathway; EMP pathway) occurs as the major 
pathway for hexose fermentation (Figure 2.1A). All LAB usually use this pathway 
except Leuconostoc, group III Lactobacilli, Oenococci and Weissella (Salminen and 
Wright, 1998). Under standard conditions such as non-limiting concentrations of 
glucose and growth factors, glucose can be converted to be more than 90% lactic acid 
by the homolactic acid bacterium Lactococcus lactis (Garrigues, Loubiere, Lindley 
and Cocaign-Bousquet, 1997). 
          2.1.1.2 Heterolactic fermentation  
                               Heterolactic fermentation is a metabolic process which is other 
main fermentation pathway rather than EMP pathway. It is performed such as the 6-
phosphogluconate/phosphoketolase pathway, for hexose fermentation (Figure 2.1B). 
This metabolism leads to significant amounts of other end-products such as ethanol, 
acetic acid, and CO2 in addition to lactic acid.  
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(A)                  GLUCOSE    (B)                GLUCOSE 
 
               Glucose-6-P             Glucose-6-P 
 
               Fructose-6-P      6-phosphogluconate 
  
                           Fructose-1,6-DP               Ribulose-5-phosphate 
                            Xylulose-5P 
Glyceraldehyde-3P Dihydroxy-acetone-P    Glyceraldehyde-3P       Acetyl-P 
 
1,3-diphosphoglycerate                    1,3-diphosphoglycerate              Acetyl-CoA 
 
Glyceraldehyde-3P     Glyceraldehyde-3P           Acetaldehyde 
  
Glyceraldehyde-2P                 Glyceraldehyde-2P   ETHANOL 
 
2-Phosphoenolpyruvate             Phosphoenolpyruvate  
 
2-Pyruvate                         Pyruvate  
 
2LACTATE                                    LACTATE 
Figure 2.1 Pathways of hexose fermentation (A) Homolactic fermentation (glycolysis,          
   Embden-Meyerhof pathway);  (B)  Heterolactic  fermentation  (6-phospho-       
   gluconate/ phosphoketolase pathway) (Salminen and Wright., 1998). 
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2.1.2 Applications of LAB 
          LAB are used for food and beverage fermentation (Table 2.1), mainly for 
acidification, flavor forming (Ayad et al., 1999), preservation, bacteriocins (Garcia-
Almendárez, Cann, Martin, Guerrero-Legarreta, and Regalado, 2008), and 
exopolysaccharides production in food (Ayala-Herna’ndez, Hassan, Goff, and 
Corredig, 2009). In addition, there are application areas for use of LAB as probiotics 
since they are defined as live micro-organisms which confer a health benefit on the 
host when administered in adequate amounts (Picard et al., 2005). The most 
commonly used strains are members of the heterogeneous group of lactic acid 
bacteria; lactobacilli, enterococci and bifidobacteria. In particular, lactobacilli and 
bifidobacteria are widely used as probiotics primarily in dairy products and dietary 
supplements (Cebeci and GÜrakan, 2003; Ouwehand, Salminen, and Isolauri, 2007; 
Picard et al., 2005). Moreover, LAB can also be used to produce bulk and fine 
chemicals, including lactic acid, polyols, and vitamins B (Hugenholtz, 2008). 
 
Table 2.1 The potential applications of LAB. 
Type of an application                             LAB                                    References 
 
Cheese manufacture               L.  lactis subsp. cremoris                 Dabour et al. (2005) 
                                                Leuconostoc spp.                             Bonetta et al. (2008) 
                                                Lactococcus lactis subsp.                Bissonnette et al. (2000) 
                                                lactis biovar diacetylactis 
                                                Brevibacterium linens                     Bockelmann et al. (2005) 
                                                Lactobacillus helveticus                  Helinck et al. (2004) 
                                                Lactobacillus delbrueckii                De Angleis et al. (2008) 
                                                subsp. lactis 
                                                Streptococcus thermophilus            Liggett et al. (2008) 
 
Food fermentation                   L. lactis 
                                                Leuconostoc spp. 
                                                Enterococcus spp. 
                                                Lactobacillus plantarum IB2          Tamang et al. (2009) 
 
Zamfir et al. (2006) 
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Table 2.1 (Continued). 
Type of an application                                 LAB                                        References 
 
Food preservation                     L. lactis W8                                           Mitra et al. (2010) 
 
Meat fermentation                    L. lactis subsp. cremoris NCDO763     Herranz et al. (2003) 
                                                  Lactobacillus sakei 
                                                  Lactobacillus plantarum 
                                                  Leuconostoc carnosum 
                                                  Leuconostoc gelidum 
                                                  Leuconostoc pseudomesenteroides 
 
Probiotics                                  Bifidobacterium sp.                                  Picard et al. (2005) 
                                                  Lactobacillus casei Shirota                      Ouwehand et al. 
                                                                                                                  (2002) 
                                                  Lactobacillus plantarum                          Cebeci and GÜrakan 
                                                                                                                   (2003) 
 
Wine making                            Lactobacillus hilgardii X1B                    Arena et al. (2002) 
                                                 Oenococcus oeni 
                                                  L.  sakei 
 
2.2 The genus Lactococcus  
         The genus Lactococcus was reclassified from some species of the genera 
Streptococcus and Lactobacillus in 1985 by Schleifer and co-worker (Teuber and 
Geis, 2006). It includes five species, Lactococcus garvieae, Lactococcus piscium, 
Lactococcus plantarum, Lactococcus raffinolactis, and Lactococcus lactis. L. lactis is 
differentiated into subspecies L. lactis subsp. cremoris, L. lactis subsp. hordniae and 
L. lactis subsp. lactis (Casalta and Montel, 2008). Lactococci are Gram-positive, 
homofermentative microaerophilic cocci which lack the cytochromes of the respiration 
chain.   
         2.2.1 Characterization of Lactococci 
                  2.2.1.1 Physiological characteristics 
                  The lactococci are usually found in the various niches of the dairy 
industry environment. They are characterized by spheres of ovoid cells occurring 
Parente  (2001) 
Leroy and De Vuyst 
(2004) 
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single, in pairs or in chains, and being often elongated in the direction of the chain 
(Wood and Holzapfel, 1995).  L. lactis does not possess flagella and does not create 
endospores (Wood and Holzapfel, 1995), while some of their strains are capable of 
excreting extracellular polysaccharide substances (EPS). Looijesteijn and coworkers 
(2001) studied the physiological function of EPS in L. lactis and found that the 
presence of cell associated EPS was shown to increase tolerance to copper and nisin 
and to protect the bacteria against bacteriophages and the cell wall degrading enzyme 
lysozyme. In addition, Van Casteren et al. (1998) reported that exopolysaccharide 
from L. lactis subsp. cremoris B40 consists of rhamnose, galactose and glucose in the 
ratio of 0.9:1.2:2.0 and the molar ratio of carbohydrate and phosphorus is 4.7:1. L. 
lactis used in dairy production, are subdivided into L. lactis subsp. lactis and L. lactis 
subsp. cremoris. L. lactis subsp. cremoris is generally distinguished from subsp. lactis 
by a few phenotypic characteristics, including lack of growth at 40 
o
C, in 4% NaCl or 
at pH 9.2 (Table 2.2) (Kim, 1999) and inability to hydrolyse arginine. In addition, it 
cannot decarboxylate glutamate to γ-aminobutyric acid (GABA), while subsp. lactis 
displays this activity (Nomura et al., 1999). Among the lactococci, Lactococcus lactis 
subsp. lactis biovar diacetylactis differs from L. lactis subsp. lactis and subsp. 
cremoris in their ability to utilize citrate with production of diacetyl. These strains 
possess the citrate permease (CitP) that enables them to transport citrate into a cell 
(Samarzija et al., 2001). The mechanism of citrate uptake in resting cell of L. lactis 
subsp. lactis biovar diacetylactis has been described by Magni et al. (1996). The pH 
gradient (pH) and the membrane potential () are driving forces for citrate uptake. 
Moreover, it seems that CitP activity requires neither Na
+
 nor Mg
+
 cations. In addition, 
Lactococci have no catalase or functional electron-transfer chain, therefore, they do 
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not require oxygen for growth and in fact, a negative effect of oxygen on the growth of 
these bacteria has often been observed. However, Duwat et al. (1995) and Gaudu et al. 
(2002) found that the respiration, in the presence of heme, resulted in the growth of L. 
lactis by inducing the changing of metabolism and improving oxygen tolerance and 
long-term survival. Moreover, L. lactis has been reported that it possesses oxygen 
metabolizing enzymes like superoxide dismutase (Sanders et al., 1995) or NADH 
oxidases. 
 
Table 2.2 Physiological and other properties of dairy Lactococci used for identifi- 
                 cation  and differentiation. 
        Properties                   L. lactis subsp.          L. lactis subsp.               L. lactis  
                                              lactis                     cremoris                 subsp. lactis 
                                                                                                          biovar. diacetylactis 
Growth at 10 
o
C                         +                                 +                                   + 
Growth at 40 
o
C                         +                                 _                                   + 
Growth at 45 
o
C                         _                                 _                                   _ 
Growth in 4% NaCl                   +                                 _                                   + 
Growth in 6.5% NaCl                _                                 _                                   _ 
Growth at pH 9.2                       +                                 _                                   + 
NH3 from arginine                     +                                 _                                   + 
CO2 from citrate                        _                                  _                                   + 
Diacetyl and acetoin                  _                                  _                                   + 
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       2.2.1.2 Genomic characteristics 
                    1) Plasmid 
                         Between 1 and 12 plasmids of different sizes can be found in 
different strains of L. lactis (Wood and Holzapfel, 1995) and sizes are varied from 
about 2 to more than 100 kb (Teuber and Geis., 2006). The complete sequences of four 
plasmids of L. lactis subsp. cremoris NIZO B697, a derivative of strain SK11, have 
been reported by Siezen et al. (2005). This strain was found to contain the plasmids 
pSK11A, pSK11B, pSK11L and pSK11P which have sizes about 10,372, 13,332, 
47,165 and 75,814 bp, respectively. Recently, the complete 42,180-bp nucleotide 
sequence of the mobilization plasmid pNZ4000, encoding for exopolysaccharide 
(EPS) production in Lactococcus lactis NZ4010, has been reported by Van 
Kranenburg et al. (2000).  
                                    As plasmids are mobile elements, they can be lost by growth 
without lactose or casein, by growth at high sublethal temperatures (about 38-42 
o
C), 
by ethidium bromide treatment, by freezing and thawing or by freeze-drying, and 
acquired by natural conjugation or transduction at reasonable rates (Mills et al., 2006). 
The lactose plasmid from L. lactis subsp. cremoris SK11, pSK11L, is extremely stable 
in L. lactis subsp. cremoris strains. However, it has been shown in the laboratory that 
pSK11L displays a number of phenotypes in L. lactis LM0230 which are not observed 
in L. lactis subsp. cremoris SK11 or EB5. Among these are plasmid instability and 
temperature-sensitive plasmid maintenance. The stabilities of plasmids under these 
different treatments are strain dependent. Kim et al. (2001) demonstrated the survival 
response and rearrangement of plasmid DNA of L. lactis LL41-1 during long-term 
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starvation and found that the original plasmids presenting in the parent were 
rearranged in a certain way, and an entirely new plasmid was generated. 
                                    In addition, many of the functions encoded on plasmids turned 
out to be related to or necessary for growth of lactococci in milk. According to Wood 
and Holzapfel (1995), the following functions possibilities exist for the identification 
of plasmids encoded in L. lactis. 
   (i) Lactose transport and metabolism 
   (ii) Casein degradation by cell wall protease 
   (iii) Citrate and oligopeptide transport (permease) 
  (iv) Bacteriophage protection by restriction/ modification and                   
                               abortive infection 
   (v) Formation of extracellular polysaccharides (slime) 
   (vi) Bacteriocin production and immunity 
(vii) Insertion (IS) element dependent recombination and        
      cointegrate formation 
   (viii) Antibiotic resistance 
   (ix) Conjugal transfer and mobilization of plasmids 
   (x) Plasmid replication 
   These properties can contribute to the desired flavor and texture 
of the product and optimal growth on the milk components lactose and casein, as well 
as stability and survival.  
   2) Chromosomal DNA 
              The genome of L. lactis is AT-rich and consists of a circular 
chromosome of about 2.0 to 2.7 Mbp (Davidson et al., 1995). Because of the closely 
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relatedness in phenotype and genotype between L. lactis subsp. lactis and L. lactis 
subsp. cremoris, Le Borgeois et al. (1992; 1995) and Tulloch et al. (1991) performed 
study on the combination between physical and genetic map of the chromosome in 
independent lactococcal strains, IL1403, DL11 and MG1363 which belong to 
subspecies lactis for the two first and cremoris for the last one, by using pulsed-field 
gel electrophoresis (PFGE). They revealed that the chromosome size in the strains 
IL1403 and DL11 are 2,420 kb and 2,580 Kb while the MG1363 chromosome 
appeared to be 2,560 kb long. The comparison of physical maps of the three strains 
showed an overall conservation of restriction site locations for the L. lactis subsp. 
lactis strains but not for the L. lactis subsp. cremoris strain. At the genetic 
organization level, different kinds of rearrangements were observed. A large inversion 
convering almost half of the chromosome (Le Borgeois et al., 1995) was identified by 
comparing strains of the two different subspecies. In addition, the divergences of 
certain regions of chromosome between these two subspecies, latis and cremoris, have 
been described by Delorme et al. (1994). The results indicated that the conserved 
regions differ by less than 20%, whilst variable regions differ by more than 60%.  
Moreover, Davidson et al. (1995) reported that the genetic maps of the chromosomes 
in the different L. lactis subsp. cremoris strains, MG1363 and FG2, have an inversion 
of approximately 40% of the chromosome when compared with the maps of two L. 
lactis subsp. lactis strains, DL11 and IL1403, and the translocation or inversion of four 
discrete regions had occurred between the two L. lactis subsp. cremoris strains 
(Daveran-Mingot et al., 1998). 
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   3) IS element and Bacteriophage 
              Insertion sequence elements of the genus Lactococcus 
commonly present in both the chromosome and the plasmids. The sequencing data 
allowed the prediction of some very interesting features of the lactococcal genome. 
Bolotin and coworkers (2001) performed sequencing the genome of the laboratory 
strain IL1403, using a novel two-step strategy that comprises diagnostic sequencing of 
the entire genome and a shortgun polishing step. It was found that there are six 
different IS elements in the IL1403 chromosome. Non-random distribution of IS 
elements indicates that the chromosome of the sequenced strain may be a product of 
recent recombination between two closely related genomes. Recently, the genome of 
L. lactis MG1363 has been sequenced and it was found that it carries 11 different IS 
elements involving a total of 67 kb of DNA (Wegmann et al., 2007). Two unique ISs 
which are IS712 and IS1675, are found in  L. lactis MG1363 and are not presented in 
L. lactis IL1403 and L. lactis SK11 whereas IS981  and IS982 are contained in the 
SK11 strain (Table 2.3). 
Table 2.3 IS elements  in  different  Lactococcus lactis  strains (From Wegmann et al.,   
                 2007). 
IS elements L. lactis strain
a
 
          MG1363                      IL1403                          SK11 
IS904                                       9(1)                               9                                   7 
IS1077                                     9(9)                               7                                 10(1) 
IS905                                     14(8)                               1                                 13 
IS981                                     16(1)                             10                                 30(1) 
IS982                                       2(1)                               1                                 55(1) 
IS983                                       0                                  15                                   0  
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Table 2.3 (Continued). 
IS elements L. lactis strain
a
 
          MG1363                      IL1403                          SK11 
 IS712                                          8(1)                                  0                                      0 
IS-LL6                                     9(9)                               0                                   3      
IS946                                         1                                 0                                  2 
IS1216                                       1                                 0                                  3 
IS1297                                       1                                 0                                  7 
IS1675                                       1                                 0                                  0 
Total                                         71                              43                               130 
a
 Number in parentheses indicates pseudogenes. 
 
              Lactococcal phages are classified into 12 species based on 
morphology and DNA homologies (Durmaz and Klaenhammer, 2000). The c2 
(prolate-headed) species and the 936 and P335 (small isometric-headed) species are 
the most important taxa, since these are the major organisms that disrupt dairy 
fermentations worldwide. While the 936 species is composed of only lytic phages, 
P335 species exhibits high level of DNA homology between temperate and lytic 
members. P335 phages have been appearing in cheese plants and are now considered 
members of an important new phage species. The sequencing of the L. lactis MG1363 
genome has shown that the L. lactis MG1363 chromosome harbors six regions that 
represent bacteriophage-related sequence (Wegmann et al., 2007). Two sites appear to 
contain complete prophage genomes, designated phiT712 (42,085 bp) and MG-3 
(44,200 bp). The remaining bacteriophage sequences, designated MG-1 (19,053 bp), 
MG-2 (6,019), MG-4 (18,029 bp) and MG-5 (10,598 bp), appear to represent remnant 
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or satellite phages. The bacteriophage sequences encompass approximately 5.5% of 
the L. lactis MG1363 genome, representing a large portion of the observed genomic 
differences between L. lactis MG1363, L. lactis SK11 and L. lactis IL1403. 
Furthermore, it results that lysogenic bacteriophages significantly contribute to 
genome variability within this species. In addition, comparing the six prophages 
present in L. lactis IL1403 and L. lactis MG1363 revealed only one common 
integration site, and showed that two phages, MG-1 and bIL310, displayed the highest 
level of homology and synteny whereas a similar phage is not presented in L. lactis 
SK11 (Wegmann et al., 2007). The phage genomes in L. lactis SK11 and L. lactis 
IL1403 are not interrupted by IS elements, except for phage bIL311 in L. lactis 
IL1403, which contains two IS983 elements (Chopin et al., 2001). However, Deveau 
and coworkers (2006) have performed the classification of L. lactis phages by 
stringent DNA-DNA hybridization studies, electron microscopy observation, and 
sequence analyses. A new classification scheme for lactococcal phages is proposed 
that the groups of phase be reduced for 12 to 8. Recently, the genetic organization of 
six prophages presenting in the genome of L. lactis IL1403 has been reported by 
Chopin et al. (2001) who found that the three larger prophages (36-42 kb) belong to 
those already described P335 group of temperate phages, whereas the three smaller 
ones (13-15 kb) are most probably satellites relying on helper phages for 
multiplication. P335 temperate phages have variable genomes, sharing homology over 
only 10-33% of their length. In contrast, virulent phages have highly similar genomes 
sharing homology over >90% of their length. Ventura and coworkers (2007) have also 
described the genetic organization of six and five apparent prophage-like elements 
present in the genomes of the Lactococcus lactis subsp. cremoris MG1363 and SK11, 
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respectively. The phylogenetic investigation as well as bioinformatic analyses 
indicated that all 11 prophages belong to subdivision of the lactococcal P335 group of 
temperate bacteriophages. 
Table 2.4 Features of sequenced L. lactis genomes.  
Strains Size  
(Mbp) 
%GC plasmids Pseudo-
genes 
Pro-
phages 
Proteins Ref. 
L. lactis subsp. 
lactis IL1403 
L. lactis subsp. 
cremoris SK11 
L. lactis subsp. 
cremoris 
MG1363 
2.3 
 
2.4 
 
2.5 
35.4 
 
30.9 
 
37.1 
0 
 
5 
 
0 
1 
 
144 
 
81 
3 
 
4 
 
2 
2321 
 
2509 
 
2436 
Bolotin  
et al. (2001) 
 
Pfeiler  
et al. (2007) 
 
Wegman  
et al. (2007) 
 
         2.2.2 Natural diversity of Lactococci 
                  Lactococcus is viable in a number of diverse environments such as plant 
origin or in the gastrointestinal tracts of animals, insects, and humans, and also in 
fermented foods mostly from dairy origin. They are generally into close proximity to a 
wide variety of other microorganisms with a large reservoir of gene transfer 
(Wegmann et al., 2007). The presence of lactococci in raw milk is due to 
contamination from forage during milking. The two lactococci most commonly found 
in raw milk, cheese and other dairy products are L. lactis subsp. lactis and L. lactis 
subsp. cremoris as well as Lactococcus raffinolactic and Lactococcus garvieae which 
have also occasionally been found in raw milk and cheese (Casalta and Montel, 2008).  
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                  Plant environment is a second natural niche for lactococci. Most plant-
associated strains belong to L. lactis subsp. lactis and have the lactis phenotype (Van 
Hylckama Vlieg et al., 2006). Owing to the highly variable niches with respect to 
chemical composition, for instance, the availability of carbohydrates other than lactose 
as growth substrates, plant-associated strains should possess a metabolic potential 
which helps them to survive and to live in this habitat. One could expect that 
lactococci might degrade plant sugars in order to use them as energy and carbon 
sources. Generally, the most abundant sugars in plants are cellulose, sucrose and 
starch. Despite the lack of cellulose degrading enzymes in lactococci, these bacteria 
were shown to produce those, splitting the other two sugars, disaccharide sucrose, and 
most recently, a polysaccharide starch (Okano et al., 2007). Doman and coworkers 
(2000) studied the production and genetic regulation of an amylase in L. lactis and 
found that two of the tested strains were shown to produce an amylase. One of them, 
L. lactis IBB500 started to produce the extracellular amylases in the BHI broth at the 
end of the logarithmic phase of growth and the maximal amount of enzyme was 
detected at the early stationary phase. These experiments showed that various sugars 
modulated the production of the enzyme secreted to the medium; starch was found to 
be the best inducer, while glucose strongly repressed amylolytic activity. In addition, 
Petrov et al. (2008) reported the ability of the natural strain L. lactis subsp. lactis B84, 
isolated from spontaneously fermented rye sour dough, to utilize starch as a sole 
carbon source and to produce L(+)-lactate. In addition, the gene expression of the key 
enzymes, amyl and amyY involved in starch degradation, was observed in B84 genome 
by using the methods of reverse transcription polymerase chain reaction (RT-PCR). 
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                  In addition, lactococci are capable of assimilating β-glucosides, such as 
cellobiose, salicin, arbutin and esculin, which also belong to plant sugars.  
Interestingly, it seems that some of the β-glucosides, e.g. cellobiose, can modulate the 
environment adaptation of these bacteria and prompt them to grow in milk, another 
habitat of lactococci. Aleksandrzak et al. (2000) studied the regulation of carbon 
catabolism in L. lactis. The results showed that low concentrations of cellobiose 
induce a β-glycosidase activity in plasmid-free, lactose-negative Lactococcus lactis 
IL1403 cells, enabling them to hydrolyze lactose, the main carbohydrate present in 
milk. These observations suggest that there is a kind of coupling between cellobiose 
and lactose assimilations in L. lactis, and it was proposed that the cellobiose and 
lactose are transported by a phosphotransferase system (PTS) that is negatively 
controlled by the CcpA regulator (Kowalczyk et al., 2008). 
                  Furthermore, the adaptation to growth on substrates derived from plant cell 
wall is evident from the presence of gene sets for the degradation of complex plant 
polymers. Doman-Pytka et al. (2004) demonstrated that the 11-kb plasmid DNA 
fragment representing a gene-cassette, is important for the wild-type L. lactis IBB500 
strain for its adaptation to the plant environment. Similarly, the capability of L. lactis 
strains isolated from vegetable products to transfer the ability to ferment raffinose and 
sucrose, was observed in conjugation experiments with the recipient strain L. lactis 
MG1614. Pulsed-field gel electrophoresis analysis showed that all transconjugants had 
acquired large chromosomal insertions at two main sites. Nisin-sucrose 
transconjugants had gained inserts of 70 kb, while those that fermented sucrose 
without nisin production contained inserts of between 50 and 110 kb (Kelly et al., 
1998; 2000). 
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                  Moreover, the strains isolated from fermenting plant material do not 
harvest amino acids through proteolysis but depend on amino acid biosynthesis (Ayad 
et al., 1999). Therefore, it can be anticipated that strains adapted to the plant 
ecological niche will exhibit large metabolic differences and their metabolic diversity 
will most certainly exceed that of dairy strains (Siezen et al., 2008). Plant-derived 
lactic acid bacteria are expected to show additional capabilities compared with milk-
derived strains, for instance, plant-derived strains demonstrate greater tolerance to 
stress than milk-derived strains. Therefore, the use of plant-derived strains could result 
in dairy products with improved taste, and these strains might also be used to perform 
additional functions (Nomura et al., 2006). Recently it has been shown that strains 
isolated from a nondairy environment, KF147 and KF282, exhibited tolerance to high 
salt concentration and high pH value, and fermented more kinds of carbohydrates than 
the milk-derived strains (Nomura et al., 2006). In addition, some nondairy strains 
showed the ability to produce the key flavor aldehydes as a result of a unique α-keto 
acid decarboxylase and glutamate dehydrogenase activities which convert glutamate to 
α-ketoglutarate. These two enzymes involve in the first step in the production of flavor 
compounds from amino acid, and present at rate-limiting concentrations in cheese 
(Van Hylckama Vlieg et al., 2006; Tanous et al., 2002).  
         2.2.3 Adaptive response to environment 
                  L. lactis is widely used as a starter in dairy technology. During the food 
process as well as in its natural environment or in the intestinal tract, it is subject to a 
variety of adverse conditions, including acids, oxidation, heating and cooling, high 
osmolarity such as dehydration, bile salts, ethanol and starvation. In response to these 
stress conditions, bacterial cells are able to rapidly and transiently induce specific or 
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general protection mechanisms (Sanders et al., 1999) such as enzymes involved in 
particular chaperone proteins and proteolysis, which act in the cytoplasm or in the cell 
envelope to repair or degrade abnormal proteins.  
                  Stress factors induce cellular responses that vary with the type, magnitude, 
and method of stress application. Factors that cause the stress response during dairy 
starter-culture production and cheese manufacture include the follows: 
                  2.2.3.1 Changes in temperature 
                           1) Heat shock  
                                    The major problem encountered by cells at high temperature is 
the denaturation of proteins and their subsequent aggregation. In addition, 
destabilization of macromolecules such as ribosome and RNA, and alterations of 
membrane fluidity were also described (Van de Guchte et al., 2002). The heat-shock 
(HS) response to increase in temperature causes the induction of a small group of 
proteins, the heat shock proteins. Heat shock proteins such as DnaK, DnaJ, GroEL, 
GroES and GrpE, play essential physiological roles as molecular chaperones in 
protecting cells against damage due to thermal stress by binding to cellular proteins in 
a manner that maintains their native conformation and minimizes denaturation (Yousef 
and Juneja, 2003). Whitaker and Batt (1991) have characterized the heat shock 
response in L. lactis subsp. lactis and found that a shift in temperature from 30 to 42 
o
C was sufficient to arrest the growth of L. lactis subsp. lactis, but growth resumed 
after a shift in temperature back to 30 
o
C. At 42 
o
C, the two heat shock-induced 
proteins appeared to be homolog to GroEL an DnaK, based on their molecular weights 
and reactivity with antiserum against the corresponding Escherichia coli proteins. 
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                           2) Low temperature (cold stress) 
                                    Starter LAB is exposed to low temperatures during frozen 
storage, as well as during low-temperature fermentation. Whereas growth at high 
temperature is harmful to a cell, growth at low temperatures merely slows down 
biological processes. Several bacteria respond to a decrease in temperature by 
inducing a set of proteins, called cold shock proteins (CSPs) (Van De Guchte et al., 
2002). These proteins can function as RNA chaperones, transcriptional activators, 
freeze-protective compounds that are also found in E. coli and Bacillus subtilis (Bae et 
al., 2005; Graumann and Marahiel, 1998; Wouters et al., 2000). Wouters et al. (1999) 
have studied the low-temperature responses of L. lactis MG1363 and characterized the 
effects of multiple csp gene disruptions on adaptation to cold and gene regulation of L. 
lactis (Wouters et al., 2001). It resulted in the identification of a group of 7-kDa 
proteins that appear to represent the most highly induced proteins upon a rapid 
downshift in temperature and it was also found to have five members in the CSP 
family (Wouters et al., 1998). In addition, they found that the deletion of csp genes 
affected freeze survival of L. lactis, the remaining counterparts of the lactococcal CSP 
family and the several cold-induced proteins (CIPs) production. Recently, Yinghua et 
al. (2008) demonstrated that CspC, a 6.2 kDa cold-shock protein, improved the 
recovery of cells, and a 7 kDa cold-shock protein, CspD, increased the viability after 
freezing (30-40 folds). Furthermore, factors affecting the survival of LAB during 
freezing-thawing cycles have been reported by Lee (2004), in a study including 
different diluents, growth phases, and cold temperatures. Viability experiments 
showed that this strain displaying cold shock cryotolerance had an improved survival 
capacity in stationary phase. Similarly, the survival capacity of L. lactis subsp. lactis 
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IL1403 to cold temperatures had also been improved in stationary phase (Panoff et al., 
1994). Panoff et al. (1995) demonstrated the physiology of the cold-shock response in 
L. lactis subsp. lactis IL1403 at a subzero temperature and found that pre-incubation 
of cells at 8 
o
C led to an enhanced capacity to survive exposure to freezing 
temperature (-20 
o
C). Moreover, the effects of low temperature stress on the glycolytic 
activity of L. lactis were studied (Wouters et al., 2000). The maximal glycolytic 
activity increased approximately 2.5-fold at 10 
o
C for 4 h compared with at 30 
o
C. 
Analysis of cold adaptation of strains with disrupted genes involved in sugar 
metabolism showed that both the phosphoenolpyruvate-dependent sugar 
phosphotransferase system (PTS) subunit HPr and catabolite control protein (CcpA) 
are involved in the increased acidification at low temperatures, and the protein 
analysis showed that the production of both HPr and CcpA was induced up to two- to 
three-fold upon exposure to low temperature. 
                  2.2.3.2 pH  
                           Milk fermentations by lactic acid bacteria (LAB) are extensively used 
to produce cheeses and other dairy products. Generally, in milk fermentations, LAB 
are able to degrade lactose resulting in lactate accumulation and consequently 
acidification of the media to as low as pH 4.0 (Rallu et al., 1996). The further growth 
and metabolism may be inhibited either by acidification or lactate even if nutrients are 
still available. Lactic acid is a weak organic acid that it is not charged at low pH and 
can easily pass the cell membrane in the protonated form. Budin-Verneuil et al. (2005) 
and O’Sullivan and Codon (1999) showed that L. lactis strains, including MG1363, 
display an inducible acid tolerance response (ATR) when they encounter a moderate 
acid pH during logarithmic growth. ATR improves the cell survival in normally lethal 
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acid conditions. Furthermore, in proteomic characterization of acid tolerance response 
of L. lactis MG1363 in different media, Budin-Verneuil et al. (2005) showed that the 
development of ATR was fully dependent on de novo protein synthesis in chemically 
defined culture media and only partly dependent in M17. Bacteria are equipped with a 
number of mechanisms that confer acid tolerance. Among these mechanisms are 
proton translocation, arginine deaminase (ADI) pathway, amino acid decarboxylation-
antiporter reactions, and the citrate transport system (Yousef and Juneja, 2003). 
                           1) Proton movement: H
+
-ATPase 
                                    The maintenance of the cytoplasmic pH (pHin) which is more 
alkaline than the extracellular pH (pHout), is directly required for the survival of the 
lactic acid bacteria, because many cytoplasmic enzymes have their pH optima in a 
neutral range (Amachi et al., 1998). The primary mechanism of L. lactis for surviving 
at low pH is the membrane-bound FoF1 ATPase. It functions to maintain a favorable 
intracellular pH and protect cells during exposure to acidic environments by 
translocating protons to the environment at the expense of ATP hydrolysis (Yousef 
and Juneja, 2003). O’ Sullivan and Condon (1999) demonstrated that the intracellular 
pH (pHi) plays a major role in the induction of this multistress resistance response. 
The pHi was dependent on the extracellular pH and on the specific acid used to reduce 
the extracellular pH (pHo). Siegumfeldt et al. (2000) described the dynamics of 
changes in the pHi values of a number of LAB in response to a rapid drop in the 
extracellular pH by using method based on fluorescence ratio imaging of single cells. 
It was found that the pHin decreased as the pHout decreased in order to maintain a 
constant transmembrane pH gradient rather than a constant pH. Genes encoding FoF1 
ATPase in L. lactis subsp. cremoris MG1363 have also been cloned and sequenced. 
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Afterward, a mutant strain was constructed in which the original atp promoter on the 
chromosome was replaced with an inducible nisin promoter. It was shown that a 
mutant strain in which expression of H
+
-ATPase on the chromosome was completely 
dependent on the presence of nisin for growth. It is indicated that the H
+
-ATPase is 
essential for growth of L. lactis under these conditions (Koebmann et al., 2000). 
Moreover, the major role of this enzyme in regulation of the cytoplasmic pH has been 
confirmed with the acid sensitivity of a mutant of L. lactis subsp. lactis C2 with a 
reduced membrane-bound ATPase activity (Amachi et al., 1998). 
                           2) Arginine deiminase (ADI) pathway  
                                   Most of LAB metabolize arginine by the arginine deiminase 
(ADI) pathway (Figure 2.2). This pathway consists of three enzymes such as arginine 
deiminase, ornithine carbamoyltransferase and carbamate kinase. A fourth component, 
identified in L. lactis, is a membrane-bound antiport protein that catalyzes the 
exchange between arginine and ornithine. These enzymes catalyze the conversion of 
arginine to ornithine, ammonia, and carbon dioxide and generate 1 mol of ATP per 
mole of arginine consumed. The ADI pathway is a mechanism for survival in acidic 
environments by generating ammonia. The development of acid tolerance depends on 
the rise in pH associated with ammonia production (Marquis et al., 1987). The 
enzymatic properties of the ADI pathway are well documented in a variety of bacteria. 
The enzymes in the ADI pathway are inherently acid tolerant and are activated in 
response to low pH in several species of Streptococcus (Cotter and Hill, 2003). As 
such, these enzymes allow bacteria to recover from acid stress severe enough to 
prevent the cell membrane from functioning normally. In most LAB, the ADI pathway 
is repressed by glucose and induced by arginine. The ADI pathway imparts LAB with 
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enhanced tolerance to acid, primarily through the continuous production of acid-
neutralizing ammonia from arginine. 
 
 
 
 
 
 
 
 
Figure 2.2 Metabolic fate of arginine in bacteria by arginine deiminase (ADI) or argi-              
                   nine decarboxylase pathway (Chou, Weimer and Cutler, 2001). 
 
                                    The arginine deiminase system provides a source of ATP 
derived from catabolism of arginine to ornithine, CO2, and ammonia in a variety of 
organism, including many streptococci and members of the genus Pseudomonas 
(Marquis et al., 1987). The system is generally inducible and under the control of 
catabolite repression. Larsen et al. (2004) showed that ArgR and AhrC, which are 
transcrtiptional regulators, are both required for regulation of arginine metabolism in 
L. lactis. As one of the end products of this pathway is ammonia, ADI activity results 
in an increase in the extracellular pH (pHo) and, therefore, in an enhanced survival in 
low pH conditions. 
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                           3) Degradative amino acid decarboxylases 
                                    Since L. lactis increases the medium acidity through its 
anaerobic fermentation, it is likely to have acid-resistance mechanism to maintain 
viability under low pH conditions. Amino acid decarboxylation involves transporting 
an amino acid into the cell where it is decarboxylated. A proton is consumed in the 
reaction, and the product is exported from the cell via an antiporter. The result of this 
reaction is a decrease in intracellular acidity. Glutamate decarboxylase (GAD) 
constitutes a glutamate-dependent acid resistance mechanism with a glutamate-GABA 
(-aminobutyrate) antiporter (Nomura et al., 2000). Sanders et al. (1998) sequenced 
the L. lactis gadCB genes and suggested that it encoded a glutamate-dependent acid-
resistance mechanism comprised of glutamate-GABA antiporter and GAD. In 
addition, it was shown that L. lactis gadB mutant and a strain unable to express both 
gadB and gadC encoding GAD and the glutamate-GABA antiporter, respectively, was 
more sensitive to low pH than the wild type when NaCl and glutamate were present. 
Furthermore, the biochemical characteristics of GAD indicated that there was only one 
GAD structural gene in L. lactis (Nomura et al., 1999). Nomura et al. (2000) studied 
the sequence of gadB gene in L. lactis subsp. lactis and in L. lactis subsp. cremoris 
and found that L. lactis subsp. lactis strains show glutamate decarboxylase activity, 
whereas L. lactis subsp. cremoris strains do not. The gadB gene encoding glutamate 
decarboxylase was detected in the L. lactis subsp. cremoris genome but was poorly 
expressed. 
                           4) Citrate transport system 
                                    Citrate is present in milk at low concentrations and is co-
metabolized with glucose to yield aroma compounds through the diacetyl/acetoin 
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biosynthetic pathway (Curic et al., 1999) (Figure 2.3). Citrate fermentation results in 
the formation of an electrochemical proton gradient across the cell membrane (proton 
motive force) by a secondary mechanism in which the CitP plays a crucial role 
(Bandell et al., 1998). Mechanism of citrate metabolism in L. lactis CRL264 resistance 
against lactate toxicity at low pH has been reported by Magni et al. (1999). 
Measurement of the flux through the citrate fermentation pathway showed that the 
pathway was constitutively expressed, but its activity was significantly enhanced at 
low pH and the flux was correlated with the magnitude of the membrane potential and 
pH gradient that were generated when citrate was added to the cells. Garcia-Quintans 
et al. (1998) studied the influence of the extracellular pH on the expression of citP and 
found that in lactococci both transcription of citP and citrate uptake increased when 
cells were grown at low pH. This increase in citrate transport leads to more efficient 
glucose utilization, which results in a growth advantage for L. lactis subsp. lactis 
biovar diacetylactis at acid pH. In addition, acid growth can enable to trigger the 
conversion of citrate into α-acetolactate via pyruvate, by induction at the 
transcriptional level of diacetyl/acetoin biosynthetic pathway but no influence on 
levels of lactate dehydrogenase and pyruvate dehydrogenase, presumably contributing 
to lactococcal pH homeostasis by synthesis of neutral compounds and by decreasing 
levels of pyruvate (Garcia-Quintans et al., 2008). This is correlated with the results of 
Sánchez et al. (2008), showing that the beneficial effect of citrate on growth of L. 
lactis CRL264 under acid stress conditions (pH 4.5) is not primarily due to the 
concomitant alkalinization of the medium but it is caused by less expenditure of ATP, 
derived from glucose catabolism, to achieve pH homeostasis. Frees and coworker 
(2003) have also investigated the proteins which are induced when L. lactis is exposed 
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to condition of low pH (pH 4.5) by using two-dimensional gel electrophoresis. It was 
found that reducing the pH of the growth medium with hydrochloric acid induced the 
synthesis of a small subset of proteins such as the oxidative stress proteins superoxide 
dismutase, alkylhydroperoxidase and the autoinducer synthesis protein, LuxS, as well. 
When the extracellular pH is reduced to 4.5, the intracellular pH is reduced to 5.0-5.5 
within a few minutes (Siegumfeldt et al., 2000) and thus, protein denaturation is 
expected to take place leading to an induction of both HrcA- and CtsR-controlled 
genes. A differential induction of heat shock proteins as members of the CtsR regulon, 
ClpE and ClpP was also observed at pH 5.5, and it is indicated that CtsR responds 
either to a signal different from misfolded proteins or to lower concentrations of 
denatured proteins than HrcA or another regulatory element is controlling clpE and 
clpP expression. 
.  
 
 
 
 
 
  
 
 
Figure 2.3 Acid induction of citrate transport, citrate metabolism, and diacetyl/acetoin  
pathways in L. lactis (Garcia-Quintans, Repizo, Martin, Magni, and Lopez, 
2008). 
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                  2.2.3.3 Oxidative stress and DNA damage 
                            Oxidative stress can be defined as an excess of reactive oxygen 
species (ROS) that have strong oxidizing potential for cells (Rochat et al., 2005). 
During the cellular processes, oxygen is partially reduced to water, leading to the 
formation of reactive oxygen species, which are the superoxide anion (O2
-
), the 
hydroxyl radical (OH
*
), and hydrogen peroxide (H2O2). These intermediates have a 
high oxidizing potential and thus are responsible for cellular oxygen toxicity (Miyoshi 
et al., 2003). At the molecular level, O2
-
, OH
*
 and H2O2 can react with cellular targets 
such as proteins, lipids and nucleic acids (Rochat et al., 2005) as well as many effects 
of O2 are also observed at the metabolic level such as the formation of H2O2 which 
causes a reduction of the growth rate of L. lactis, and even its death. The most 
common oxidative stress resistance mechanism found in L. lactis is performed by a 
coupled NADH oxidase/NADH peroxidase system. Recently, Jiang and Bommarius 
(2004) have successfully applied the sequence comparison-based approach to develop 
a novel hydrogen peroxide-forming NADH oxidase (nox-1) from L. lactis that reduces 
oxygen directly to hydrogen peroxide. A second common resistance mechanism is 
provided by the action of a superoxide dismutase, SOD, which removes O2
-
 anion. 
Most LAB have SOD activity. A unique manganese-containing SOD (MnSOD) has 
been identified in L. lactis, during an analysis of acid stress-induced protein expression 
(Sanders et al., 1995). L. lactis sodA has a low initial expression under anaerobic 
condition which is shifted to a high gene expression level under aerated conditions. An 
alternative mechanism to eliminate O2
-
 anion, which could compensate the low SOD 
activity, can be provided by high levels of intracellular glutathione (Li et al., 2003). In 
addition, Woo-Suk and So (1999) characterized the superoxide dismutase in L. lactis 
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and found that the SOD activity was found to be growth-phase dependent by 
increasing the activity until the late stationary phase in aerobically grown cells. In 
addition, it was found that L. lactis possessed a single manganese-containing SOD 
(MnSOD) after the activity of SOD also increased when the concentration of 
manganese in the medium increased. Another oxidative stress resistance mechanism is 
supported by RecA activity. This protein plays a key role in the SOS response and 
homologous recombination. Duwat et al. (1995) constructed a L. lactis recA mutant 
strain, and showed that RecA was involved in resistance to oxidative and thermal 
stresses. They observed that during exponential and stationary growth phase, recA 
mutants were highly sensitive to aeration, resulting in a reduction in growth rate and 
viability. After adding an iron chelator to aerated cultures of L. lactis recA mutants, 
bacterial doubling time was restored close to that of anaerobic conditions, leading to 
the observation that ROS are responsible for oxygen toxicity and that RecA plays an 
essential role in the repair of DNA damage caused by these compounds. Moreover, 
from the study of the function of RecA under thermal stress, it was found that 
activation of recA by oxidative stress could confer cross-protection against thermal 
stress. A single stimulus can activate various stress resistant mechanisms such 
formamidopyrimidine DNA glycosylase (fpg), another DNA repair gene, conferring 
protection against various types of stress in L. lactis. Because of the overlapping of the 
stress resistant mechanisms in L. lactis, cells under one specific stress condition could 
trigger different stress responses. Control of stress response could also be achieved by 
cellular systems that sense and transmit environmental signals into the cell, thereby 
modulating gene expression and physiological changes. Two-component regulatory 
systems are composed of a membrane-anchored sensor protein, usually a histidine 
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protein kinase, and an intracellular response regulator. In L. lactis, six of these systems 
have been identified and it was found that three of these systems (systems B, D and F) 
were involved in specific susceptibility to acid, osmotic, and oxidative stress 
(O’Connell-Motherway et al., 2000), respectively. The system F mutant strain 
obtained by insertional mutagenesis of L. lactis, has greater H2O2 sensitivity than that 
of the wild-type strain. 
                  2.2.3.4 Starvation 
                           The depletion of essential nutrients from the growth medium can lead 
to growth arrest of the cells and entry into stationary phase. During stationary phase, 
most of the LAB seem to have the capacity to maintain an active metabolic state (Van 
de Guchte et al., 2002), with cell adaptation such as the changing in cell size and fatty 
acid composition, decreasing in the overall rate of protein synthesis, and induction of 
distinct sets of proteins (Hartke et al., 1994). In particular, carbohydrate (sugar) 
starvation is important to understand the starvation response because it leads to cell 
energy depletion (Van de Guchte et al., 2002). Amino acid catabolism plays a role in 
survival of L. lactis, therefore, survival capacity of lactococci upon nitrogen starvation 
is related to the protein synthesis (Van de Guchte et al., 2002). Recently, Ganesan et 
al. (2007) have characterized the ability of lactococci to become nonculturable under 
carbohydrate starvation while maintaining metabolic activity. They found that the cells 
contained at least 100 pM of intracellular ATP after 6 months of starvation and amino 
peptidase and lipase/esterase activities decreased below detection limits during the 
nonculturable phase. In addition, the cells retained the ability to transport amino acids 
via proton motive force and peptides via ATP-driven translocation during sugar 
exhaustion and entry into nonculturability. Similarly, the influence of carbohydrate 
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and arginine starvation on culturability and amino acid utilization of Lactococcus 
lactis subsp. lactis has been studied by Stuart et al. (1999). Results indicated that 
lactococci remain viable in the absence of lactose or arginine. The cells were able to 
use other amino acids to survive, produce ATP, and maintain cellular integrity without 
being culturable on agar. In addition, Hartke et al. (1994) have reported that 
carbohydrate-starved cultures of L. lactis subsp. lactis IL1403 showed enhanced 
resistance to heat, ethanol, acid, osmotic and oxidative stresses. This cross-protection 
seems to be established progressively during the transitional growth phase, with 
maximum resistance occurring when cells enter the stationary phase. Moreover, the 
survival capacity of lactococci upon carbohydrate starvation is related to the 
maintenance of glycolytic capacity. Kunji et al. (1993) have studied the physiological 
responses of L. lactis ML3 to alternating conditions of growth and carbohydrate 
starvation and found that loss of glycolytic activity is associated with loss of 
glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate mutase and pyruvate 
kinase activities. However, the glycolytic activities can be restored to 100% values 
with addition of sugar to starved cultures. Moreover, the breakdown of proteins during 
starvation appears to be largely nonspecific and the rate of synthesis of protein 
decreases rapidly in the first hour of starvation. From the onset of starvation, at least 
45 proteins are no longer synthesized. During starvation, relative induction of fourteen 
to fifteen proteins can be observed. Recently, the stability of mRNA was investigated 
at the genomic scale during carbon starvation adaptation of L. lactis IL1403. Gene 
expression was mostly controlled by altered transcription prior to carbon source 
exhaustion, while the influence of mRNA stability increased during the starvation 
phase (Redon et al., 2005). 
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                           In addition to carbohydrate, phosphate is an essential component of 
bacterial cells because phosphate starvation can be deleterious for both energy supply 
and DNA/RNA synthesis (Van de Guchte et al., 2002). Phosphate starvation induces 
many genes that code for proteins transporting phosphate into the cells and enzymes 
that release phosphate from organic compounds. The phosphate starvation-induced 
Pho regulons of the Gram-negative bacterium E. coli and of the Gram-positive 
bacterium Bacillus subtilis have been well characterized. The pho genes are regulated 
by a two-component signal transduction system in these bacteria. In the genomic 
sequence of L. lactis, a putative pst operon, the first gene of which codes for a putative 
phosphate transport substrate-binding protein, can be found. It has been suggested that 
also the transcription of the L. lactis pst operon is regulated by a histidine kinase 
sensor and a response regulator. Sirén et al. (2008) have isolated the pst promoter of L. 
lactis and used it for the efficient heterologous production of two industrially 
interesting enzymes: α-amylase and β-galactosidase.                              
                  2.2.3.5 Osmotic stress  
                            In various applications in the food and feed industry, lactic acid 
bacteria can be exposed to osmotic stress when important quantities of salt or sugar are 
added to the product. In response to high osmolality, bacteria accumulate compatible 
solutes (betaine, proline), which restore turgor pressure and stimulate growth (Guillot 
et al., 2000). O’Callaghan and Condon (2000) have investigated differences between 
certain strains of L. lactis in their tolerance to low water activity. A strong correlation 
was observed between usage of the compatible solute glycine betaine and tolerance to 
sodium chloride. All the NaCl tolerant strains were stimulated by the presence of 
glycine betaine. Glycine betaine accumulation occurs either as a result of transport or 
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by synthesis from choline. Molenaar et al. (1993) have studied the accumulation of 
glycine betaine in L. lactis ML3 and found that glycine betaine was created via a 
constitutively expressed high affinity transport system whereas proline was 
transported via an inducible transport system. However, the capacity to accumulate 
betaine is extremely variable among lactococci strains. L. lactis subsp. cremoris was 
described as more sensitive to osmotic stress than subsp. lactis strains (Obis et al., 
2001). Obis and coworkers (1999) have characterized the osmoadaptative capacity of 
L. lactis and reported that the betaine transport capacity of L. lactis NCDO763 is 
linked to a single high-affinity ABC transporter, encoded by busA, which is in an 
operon composed of only two genes. The betaine transport capacity of L. lactis was 
found to be under osmotic control at both the genetic and biochemical levels. 
Moreover, the lacking or a low activity of the betaine transporter BusA is also 
associated with an osmosensitive phenotype (Obis et al., 2001). Furthermore, the 
effects of culture conditions on osmodependent betaine transport in L. lactis subsp. 
cremoris NCDO763 have been studied by Guillot et al. (2000) who found that sodium 
chloride, temperature and Tween-80 alter fatty acid membrane composition and 
modify the osmotic activation of betaine transport activity. The main modification in 
L. lactis membrane fatty acid composition in response to high osmolality is the 
increase of cyclopropane fatty acid (CFA), C19:0, whereas unsaturated/saturated 
ratio remains unchanged.  
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2.3 Metabolism of Lactococci 
         2.3.1 Carbohydrate metabolism 
                  The two major pathways for hexose (glucose) fermentation occuring within 
LAB, are homolactic fermentation and heterolactic fermentation. Homolactic 
fermentation follows the familiar Embden-Meyerhof-Parnas (EMP) pathway for 
glycolysis. Lactic acid is virtually the only end-product. The other fermentation 
pathway, the 6-phosphogluconate/phosphoketolase (6-PG/PK) pathway, leads to 
significant amounts of other end-products such as CO2 and ethanol in addition to lactic 
acid, and is referred to as a heterolactic fermentation.  
                  The metabolism of milk ingredients such as lactose, caseins, citrate, and 
other compounds by the two subspecies lactis and cremoris of L. lactis, provides the 
basis for the spontaneous and industrial fermentations of milk into sour milk, sour 
cream and many different types of cheeses. The production of acid from carbohydrates 
is an important and indispensable property used in the identification and 
differentiation of individual Lactococcus species (Wood and Holzapfel, 1995). The 
most important function of lactococci in industrial dairy fermentations is the 
fermentative conversion of lactose into lactic acid. The metabolic conversions 
included the lactose phosphotransferase system (PTS), the tagatose-6-phosphate 
pathway and the glycolytic pathway (Figure 2.4). The key enzymes in the utilization 
of lactose are induced during growth on lactose and often are located on plasmids 
(AkÇelik, 2001). Both fermentative pathways lead to the formation of L (+)-lactic acid 
which is excreted into the medium. A key compound in the intermediate metabolism 
in lactococci is pyruvate. Under normal anaerobic conditions of glycolysis, pyruvate is 
reduced to lactate by lactate dehydrogenase in order to regenerate NAD
+
, and serve as 
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an electron acceptor for the substrate level phosphorylation. The typical butter-flavor 
compound diacetyl is produced by the metabolism of citrate in L. lactis subsp. latis 
biovar. diacetylactis. This biovar is differing from normal L. lactis subsp. latis in that 
it possesses a plasmid encoded citrate permease. In citrate-utilizing L. lactis, citrate is 
converted initially into oxaloacetate and acetate by the enzyme citrate lyase. Acetate is 
a good indicator in citrate-containing cultures of homofermentative lactic acid bacteria 
that citrate is metabolized. Fermentation of citrate generally leads to a mixture of 
products including lactate, CO2, acetate, formate and C4-compounds (acetoin, 
diacetyl, and butanediol). 
 
 
 
 
 
 
 
 
Figure 2.4 Pathway of lactose utilization by L. lactis strains (Wood and Holzapfel,    
                  1995). 
 
         2.3.2 Nitrogen metabolism 
                  Generally, LAB has a limited capacity to synthesize amino acids using 
inorganic nitrogen sources. They are dependent on preformed amino acids being 
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present in the growth medium as nitrogen source. However, the requirement for amino 
acids differs among the species and strain variations exist within species. Cocaign-
Bousquet et al. (1995) studied the rational development of a simple synthetic medium 
for the sustained growth of L. lactis and found that the sustained growth of the 
vegetable strain, was only possible in minimal media supplemented with six amino 
acids (Glu, Met, Ile, Leu, Val, Ser), indicating that the definition of 
prototrophy/auxotrophy is partly dependent upon the medium composition. Growth of 
LAB on chemically defined minimal media is generally slow. In order to achieve a 
sufficient lactic fermentation, the dairy lactococci have developed a proteolytic 
system. All dairy lactococci used for acidification of milk (cheese manufacture) have 
proteolytic acitivity. An extracellular, membrane-anchored serine proteinase (PrtP) 
was identified as being essential for this activity. Several peptidases with different 
specificities have been identified in lactococci, but to date, all peptidases have been 
found to be intracellular. There are amino acids transport systems, two di- and 
tripeptide transport systems (DtpT and DtpP) and an oligopeptide transport system 
(Opp) accepting four to eight residue peptides. The transcription of 16 genes encoding 
12 peptidases, PI and PIII proteinases, and three transport systems of L. lactis MG1363 
in response to different environmental factors has been described by Guédon et al. 
(2001). Elevated temperature had no significant effect on the level of transcription of 
these genes PrtP1, prtP3, pepC, pepN, pepX while the opp-pepO1 operon was the 
most highly expressed genes in chemically defined medium, and their expression was 
repressed 5- to 150-fold by addition of peptide sources. 
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         2.3.3 Other metabolism 
                  For optimum growth, L. lactis requires biotin, pyridoxal, folic acid, 
riboflavin, niacinamid, thiamine, and pantothenate. Niacin, pantothenate and biotin are 
essential. Micronutrients should include molybdate, borate, cobalt, copper, manganese 
and zinc. 
2.4 Gene expression and gene regulation in LAB 
Gene expression in LAB has received much attention during the last decade. 
These studies have addressed transcription initiation and termination as well as 
translation initiation and codon usage (Kok, 1996). As with all organisms, gene 
expression systems in LAB may be divided into two categories, constitutive 
expression and controlled expression system (De Vos, 1999). Most of controlled 
expression systems were developed in L. lactis such as those based on promoters 
controlled by sugar (lactose operon promoter), by salt (gadC promoter), by 
temperature upshift (tec phage promoter), pH decrease (P170), and phage infection 
(phi31-promoter) (Renault, 2002; Grath et al., 2002). All of these systems are 
inducible expression systems. In addition, another controlled expression system is 
hierarchical control of carbohydrate utilization, which includes carbon catabolite 
repression (CCR) and integrates carbon-regulatory signals by using the HPr protein of 
the PTS system. 
         2.4.1 Inducible expression systems 
                  Sugar utilization has been widely studied in LAB because of its important 
role in the industrial fermentations. It is specifically controlled by a dedicated 
regulator (De Vos, 1999). The first system developed for controlled gene expression in 
lactic acid bacteria was based on components of the L. lactis lactose operon 
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(Djordjevic and Klaenhammer, 1998). They are organized in a 7.8 kb operon with the 
gene order lacABCDFEGX (De Vos and Gasson, 1989). Expression of the lac operon 
is regulated by the product of the lacR gene, which acts as a transcriptional repressor 
(Kok, 1996). The transcription of the lac operon is induced up to ten-fold during 
growth on lactose. Conversely, transcription of the lacR gene is similarly induced 
during growth on glucose (Van Rooijen et al., 1992). In addition, other sugar-
inducible expression systems are also used for study of gene expression in L. lactis. 
For example, during the utilization of sucrose by L. lactis, two divergently transcribed 
operons are involved, sacBK and sacAR. The expression of sac genes is repressed by 
the product of the sacR gene exhibiting homology to the LacI/GalR family of bacterial 
regulators (Luesink et al., 1999). In the absence of sucrose, the SacR binds to the 
operator sites of the sucrose operon leading to the transcriptional repression. The 
observed substrate induction and negative autoregulation of sacR by its gene product 
result in efficient transcriptional control of the sac genes in response to variations in 
extracellular sucrose concentrations. A new controlled production system to target 
heterologous proteins to cytoplasm or extracellular medium was also studied in L. 
lactis. In Lactococcus lactis NCDO2118, Miyoshi et al. (2004) demonstrated that a 
xylose-inducible nuc expression is tightly controlled and resulted in high-level and 
long-term protein production, and correct targeting either to the cytoplasm or to the 
extracellular medium. Furthermore, this expression system is versatile and can be 
switched on or off easily by adding either xylose or glucose, respectively.  
                  Generally, proteolysis in bacteria plays a central role in turnover, 
maturation, and regulation of proteins and in assimilation of extracellular proteins and 
peptides. The proteolytic system of lactococci is composed of an extracellular 
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proteinase, peptide transport systems, and intracellular peptidases. The regulation of 
the plasmid-encoded cell wall proteinase PrtP is one of the best known among the 
components of the proteolytic pathway in lactococci (Guédon et al., 2001). In several 
strains of L. lactis, the synthesis of the cell wall proteinase is reduced during growth in 
rich media compared with milk medium (Kok, 1996). Transcription regulation of the 
extracellular proteinase gene and the divergently transcribed genes required for 
proteinase production (prtP and prtM) of L. lactis SK11 has been investigated by 
Marugg et al. (1995; 1996). The results showed that a 10-fold repression of initiation 
of transcription was observed by adding a complex peptide mixture to the medium. A 
high-level production of prtP- or prtM- specific mRNAs was found in media with low 
peptide concentrations, while increasing of peptide concentrations resulted in an 
approximately eightfold decreasing in mRNA production. Furthermore, peptide-
dependent regulation of prt was examined by adding specific peptides to the growth 
medium. Out of 12 di- and tripeptides tested, only leucylproline and prolylleucine 
repressed the transcription of the prtP-gusA fusion (Marugg et al., 1995). Moreover, a 
systematic study of the transcription of 16 genes involved in the proteolytic system of 
L. lactis has been reported by Guédon et al. (2001). The transcription of several genes 
was found to be regulated by the peptide supply. Among these peptides, five 
promoters are repressed by specific dipeptides. On the other hand, pepP transcription 
is regulated by the carbon source. 
                  Amino acid biosynthesis results in a substantial energy demand and should 
be repressed when unnecessary. Conversely, in the absence of sufficient exogenous 
supply, biosynthesis should be rapidly induced and coordinated to achieve optimized 
growth of the cells (Chopin, 1993). The operons for three amino acid biosynthetic 
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pathways from L. lactis have been cloned, sequenced, and analyzed (Bardowski et al., 
1992, Delorme et al., 1992; 1993, Godon et al., 1992; 1993). Trytophan biosynthesis 
operon of L. lactis IL1403 contains seven structural genes in the order trpEGDCFBA 
and is preceded by a leader region containing a putative transcription terminator 
(Bardowski et al., 1992). The transcription pattern of the trp operon of      L. lactis and 
also three parameters controlling transcription have been described by Raya et al. 
(1998). These parameters were shown to differentially affect the amount of the 
transcripts, among which tryptophan depletion. Depletion in any amino acids increase 
transcription initiation about four-fold, and the amount of the trp transcript decreases 
abruptly upon entry of the cells into stationary phase. The branch chain amino acid 
(BCAA) pathway by which leucine, isoleucine, and valine are synthesized, has been 
widely studied in bacteria, fungi, and plants (Godon et al., 1992). In L. lactis subsp. 
lactis, the structural genes for BCAA synthesis are present in a single operon that also 
contains three additional genes, leu-ilv-ald operon (Goupil-feuillerat et al., 2000). The 
characterization of genes for the branched chain amino acids biosynthesis in L. lactis 
subsp. lactis NCDO2118 which is prototrophic strain, has been reported by Godon et 
al. (1992). The results showed that nine structural genes are clustered on a 12-kb DNA 
fragment in the order leuABCD ilvDBNCA. Upstream of these genes, the nucleotide 
sequence suggests the existence of regulation by transcriptional attenuation. In 
addition, leu genes from an auxotrophic dairy strain, IL1403, have also been cloned 
and sequenced (Godon et al., 1993). The results showed that the sequence is 99% 
homologous to the prototroph NCDO2118. Two nonsense mutations and two small 
deletions were found in the auxotroph sequence. Nevertheless, the leu genes from the 
auxotroph appear to be transcribed and regulated similarly to those from the 
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prototroph. The histidine operon of L. lactis NCDO2118 has the gene order 
hisCGDBHAFIE (Kok, 1996). Transciption of L. lactis his gene is controlled by the 
presence of histidine. The presence of histidine prevents the initiation of the 
transcription from the promoter upstream of the his operon. In addition, the 
transcription of the downstream genes may be controlled by transcription attenuation 
(Chopin, 1993). The organization of a cluster of L. lactis subsp. lactis NCDO2118 
genes, encoding eight of the nine histidine biosynthesis enzymes as well as six other 
genes of unknown function has been reported by Delorme et al. (1992). 
Complementation studies in B. subtilis and E. coli indicated at least seven his genes 
(hisC, -G, -D, -B, -A, -F and -IE) present within an 11-kb region. In addition, the 
histidine requirement of L. lactis dairy strains compared with nondairy strains has 
been described by Delorme et al. (1993). The results showed that among 60 dairy 
strains tested, 56 required histidine, whereas only 1 of 11 nondairy strains had this 
requirement. Moreover, 10 of 56 auxotrophic strains were able to grow in the presence 
of histidinol (Hol
+
), the immediate histidine precursor. This indicates that adaptation to 
milk often results in histidine auxotrophy. 
                  Environmental factors and growth condition such as pH, and temperature 
also affect gene expression through transcription and translation efficiency or stability 
of mRNAs. The pH of the medium plays an important role in gene expression by L. 
lactis. Sanders et al. (1998) demonstrated the nucleotide sequence and functional 
analysis of two genes transcribed from a chloride-dependent chromosomal promoter of 
L. lactis, gadC and gadB, and found that the expression of gadCB in L. lactis in the 
presence of chloride was increased when the culture pH was allowed to decrease to 
low levels by omitting buffer from the medium. Similarly, the presence of 0.5M NaCl 
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could induce that expression more than 1000-fold (Sanders et al., 1997). In addition, a 
chromosomal citM-citCDEFXG operon of L. lactis CRL264 has been described by 
Martín et al. (2004). This operon contains the genes encoding the three subunits of the 
citrate lyase. The increase of citM-citCDEFXG operon expression as well as the citrate 
lyase activity was observed when cells were grown under acidic pH conditions. 
Recently, Raynaud et al. (2005) studied the metabolic and transcriptomic adaptation of 
L. lactis subsp. lactis biovar diacetylactis in response to autoacidification and 
temperature downshift in skim milk. The induction of gene involved in alternative 
metabolic pathways derived from some glycolytic metabolites was observed just 
upstream of the postulated glycolytic bottlenecks, as a consequence of accumulation of 
these metabolites. Other transcriptional responses to autoacidification and to a 
decrease in temperature were induced at the end of the growth phase and were 
partially maintained during the stationary phase.  
         2.4.2 Hierarchical control of carbohydrate utilization 
                  Catabolic repression of operons is one of the important regulatory 
mechanisms observed for genes encoding enzymes that are involved in transport and 
metabolism of less preferred carbohydrates (Kowalczyk and Bardowski, 2007). It 
permits bacteria to select and utilize a carbon source in order to provide the fastest 
growth rate (Loll et al., 2007). The presence of a rapidly metabolizable carbon source 
in the growth medium of bacteria reduces the expression of genes involved in the 
utilization of other carbon sources. In Gram-positive bacteria, it has been established 
that carbon catabolite repression (CR) is mediated via a negative regulatory 
mechanism. Carbon catabolite control protein A (CcpA) is the main regulator involved 
in carbon catabolite repression and highly conserved in Gram-positive bacteria (Gaudu 
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et al., 2003 and Zomer et al., 2007). Recently, a comparison of the transcriptome data 
with putative CcpA binding site (cre site) in promoter sequences in the genome of L. 
lactis has been described by Zomer et al. (2007). The main differences in time-
dependent expression of CcpA-regulated genes were observed between the 
exponential and transition growth phases. Large effects of carbon and nitrogen 
metabolic genes were obtained in the exponential phase. Effects on nucleotide 
metabolism genes were observed primarily in the transition phase. Furthermore, gel 
retardation experiment, northern blotting, and enzyme assays showed that CcpA is 
subject to autoregulation in L. lactis. In addition, Luesink et al. (1998) has described 
the L. lactis ccpA gene and also the effects of its disruption on the catabolite repression 
of the galAMKTE genes involved in galactose catabolism. The result showed that 
CcpA can act as an activator of transcription of the las operon, containing the pfk, pyk 
and ldh genes encoding the key glycolytic enzymes phosphofructokinase, pyruvate 
kinase and L-lactate dehydrogenase, respectively, involved in energy production and 
lactic acid formation by L. lactis. Moreover, the involvement of HPr in the catabolite 
repression of galactose metabolism has been described by Luesink et al. (1999). The 
expression of the L. lactis ptsHI operon is regulated at the transcriptional level in 
response to the carbon source, since transcription levels were at least 10-fold higher in 
glucose-grown cells than in galactose-grown cells. 
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2.5 Trancriptome analysis 
         2.5.1 Purpose of transcriptome analysis 
                  Many cellular processes are regulated at the transcriptional level. For this 
reason the transcriptome of a cell, the total set of RNAs under a specific condition, 
contains information on the biological state of the cell and the genes that play a role 
under specific circumstances. Transcriptomics is the research method that studies the 
effect of specific conditions on alterations in the expression levels of complete sets of 
genes. A certain number of classical analyses allow the study of gene transcription. 
The technique of Northern blotting can be used to identify the tissues or stages 
wherein a gene is transcribed, and the size of the messenger (Bernot, 2001). In 
Northern blot analyses or multiple Northern blots, it is only possible to determine the 
expression of one or a few genes (David et al., 2005). The challenges of the global 
approach are being overcome with the development of omic tools, such as those 
provided by microarray technology, which can enable the analysis of thousands of 
genes in parallel by specific hybridization to a miniaturized, orderly array of DNA 
fragments. Microarrays contain grids of up to tens of thousands of array elements 
presented in a miniaturized format (Sensen, 2005). For DNA microarrays, those array 
elements or spots comprise minute amounts of DNA that have been either laid down 
robotically or synthesized in situ at precise locations on a solid support. These arrays 
are interrogated by allowing their immobilized sequences to hybridize by Watson-
Crick base-pairing with labeled nucleic acids derived from the samples of study. The 
intensity of hybridization over individual spots is a measure of the amount of 
homologous sequence in the sample and an array can be made to cover the entire 
known expressed gene content of an organism. Unlike the genome, the transcriptome 
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is highly dynamic and changes rapidly and dramatically in response to perturbations or 
even during normal cellular events such as DNA replication and cell division 
(Lockhart and Winzeler, 2000). This has allowed intraspecies comparative genomics 
studies as well as functional genomics studies aimed at a better understanding of 
physiological processes and regulatory networks operating in lactococci. Kuipers et al. 
(2002) described the initial set-up of a DNA microarray to enable transcriptome 
analysis of various Gram-positive bacteria, including a ssp. lactis and a ssp. cremoris 
strain of L. lactis.  
        2.5.2 Application of transcriptome analysis in Lactococci  
                  The availability of genomic information on lactococcal and other bacterial 
species has opened the way for a number of analytical and experimental approaches, 
which were impossible to perform without this data. Genome mining and comparison 
studies yield valuable information on the presence or absence of certain features 
among lactococci, as well as on evolutionary phenomena. Currently, their 
physiological features, which include substrate utilization, stress response, metabolic 
capabilities, population interaction, and probiotic properties (Zhu et al., 2009) and 
molecular biology, give a particular characterization to LAB, and as a result there are 
many applications in a broad range of studies. There are three major types of 
applications of transcriptome anlaysis in lactococci as follows: 
                  2.5.2.1 Transcriptomics to study diversity and evolution 
                           Members of the LAB group have close phylogenetic relationships 
largely due to their sharing relatively small, AT-rich genomes (~2.4 Mb) and common 
metabolic pathways (ósullivan et al., 2009). Despite their phylogenetic closeness, the 
LAB occupy a diverse set of ecological niches including fermenting plants, milk, 
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wine, sour-dough, the human and animal GI tract and the oral cavities of vertebrates. 
Such niche diversity among closely-related species suggests considerable genetic 
adaptation during their evolution. Comparative genome hybridization (CGH) has been 
used to assess the plasticity of bacterial genome structures in closely related 
microorganism to deduce the evolutionary relatedness of LAB or to understand the 
genetic diversity (Van Hijum et al., 2008). Recently, an extensive whole-genome 
diversity analysis on 39 of L. lactis strains, isolated from dairy and plant sources has 
described by Siezen et al. (2010). Comparative genome hybridization analysis with 
multi-strain microarrays was used to assess presence or absence of genes and gene 
clusters in these strains, relative to all L. lactis sequences in public databases, whereby 
chromosomal and plasmid-encoded genes were computationally analyzed separately.  
                  2.5.2.2 Transcriptomics to study adaptation, regulation and stress 
response 
                           LAB is widely found in different environments where they have 
adapted to varying conditions, such as extreme pH and changing availability of 
nutrients. Functional analysis of gene expression using metabolic and transcriptomic 
could provide insight into adaptation for autoacidification, temperature downshift and 
also regulation mechanism of L. lactis subsp. lactis biovar diacetylactis strain in skim 
milk (Raynaud et al., 2005) as well as in L. lactis IL1403 (Redon et al., 2005 ) during 
carbon starvation. Moreover, transcriptomics analysis has given the possibility to look 
at gene regulatory networks that are operative in the organism under study. Guédon et 
al. (2002) reported potential regulators in Lactococcus lactis IL1403. Among these 
regulators, most could have a direct role as transcriptional regulators, while the others 
may have less well defined functions in transcriptional regulation or more general 
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functions, such as the GTP binding protein family. Moreover, many L. lactis 
regulators have functions that could not be proposed by transposition of the knowledge 
currently available in other bacteria.  
                  2.5.2.3 Transcriptomics to study the analysis of cell-cell interaction 
                           Concern about growth and survival of LAB in several complex 
ecosystems, including starter and non-starter cultures in fermented foods as well as the 
GI tract have prompted interaction with other LAB, the natural microbiota and 
sometimes spoilage bacteria within the fermented product (Siezen et al., 2004). While 
Nouaille et al. (2009) were investigating the transcriptomic response of a dairy strain 
of L. lactis in mixed culture with the food pathogen, Staphylococcus aureus, they 
observed an advanced decrease of the growth rate regulon in the earlier carbon 
limitation due to consumption of glucose by both species. In addition, Maligoy et al. 
(2008) performed extensive studies on the transcriptome analysis of L. lactis in co-
culture with Saccharomyces cerevisiae. They revealed that the mRNA levels were 
significantly modified between the pure and the mixed cultures of L. lactis. These 
changes in transcript abundance were demonstrated to be regulated by the ethanol 
produced by the yeast. 
 
 
 
 
 
 
  
 
 
 
 
 
 
CHAPTER III 
MATERIALS AND METHODS 
 
3.1 Microorganisms 
 The six strains of L. lactis subsp. lactis UCMA5713, LD55, LD61, LL08, LL5- 
2 and S86, isolated from milk have been selected for their genetic diversity in a 
national research program (ANR Ge
´
noferment). These strains were isolated from 
various origins (places and sources). These strains were kept and obtained from the 
Laboratory of Institut National des Sciences Appliquées, Toulouse, France. These 
strains were maintained on CDM medium supplemented with 20% glycerol and were 
stored at -80 
o
C until used.   
3.2 Materials, Media and Chemicals 
 3.2.1 Materials 
  3.2.1.1 L. lactis IL-1403-specific PCR product was provided by 
Eurogentec and spotted in duplicate on positively charged nylon membrane (Roche) 
by the biochips platform (Four deposits per spot; Toulouse Genopole, France). A total 
of 1,948 Open Reading Frames (ORFs) identified in the genome were effectively 
available on these membranes (Bolotin et al., 2001). 
3.2.1.2 Primers used for real-time PCR were purchased from Eurogen- 
tec as shown in Table C1 (Appendix C). 
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3.2.2 Microbiological media 
  The main media of microbiological preparation, CDM medium, are 
given in Appendix A as described by Otto et al. (1983) and modified by Poolman and 
Konings (1988) as well as MS13R preparation was shown in the Appendix A as 
described by Novak et al. (1997). M17 broth was purchased from Difco and was kept 
at 4 
o
C until used. 
 3.2.3 Chemicals 
  3.2.3.1 Chemicals for CDM preparation 
   Glucose, sodium acetate, KH2PO4, K2HPO4, MgCl2.6H2O, 
FeSO2.7H2O, CoCl2. 6H2O were purchased from Prolabo. Ammonium citrate was 
purchased from Sigma. CaCl2. 2H2O was purchased from Panreac. ZnSO4.7H2O was 
purchased from Carlo erba. For the amino acids such as alanine, asparagines, 
glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, proline, serine, 
threonine, tryptophane, valine were purchased from Sigma whereas arginine was 
purchased from Fluka. Phenylalanine was purchased from Fluka whereas tyrosine was 
purchased from sigma. For all bases includes adenine, guanine, urcile, xanthine, 
inosine, and thymidine were purchased from Sigma as well as all vitamins such as P-
aminobenzoic acid, biotine, cyano-cobalamine (B12), folic acid, nicotinic acid, orotic 
acid, calcium-pantothenate, pyridoxamine, pyridoxine, riboflavine, thiamine, DL-6,8-
thioctic acid were obtained from Sigma. Cysteine was purchased from Fluka.  
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  3.2.3.2 Chemicals for chromosomal DNA extraction  
   Tris-(hydroxymethyl) aminomethane (Tris) was purchased from 
Prolabo. Sucrose was purchased from Merck. Proteinase K was purchased from 
Euromedex. Lysozyme was purchased from Sigma. Rnase A was purchased from 
Qiagen. 
  3.2.3.3 Chemicals for transcriptome analysis (membrane) 
   Superscript II Rnase H
-
 reverse transcriptase, dNTP, randome 
primer, RnaseH were purchased from Invitrogen Life Technologies. dCTP [α-P33] was 
purchased from Perkin whereas specific primer was purchased from Eurogentec. 
Microspin G25 columns was purchased from Amersham Biosciences. NaH2PO4.2H2O, 
Na2HPO4.12H2O, sodium chloride, EDTA, and Tris were purchased from Prolabo 
whereas Ficoll 400 and 20% SDS were purchased from Eurobio. Polyvinylpyrrolidone 
and BSA were purchased from Sigma.   
3.3 Instrumentation 
 Instruments required for analysis the biodiversity of Lactococcus lactis strains 
by transcriptomic approach such as the cultivation of microorganisms in different 
media, genomic DNA extraction, cDNA preparation, reverse transcription and labeling 
were mainly located at the Laboratoire Biotechnologie Bioprocédés, Institut National 
des Sciences Appliquées, Toulouse, France. Some instruments required for assessment 
of the quantity and purity of the total RNA, assessing of the quantity of DNA, 
detection of the hybridization signals located at Instrument Buildings of Plateforme 
Génomique, Toulouse, France.  
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3.4 Cultivation of the strains in UF-cheese model 
         Strains were cultured on skimmed raw milk ultrafiltration (UF) retentate. The 
UF retentate was pre-incubated overnight at 4 
o
C, then 45 minutes at 50 
o
C and 
homogenized during 1.5 minutes at 24,000 rpm with an ultra-turrax (Imlab, France). 
After addition of rennet (0.3 µl ml
-1
), 400 g of UF retentate was inoculated at 2 x 10
6
 
CFU/g with L. lactis subsp. lactis strains. After incubation for 8 hours at 30 
o
C, the 
cheeses were transferred at 12 
o
C during 7 days for simulation of ripening. Their 
ability to grow and acidify was compared all along the cheese repining. 
3.5 Cultivation of the microorganisms 
 3.5.1 Cell pre-culture 
  The six strains of Lactococcus lactis subsp. lactis (0.3 ml from 
cryotube) were inoculated into six bottle containing 10 ml of the Chemical Defined 
Medium (CDM) medium, described by Otto et al (1983) and modified by Poolman & 
Konings (1988), and then incubated overnight at 30 
o
C under a nitrogen atmosphere 
with an agitation speed of 250 rpm and used as first pre-culture. The cultured broth 
was then measured for optical density at 600 nm to obtain an initial OD600 of 0.1 as 
described in the formular (Appendix B). Then, it was transferred to the test tube 
containing 10 ml of CDM. Growth of the tested microorganisms was measured by 
spectrophotometer at the wavelength of 600 nm and subsequently used as an 
inoculum. 
 3.5.2 Cell cultivation 
  After growth cell entered to the logarithmic phase, the suspensions 
were then inoculated to test tubes under controlled gas environment by flushing with 
nitrogen. These tubes containing 10 ml of CDM and then incubated without shaking at 
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the same condition as described above. These tubes were prepared in duplicate. 
Bacterial growth was estimated by spectrophotometer at 600 nm. Afterwards, cultures 
were measured for pH and cells were collected by centrifugation at 5,000 rpm for 10 
min. Supernatant and cell pellet were kept at -20 
o
C for further study.   
3.6 Measurement of pH 
 All pH measurements were determined using a Metrohohm pH meter which 
was calibrated prior to use by using pH 4.0 and 7.0 buffers. 
3.7 Growth ability of the microorganism in different media 
 The six strains of Lactococcus lactis subsp. lactis were grown in different 
media. These media included M13 and M17. 
 3.7.1 Cultivation of the strains in the M13 medium 
  3.7.1.1 Cell pre-culture 
   These strains from the cryotube (0.3 ml) were inoculated into 
the anaerobic test tubes which flushing with nitrogen gas, containing 20 ml of CDM 
medium supplemented with 5% glucose. The control contained no strain. They were 
incubated in the rotary shaker under the condition as described above for overnight. 
The cultured broth was then measured for optical density at 600 nm until an initial 
OD600 of 0.1 was obtained and subsequently used as an inoculum.  
  3.7.1.2 Cell cultivation 
   Five milliliters of culture broth were added to the 15 ml of 
Falcon tube, and then the cells were harvested by centrifugation at 5,000 rpm for 10 
min at 4 
o
C. The cell pellet was washed with a 0.9% NaCl solution twice and collected 
cell by re-centrifugation in the same condition. The pellets were then re-suspended in 
5 ml of NaCl, and mixed well with pipette. The cell suspensions were subsequently 
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transferred to 10 ml of M13R medium. These tubes were prepared in duplicate. The 
growth culture was measured with spectrophotometer at the wavelength of 600 nm. 
Cell suspension was also measured for pH and harvested by centrifugation at the same 
condition as described above. The supernatant and the cell pellet were kept at -20 
o
C 
for further study.   
 3.7.2 Cultivation of the strains in the M17 medium 
  3.7.2.1 Cell pre-culture 
   The strains (0.3ml) from cryo-tube were inoculated into six 
bottle containing 20 ml of M17 medium supplemented with 1% of glucose under  
controlled gas environment by flushing with nitrogen gas. These bottles were 
incubated in a rotary shaker, 250 rpm, at 30 
o
C overnight. They were then measured by 
spectrophotometer at the wavelength of 600 nm to obtain an initial OD600 of 0.1 as 
described in the formular (Appendix B).  Then, the cultured broth was inoculated into 
six bottle containing 25 ml of M17 medium supplemented with 1% glucose under the 
same control condition as described above. They were incubated in a rotary shaker, 
250 rpm, at 30 
o
C. The growth culture was measured by spectrophotometer at the 
wavelength of 600 nm until an initial OD600 of 0.1 was obtained and subsequently 
used as an inoculum.  
  3.7.2.2 Cell cultivation 
   The culture broth was inoculated into test tube containing of 10 
ml of the same medium containing 1% of glucose. These tubes were prepared in 
duplicate and they were incubated at 30 
o
C without shaking. The growth was measured 
by spectrophotometer at the wavelength of 600 nm. Cell suspension was measured for 
pH and harvested by centrifugation at the same condition as described above. In 
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addition, the culture broth was also inoculated in bottle containing 50 ml of the same 
medium supplemented with 1% glucose (3 bottles/ strain). The bottles were incubated 
and the cultures were measured for growth at the same condition as mentioned above. 
Then, the cells of the tested microorganism were harvested by centrifugation at 5,000 
rpm at 4 
o
C for 10 min. The supernatant and the cell pellet were kept at -20 
o
C for 
further study.   
 3.8 Transcriptomic analysis of Lactococcus lactis subsp. lactis strains
 3.8.1 RNA extraction 
  Total RNA was extracted from cells grown for 24 h in UF-cheese (Ulve 
et al., 2008). 
 3.8.2 Assessing the quantity and purity of total RNA 
  RNA was spectophotometrically quantified (at 260 and 280 nm) by 
using the NanoDrop (ND1000) spectrophotometer and the integrity of total RNA was 
assessed on Agilent 2100 bioanalyzer (Nanopuce). 
 3.8.3 cDNA preparation 
  cDNA was synthesized from RNA in the mixture containing 10 µg of 
total RNA and mixed with 1 µl of random hexamer primers (500 ng/µl), and 1 µl of L. 
lactis specific primers (500 ng/µl). Then, the sterile water was added to a final volume 
of 24 µl. The mixture was incubated at 70 
o
C for 5 min in the water bath and then 
cooled down rapidly on ice. Reverse transcription was performed for 1 h at 42 
o
C with 
1.5 µl of SuperScriptII reverse transcriptase (200 U/µl), 5 µl of dithiothreitol (0.1M), 
1.5 µl of each dATP, dGTP, dTTP (10 mM), 5 µl of [α-33 P]-dCTP (10µCi/µl) and 10 
µl of 5x first strand buffer. After one hour, 0.5 µl of unlabeled dCTP (10mM) and 0.5 
µl of SuperScriptII were added and then the reaction was carried out for one more 
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hour at 42 
o
C. The reaction was stopped by heating at 70 
o
C for 15 min and the 
remaining of the RNA was hydrolyzed by RNaseH (2 U) at 37 
o 
C for 20 min and then 
stored in ice until cDNAs purification. Before hybridization, labeled cDNA was 
purified by using Microspin G25 columns (Amersham Biosciences) according to the 
manufacturer’s instructions.  
 3.8.4 Hybridization and detection  
  Prior to hybridization, membranes were washed for 5 min at room 
temperature in 50 ml of 2X SSPE (1X SSPE; 0.18 mM NaCl, 1 mM EDTA and 10 
mM phosphate buffer, pH 7.7) and prehybridized for 2 to 4 h at 68 
o
C in 5 ml of 
hybridization buffer (5X SSPE, 2% SDS, and 1X Denhardt’s reagent). Labeled cDNA 
was heated for 10 min at 95 
o
C and then cooled down rapidly to 4 
o
C for 5 min. The 
whole sample was collected by centrifugation. Afterwards, membrane hybridization 
was carried out for 14 to 16 h at 68 
o
C with 5 ml of hybridization buffer containing 
labeled and denatured cDNA. Membranes were washed three times with 50 ml of 
washing solution (0.5X SSPE and 0.2% SDS) for 5 min at room temperature and three 
times with 50 ml of preheated washing solution for 20 min at 68 
o
C. After 
hybridization, dried membranes was exposed to a phosphorimaging screen for 3 days 
and scanned with a phosphofluoroimager (Storm scanner; Amersham Biosciences).  
3.9 Comparative genomic hybridization (CGH) 
 3.9.1 Genomic DNA extraction 
  Pellet of the six strains were resuspended with TE buffer (Tris 10 mM, 
EDTA 10 mM), whereas two hundred microliters of an aliquote of L. lactis subsp. 
lactis IL1403 were inoculated in M17 medium supplement with 1% glucose and used 
as reference strain.  The cultured broth of IL1403 strain was incubated at 37.5 
o
C, 
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overnight. Two milliliters of the suspension were pipetted into the eppendrof tube (3 
repetition/strain) as well as four milliliters of IL1403 suspension were taken to 
eppendrof tube. Afterwards, cells were collected by centrifugation at 14,000 rpm for 3 
min. The pellet was then suspended in 250 µl of Solution C1(set-lysozyme-RNase: 
20% Saccharose, 50 mM Tris, pH7.5, 5 mM EDTA, 1 mg/mL of Lysozyme and 10 
Unit/mL of RNase) and incubated in the water bath at 37 
o
C for 1.5 h. The cell 
suspensions were subsequently suspended with solution C2 (Tris-EDTA-SDS: 10 mM 
Tris, pH 8, 5 mM EDTA, 1% SDS) and then vigorously mixed. One hundred 
microliters of Proteinase K (concentration 4 mg/mL of TE) were added to the 
suspension and incubated in the water bath at 55 
o
C for overnight. 
Phenol/chloroform/isoamyl alcohol (500 µl), pH 7.8 were added to the suspension and 
then vigorously mixed by hand and vortex for 1 min. Afterwards, the cell suspensions 
were harvested by centrifugation at 14,000 rpm for 10 min. The aqueous phase at the 
top was transfered to the new eppendrof and then re-extract with 500 µl of 
phenol/chloroform/isoamyl alcohol for 2 to 3 times. Furthermore, five hundred 
microliters of isopropanol were added and collected by centrifugation again at the 
same condition as described above for 3 min at room temperature. The pellet was 
suspended in 150 µl of LiCl (0.4M) and then mixed with pipette. The cell pellet was 
subsequently added with ethyl alcohol (70%) and harvested by centrifugation at 
14,000 rpm for 3 min at 4 
o
C.  Pellet was mixed with 100 µl of TE buffer, and 
quantified the DNA by loading on the gel agarose. 
 3.9.2 Genomic DNA fragmentation 
  Eighty micrograms per milliliter of genomic DNA was diluted with 
sterile water in the eppendrof.  The diluted sample DNA was sonicated at 20 units 
  
 
 
 
 
 
 
59 
 
speed for 5 min. The sonicate probe was dipped into the DNA solution for a minute 
and then left for 5 min. DNA solution was stored on ice during the time of operation. 
This method was performed to obtain 500 bp genomic DNA in length in all strains. 
The size of fragmented genomic DNA was confirmed by 1.5% of agarose gel 
electrophoresis. 
 3.9.3 Assessing the quantity of DNA 
  DNA was quantified by using the NanoDrop (ND1000) spectrophoto-
meter at 260 and 280 nm. 
 3.9.4 DNA labeling 
  Two micrograms of diluted DNA were pipetted into 31 µl of sterile 
water in microtube. They were heated in the boiling water for 5 min and then were 
rapidly placed on ice at 4 
o
C for 5 min. The suspension was collected as briefly at 4 
o
C. Reaction was performed by adding 1 µl of random primers (500ng/ µl), 1 µl of 
specific primers of  L. lactis (500ng/ µl), 5 µl of Ecopol buffer, 1.5 µl of each dATP, 
dTTP and dGTP (1mM), 5 µl of [α33P] dCTP and 1 µl of Klenow fragment of DNA 
polymerase I. The reaction was incubated at 37 
o
C for 1 h. The reaction was stopped 
by putting on ice and spinned the sample at 3,800 rpm for 2 min. Afterwards, the 
labeled DNA was purified by using Microspin G25 columns (Amersham Biosciences) 
according to the manufacturer’s instructions.  
 3.9.5 Hybridization and detection  
  Prior to hybridization, membranes was washed for 5 min at room 
temperature in 50 ml of 2X SSPE (1X SSPE; 0.18 mM NaCl, 1 mM EDTA and 10 
mM phosphate buffer, pH 7.7) and prehybridized for 2 to 4 h at 68 
o
C in 5 ml of 
hybridization buffer (5X SSPE, 2% SDS, and 1X Denhardt’s reagent). Labeled cDNA 
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was heated for 10 min at 95 
o
C and then cooled down rapidly to 4 
o
C for 5 min. The 
whole sample was collected by centrifugation. Afterwards, membrane hybridization 
was carried out for 14 to 16 h at 68 
o
C with 5 ml of hybridization buffer containing 
labeled and denatured cDNA. Membranes were washed three times in 50 ml of 
washing solution (0.5X SSPE and 0.2% SDS) for 5 min at room temperature and three 
times in 50 ml of preheated washing solution for 20 min at 68 
o
C. After hybridization, 
dried membranes was exposed to a phosphorimaging screen for 3 days and scanned 
with a phosphofluoroimager (Storm scanner; Amersham Biosciences).  
3.10 Data analysis 
 Hybridization signals were quantified and assigned to gene names with the 
Bioplot software developed by Sokol, S. in Plateforme Génomique, Toulouse. Three 
individual repetitions were made for experiment. Local background was removed from 
all spot intensities. 
For transcriptomic experiments, signals were normalized by the mean intensity  
of the corresponding membrane. Expression ratios were calculated between the strain 
of interest and strain LD61 which was considered as the reference for expression 
studies in milk (Raynaud et al., 2005). In order to be compared, transcriptomic 
analysis were performed in parallel for all the strains in a same series and repeated 
three times independently. The statistical significance of expression ratios was 
evaluated using False Discovery Rate (FDR) calculations and a statistical threshold of 
7%. In order to determine expression changes at the level of the functional 
(sub)categories (global tendencies), over- and under-expressed gene enrichments in 
the different groups were calculated with the Wilcoxon test. This test was performed 
without any a priori selection of expression data and we have considered a significant 
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p-value of 5% (Dressaire et al., 2008). The classification of Bolotin and co-worker 
was used (Bolotin et al., 2001). 
For CGH experiments, genes were declared as absent or highly divergent if 
they were detected as absent by all the three statistical methods (a, b and c). In the 
statistical method a, genes corresponding to spot intensities less than a cut-off value in 
at least two repetitions out of three were declared as absent. For each membrane, a cut-
off value was defined as the detection limit plus two times its standard deviation. The 
detection limit of each membrane was calculated as the mean intensity of the 178 
empty spots (spots containing no probe). The b and c statistical treatments were 
performed on whole detected spots without any previous selection. In this case the 
ratios of the signal intensities were calculated between the studied strain and the 
sequenced reference strain, IL1403 (Bolotin et al., 2001), after subtraction of the local 
background and signal normalisation. Two normalisation methods were used: either 
by the mean intensity of the corresponding membrane (method b) or by the intensities 
of a subset of conserved genes with minimal sequence divergence between the 
samples analyzed (method c) (Van Hijum et al., 2008). We chose the subset of 57 
conserved genes previously identified for L. lactis strains by van Hijum and co-
workers using three Streptococcus strains as reporter genomes, and we removed four 
genes (atpA, rplW, rpmC and ychH) from this subset because they were missing on our 
membranes. Absent genes were those corresponding to ratios of normalized intensities 
(strain of interest compared with IL1403) lower than 0.5. This threshold of 0.5 was 
chosen because it was previously used in CGH data analyses (Fukiya et al., 2004; 
Taibi et al., 2010).  
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Genes were declared to be divergent when the ratios of their normalized 
intensities (compared to IL1403) by method c were lower than 0.76. The 0.76 criterion 
was chosen after estimation of the average technical variation of the signal ratios using 
three independent repetitions of each tested strain. However, it should be kept in mind 
that the number of divergent genes could be biased, since low CGH ratios could also 
result from artifacts (cross-hybridization with another gene in the genome, small GC- 
rich region).  
ORFs detected as absent with all statistical approaches (low spot intensity and 
low intensities ratios with both normalisations) were subjected to PCR-amplification 
using the genomic DNA preparation already used for CGH experiments. Primers were 
those previously designed by Eurogentec. Taq polymerase (NewEngland BioLabs) and 
Phusion polymerase (Finnzymes) were used, and the hybridization temperature was 
ranging between 42 and 55 
o
C.  
Clustering analysis was performed with the R free statistical software 
(http://www.r-project.org/) to find the clusters of genes that have similar expression 
profiles compared with the reference strains. 
3.11 Real time PCR 
          Samples of 10 µg of total mRNA were retrotranscribed by using 2 l of random 
primer, each deoxynucleoside triphosphate (0.3 mM), and superscript II transcriptase
 
(6U l-1; Invitrogen) (Maligoy et al., 2008) and incubated for 1 h at 42 oC. The 
reaction was stopped by incubation for 15 min at 70 
o
C. RNaseH (0.05U; Invitrogen) 
was added before purification of cDNA by Microspin G25 columns (Amersham 
Biosciences). Primers for real-time PCR (Appendix C) were designed with Bio-Rad 
Beacon Designer software to have
 
lengths of 20 to 25 bases with GC contents of more 
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than 50%, and
 
melting temperatures of about 60 °C. The primer used for amplifying 
the PCR products
 
of 88 to 145 bases long. The specificities of the primers for
 
the genes 
of interest were controlled by using the L. lactis
 
IL1403 genome with Vector NTI 
software (Invitrogen). Real-time PCR was carried out on a MyIQ
 
unit with Sybr green 
supermix (BioRad). After cDNA was diluted, 5 l was added to 20 l of PCR mixture 
(12.5 l Sybr green supermix, 4 l of primer at 10 M, and 3.5 l of RNase-free 
water). Three or four dilutions of cDNA were performed to determine the efficiencies 
of real-time PCR. A negative control was replaced by water. Thermal cycling 
conditions were denaturation at 95 
o
C for 3 min and 40 repeats of 95 
o
C for 15 s and 
60 
o
C for 45 s and annealing step where fluorescence measurements were recorded. 
The pbp2A and smc genes were chosen as internal normalization controls, since they 
did not show significant expression variation in these experiments. The
 
Pfaffl analysis 
method (Pfaffl, 2001) was used to calculate the change
 
in transcript levels between 
strains UCMA5713, LD55, LL08, LL52, and S86 and the reference strain LD61. Four 
genes (yaiA, feoA, ipd and pyrR, coding for hypothetical protein, ferrous ion transport 
protein, indole-3-pyruvate decarboxylase and bifunctional pyrimidine regulatory 
protein PyrR uracil phosphoribosyltransferase, respectively) were tested, and three 
independent measurements were performed for each genes between the interesting 
strain and the reference strain (LD61). For direct comparison
 
with transcriptomic data, 
quantitative reverse transcription-PCR
 
results were expressed as ratios in transcript
 
concentrations between the strain of interest and the reference strain, corrected
 
by 
using the pbp2A or smc normalization ratios.  
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3.12 Physiological characteristics analysis of L. lactis subsp. lactis 
 3.12.1 Cultivation of microorganisms 
  3.12.1.1 Cell pre-culture 
     The six strains of Lactococcus lactis subsp. lactis (0.15 ml) 
from stock solution in the cryotube were inoculated in bottle containing 10 ml of CDM 
in anaerobic conditions under the nitrogen atmosphere and were incubated in a rotary 
shaker, 250 rpm, at 30 
o
C overnight. The growth culture was measured by 
spectrophotometer at the wavelength of 600 nm until the initial OD600 of 0.1 was 
obtained. Then, it was transferred to the anaerobic tubes containing 10 ml of CDM 
under the nitrogen atmosphere. The culture was incubated at the temperature of 30 
o
C 
with agitation speed of 250 rpm overnight. Growth of the tested microorganism was 
measured by spectrophotometer at the wavelength of 600 nm and subsequently used as 
an inoculum. 
  3.12.1.2 Cell cultivation 
     The suspensions were inoculated to test tubes which controlled 
gas environment by flushing with nitrogen gas. These tubes containing 10 ml of CDM 
and then incubated without shaking at the same condition as described above. These 
tubes were carried out in duplicate. The growth culture was measured by 
spectrophotometer at the wavelength of 600 nm. Afterwards, cells were measured for 
pH and collected by centrifugation at 5,000 rpm for 10 min. Supernatant and cell pellet 
were kept at -20 
o
C. 
 3.12.2 Test for purine biosynthesis 
  The six strains of L. lactis subsp. lactis were determined for growth 
ability in CDM medium under the different conditions as following; without purine 
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base or without pyrimidine base or without both nitrogenous bases. The control 
contained only bases in the medium. Afterwards, the cell culture was incubated at the 
same condition as described above. The culture was carried out in duplicate. The 
growth culture was measured by spectrophotometer at the wavelength of 600 nm. 
Cells were measured for pH and collected by centrifugation at 5,000 rpm for 10 min. 
Supernatant and cell pellet were kept at -20 
o
C. 
 3.12.3 Test for branch chain amino acid (BCAA) requirement 
  L. lactis subsp. Lactis for the six strains were determined for amino 
acid requirement by growing the strains in the CDM medium under various conditions 
as following; without isoleucine, without leucine, without valine, and without all 
BCAA. The control contained only branch chain amino acids. The culture was carried 
out in duplicate. The growth culture was measured by spectrophotometer at the 
wavelength of 600 nm. Cells were measured for pH and collected by centrifugation at 
5,000 rpm for 10 min. Supernatant and cell pellet were kept at -20 
o
C. 
  
 
 
 
 
 
 
CHAPTER IV 
RESULTS 
  
4.1 Phenotypic analysis of the strains in different media 
Six strains of L. lactis subsp. lactis, namely UCMA5713, LD55, LD61, LL08, 
LL52 and S86 were selected from the Génoferment culture collection to assess the 
intra-subspecies diversity at the phenotypic levels. Five strains (LD55, LD61, LL08, 
LL52 and S86) were typically found in dairy fermentations but one, strain 
UCMA5713 was a plant-associated strain isolated from the French Normand meadow 
(Table 4.1). Strain LD61 is the reference strain usually used in dairy industry.  
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     Table 4.1 Strain origins, genomic characteristics and taxonomy.  
Strains 
 
Origins 
Eco R1 
Ribotype 
Chromosome  
size 
(Mb) 
Biovar 
diacetylactis
1
   
S86 
Starter  
(France) 1797-S-1 2.482 ± 35 
 
No 
LD55 
Camembert  
(Normandy, France) 1797-S-4 2.595 ± 93 
 
No 
LD61 
Soft cheese starter 
 (France) 58-S-6 2.579 ± 59 
 
Yes 
LL08 
Raw milk  
(Normandy, France) 199-S-7 2.545 ± 33 
 
No 
UCMA5713 
Grassland  
(Normandy, France) 1797-S-1 2.362 ± 14 
 
No 
LL52 
Soft cheese stater  
(France) 199-S-7 2.677 ± 27 
 
No 
       1
: results from Passerini et al. (2010) who revisited the definition of the biovar diacetylactis     
      and positioned the six strains in this taxonomy. 
 
4.1.1 Phenotypic analysis of the strains in UF-cheese model 
    The present study was performed to see ability of these strains to grow and 
acidify in UF-cheese model. Strains were cultured on skimmed raw milk 
ultrafiltration (UF) retentate. After pre-incubated overnight at 4 
o
C, then 45 minutes at 
50 
o
C, the cultures were homogenized during 1.5 minutes at 24,000 rpm with an ultra-
turrax (Imlab, France). The homogenized-cultures were subsequently added with 
rennet, then UF retentate was inoculated at 2 x 106 CFU/g with L. lactis subsp. lactis 
strains.  After incubation for 8 hours at 30 
o
C, the cheeses were transferred at 12 
o
C 
during 7 days for simulation of ripening as described above. Their ability to grow and 
acidify this medium was compared all along with the cheese repining (Figure 4.1). 
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    Results shown in Figure 4.1 revealed that the cell population profiles were  
similar for all strains, leading to a constant value ranging between 1.9 and 2.3 x 109 
CFU/g of cheese at the end of the cultivation (after 7 days). The growth rate, 
calculated from the growth phase between UF-cheese inoculation and 8 hours, 
confirmed the large growth similarities for all the six strains with values ranging 
between 0.78 and 0.88 h
-1
 (data not shown). However, acidification properties of the 
six strains differed in UF-cheese model, with end pH values between 4.58 
(UCMA5713) and 4.85 (LD61). This end pH variation was considered to be 
significant in dairy industry for cheese quality. 
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Figure 4.1 Growth of the six L. lactis strains and pH profile during UF-cheese            
                  ripening (average  of  at  least  three  independent  experiments   
                  with  standard deviation). 
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4.1.2 Phenotypic analysis of the six strains in synthetic CDM medium 
    The further study was carried out by using other sugar, like glucose as 
carbon source on media commonly used in laboratories, i.e. the synthetic CDM 
medium. The CDM was a synthetic medium that contained 18 amino acids, 12 
vitamins and 6 bases. Cultures were cultivated in anaerobic tubes at 30 
o
C under a 
nitrogen atmosphere and agitation speed of 250 rpm. The growth of strains was 
examined by measuring the optical density of the incubated culture broth at 600 nm. 
The final pH values were measured after 24 hours of growth and the results of these 
studies were shown in Table 4.2. Results showed that the strains exhibited the 
similarity of final cell population in all strains with a values ranging between 1.21 and 
1.83 x 10
9
 CFU/g after 24 hours of growth on CDM. However, end pH value was 
around 4.5 in all five strains except in the LL52 strain which reached the low final pH 
value of 4.12 on CDM medium. 
 
Table 4.2 Final cell population and pH for the six strains after 24 hours of growth on  
                 CDM medium. 
Strains Final  
cell population 
(x10
9
 CFU/g) 
Final pH 
UCMA5713 1.64  ± 0.01  4.54 ± 0.01 
LD55 1.57  ± 0.10  4.57 ± 0.01 
LD61 1.83  ± 0.27  4.46 ± 0.00 
LL08 1.61  ± 0.01  4.57 ± 0.01 
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Table 4.2 (Continued). 
Strains Final  
cell population 
(x10
9
 CFU/g) 
Final pH 
LL52 1.21  ± 0.00  4.12 ± 0.01 
S86 1.57  ± 0.06  4.55 ± 0.01 
 
4.1.3 Phenotypic analysis of the six strains on M17 medium 
    After the study of growth ability on CDM medium, M17 medium, which 
was the complex medium for isolating and enumerating lactic streptococci in yogurt, 
cheese starters and other dairy products, was used to determine the growth ability with 
glucose as carbon source. The cultures of the tested strains were cultivated in 
anaerobic tubes at 30 
o
C under a nitrogen atmosphere and agitation speed of 250 rpm 
as described above. Afterwards, the growth of strains was examined by measuring the 
optical density of the incubated culture broth at 600 nm. The final pH values were 
measured after 24 hours of growth. The results of these studies were shown in Table 
4.3. Results showed that the final cell population was very similar for all the strains, 
leading to a constant value ranging between 2.18 and 2.50 x 10
9
 CFU/g after 24 hours 
of growth on M17 medium. In addition, end pH value was observed to be around 4.5, 
more precisely at 4.54, in all six strains. 
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Table 4.3 Final cell population and pH for the six strains after 24 hours of growth on  
                 M17 medium. 
Strains Final  
cell population 
(x10
9
 CFU/g) 
Final pH 
UCMA5713 2.18 
 
± 0.05  4.53 ± 0.02 
LD55 2.35 ± 0.01  4.55 ± 0.01 
LD61 2.39 
 
± 0.01  4.51 ± 0.00 
LL08 2.38 
 
± 0.02  4.57 ± 0.02 
LL52 2.25 
 
± 0.04  4.55 ± 0.00 
S86 2.50 
 
± 0.04  4.53 ± 0.01 
 
4.1.4 Phenotypic analysis of the six strains on M13 medium 
    The further study was carried out by using M13 medium which differed 
from CDM medium by lacking 12 amino acids, 7 vitamins and all bases. Cultures 
were cultivated in anaerobic tubes at 30 
o
C under a nitrogen atmosphere and agitation 
speed of 250 rpm. The growth of strains was examined by measuring the optical 
density of the incubated culture broth at 600 nm. The final pH values were measured 
after 24 hours of growth. However, results showed that none of the six strains were 
able to grow on M13 medium. 
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4.2 Comparative hybridization analysis 
 Array-based comparative genome hybridization (CGH) was used to determine 
the core genome (similar genomic content) of the six strains of L. lactis subsp. lactis 
exhibiting a dairy phenotype. We have also included in these experiments the genome 
of the sequenced strain L. lactis subsp. lactis IL1403, which was used for microarray 
platform design. Genomic DNA in each strain was extracted from cells grown 
overnight on M17, then it was sonicated and labelled by random priming at the 
conditions as described above. Afterwards, the purified labeled DNA was hybridized 
on nylon membrane containing the PCR fragments of L. lactis IL1403. Membranes 
were exposed to a phosphoimager screen for three days and scanned with a 
phosphofluoroimager. Signal intensities were quantified, tested statistically, and 
assigned to gene names with the Bioplot software. Local background was removed 
from all spot intensities. Genes were declared as absence or highly divergence if they 
were detected as absence by all the three statistical methods (a, b and c) as described 
in Materials and Methods Section. Using the IL1403 strain, we identified 19 genes 
with absolute intensities lower than the cut-off value and thus declared as absence 
using the statistical method a (see Material and Methods). These genes were thus 
tagged as missing on the microarray platform and omitted in the subsequent analyses. 
Therefore, the 1,929 genes were analyzed in the CGH experiments. No control was 
necessary to identify false positive genes (genes declared as presence while they are 
absent) was included in the CGH experiment.    
In order to analyse genomic divergences between the strains, ratios of 
intensities were calculated between the tested strain and the IL1403 strain as indicated 
in Materials and Methods (normalization method c using likely conserved genes). 
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These ratios, given in Appendix D, were plotted as a function of gene position on the 
IL1403 strain chromosome (Figure 4.2). Results in Figure 4.2 showed that only a few 
genes had low ratios (no more than 10% of the genes exhibited ratios lower than 0.76 
and was thus declared as divergence), indicating strong similarities between the 
sequences of the six strains. However, one can observe that the sequence of the 
reference LD61 strain was very close to the sequence of the IL1403 strain, while the 
other five strains shared diversity in the same regions. Seven diversity regions were 
detected: i) regions 2, 3, 5, 6 containing phage-related genes (i.e. pi1, pi2, pi3 and 
ps3) were visually enriched in low ratios in these five strains (S86, LD55, LL08, 
LL52, UCMA5713), indicating that these transposable elements could be a source of 
sequence divergence between L. lactis subsp. lactis strains; and ii) regions 1 and 7 
containing in particular genes related to the cell envelope (ycbBDFHIJ genes in locus 
1 and pspB in locus 7) and region 4 including genes involved in citrate and malate 
metabolism (citRCDEF and mae genes, respectively). These divergent regions could 
include absent or highly divergent genes but also present genes with low genomic 
divergence.  
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Figure 4.2 CGH results  normalized  using  likely  conserved  genes  and expressed as  
                   ratios of the  signal  intensities  of  the studied strains against the reference  
                   IL1403  strain (statistical method c, Table S1).  Ratios  lower than 1 in the  
                  six strains were plotted as a function of gene position  on the IL1403 strain   
Locus 
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                  chromosome.   Locus 1:   position  ~ 0.20   Mbp,   ycbABCDKFGHIJ   and   
                  ycaFG genes;  Locus 2:  position ~ 0.44 Mbp, pi1 genes; Locus 3: position   
                  ~ 1.03  Mbp,  pi2  genes;  Locus 4:  position  ~ 1.20 Mbp, citRCDEF, mae,  
                 ymbCDHIJK  and  ymcABCDEF  genes;  Locus 5: position ~ 1.41 Mbp, pi3  
                 genes;  Locus 6:  position  ~ 2.01  Mbp, ps3 genes; Locus 7: position ~ 2.30  
                 Mbp,  pspAB  and  ywjABCDEFGH  genes.  Genes  were  declared  as  only  
                 divergence when their ratios were lower than 0.76. 
 
              Utilisation of these CGH ratios in order to predict gene deletions was not 
trivial when strains were genetically close. The low ratios could indeed correspond to 
the absent genes as well as the genes with the low sequence identity with IL1403 
strain and the low hybridization efficiencies (Van Hijum et al., 2008). Only 
sequencing experiments had the resolving power to give a definitive answer on the 
presence or the absence of the specific gene in the tested strains. In our experiment, 
after subtraction of the local background value, we have identified absent or highly 
divergent genes when the genes were declared as absence by the three different 
statistical methods a, b and c (see Materials and Methods). Method a was based on the 
absolute signal intensity with empty spot threshold constraint. The two other 
procedures b and c were comparative to the IL1403 strain and based on two different 
statistical normalisations, i.e. normalisation by whole spot mean intensity (method b) 
and by a subset of conserved genes (method c). From the 1,929 ORFs spotted on the 
microarray membranes, only 16 genes were identified as absence in at least one of the 
six strains tested in CGH experiment (Table 4.4): UCMA5713, pspB, citR, pi109, 
pi147, pi202, pi207, ps313 and ps315, in LD55, citR, pi147, pi202, pi203, pi204, 
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pi207, pi213, pi225 and pi226, in LL08, citR, pi202 and ps315, in LL52, citR, pi204, 
ps305, ps310, ps311 and ps313, and in S86 pspB, citR, pi202, pi203 and pi204 were 
absent. In order to discriminate absent genes from highly divergent genes (false 
negative genes), PCR amplifications specific of these 16 genes were also performed 
on genomic DNA using hybridization temperatures between 42 and 55 
o
C. In our PCR 
conditions, amplified fragments were detected for gene pi202 in strains UCMA5713, 
LD55 and S86, for genes pi109 and pi207 in strain UCMA5713, and for genes ps311 
and ps313 in strain LL52. Following these PCR experiments, the number of genes 
declared absent in at least one of the six strains was therefore reduced to 14 genes.  
         No ORF was commonly absent in the six strains, meaning that no IL1403-
specific ORF was detected. The number of absent ORFs ranged from 8 in the LD55 
strain to 0 in the LD61 strain even if the divergent locus could be observed in the 
LD61 strain on Figure 4.2. Among the 14 genes absent ORFs, 12 ORFs were involved 
in the phage related functions and prophages functional category, more specifically 
related with prophages pi1, pi2 and ps3. Only two absent ORFs were linked to 
metabolic functions, pspB encoding a glucosyltransferase-S of the cell envelope 
functional category and citR, coding for a citrate lyase regulator. This experiment 
underlined a very large core genome with 1,915 genes of the IL1403 strain genome 
present in all of the six studied strains with a dairy phenotype.  
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Table 4.4 Absent  genes  identified  by  CGH  analysis in at least one of the six strains  
                UCMA5713, LD55, LL08, LL52 or S86. Successful PCR amplifications are   
                 shown by *. 
                   Strains   
Genes UCMA 
5713 
LD55 LL08 LL52 S86 
pspB absent -  - - absent 
pi109 absent* -  - -  - 
pi147 absent absent  - -  - 
pi202 absent* absent* absent -  absent* 
pi203 -  absent  - - absent 
pi204  - absent  - absent absent 
pi207 absent* absent  - -  - 
pi213  - absent  - -  - 
pi225  - absent  - -  - 
pi226  - absent  - -  - 
ps305  - -  - absent  - 
ps310  - -  - absent  - 
ps311  - -  - absent*  - 
ps313 absent -  - absent*  - 
ps315 absent - absent -  - 
citR absent absent absent   absent  absent 
 
4.3 Gene expression analysis 
The differential transcriptomic analysis of the core genome of the five strains, 
UCMA5713, LD55, LL08, LL52 and S86, compared with the reference LD61 strain 
were examined with DNA arrays (L. lactis subp. lactis IL1403-specific amplicons 
spotted) after 24 hours of growth in UF-cheese. Total RNA was extracted from cells 
grown 24 hours in UF-cheese. The quality and quantity of total RNA were verified 
and were used to perform retrotranscription. Afterwards, the synthesis of radiolabelled 
cDNA, nylon arrays hybridizations and washings were performed as described in 
Materials and Methods. Membranes were exposed to a phosphoimager screen for 
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three days and scanned with a phosphofluoroimager. Signal intensities were 
quantified, tested statistically, and assigned to gene names with the Bioplot software. 
Local background was removed from all spot intensities. Signals were normalized by 
the mean intensity of the corresponding membrane. Expression ratios were calculated 
between the strain of interest and LD61 strain which was considered as the reference 
strain for expression studies in milk (Raynaud et al., 2005). The complete 
transcriptomic ratios were given in Appendix D. Significant ratios corresponding to 
the genes differentially expressed in each strain in comparison with the LD61 strain 
were selected with the usual statistical criterion of the FDR  7%. 
In order to check if the transcriptomic ratios were under-estimated for the 
genes with low hybridization efficiencies (corresponding to low CGH ratios), we have 
calculated the correlation coefficients between all the 1,915 genes expression ratios 
and the CGH genes ratios using the LD61 strain as the reference strain. With Pearson, 
Spearman or Kendall methods, correlation coefficients were lower than 0.05, indicate 
that such a bias was not significantly present in our experiments.  
To establish the relationships of the different strains, the two-dimensional 
hierarchical clustering of the entire data set (gene expression ratios of the significant 
and non-significant regulated-genes for the five strains UCMA5713, LD55, LL08, 
LL52 and S86) resolved the gene expression ratios back to their strain origin (Figure 
4.3). Gene expression ratios were clustered along the vertical axis with strains along 
the horizontal axis. Clustering parameter was an agglomeration method of Ward. 
Figure 4.3 exhibited that the strain dendrogram grouped LD55 strains (dairy origin) 
and the UCMA5713 strain (non-dairy origin) while the LL08 strain was the most 
divergent compared with the other four strains. 
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 S86      LL52      UCMA        LD55       LL08 
        5713 
 
Figure 4.3 Two-dimensional hierarchical clustering resolving the gene expression  
                   ratios back to their strain origin. 
 
To establish a link between genomic composition and gene regulation, we 
have measured if genes declared as divergence were statistically over-represented in 
the group of genes whose expression were significantly different from the LD61 strain 
(ratio selected with FDR  7%). By using a hypergeometrical distribution that is a 
discrete probability distribution that describes the probability of k successes in n 
draws from a finite population without replacement, probabilities higher than 12% 
  
 
 
 
 
 
 
81 
 
were observed for each of the tested strain showing no significant enrichment of 
divergent genes in the group of differentially regulated genes.    
The number of genes differentially expressed was determined for each strain. 
A total of 968 different genes were differentially regulated in at least one of the five 
strains compared with the LD61 strain. For each strain, genes were equally partitioned 
between higher- and lower-expression levels compared with the LD61 strain. The 
strains, UCMA5713, LD55 and S86 exhibited 254, 332 and 270 differentially 
expressed genes, respectively, while the other two strains, LL08 and LL52, revealed 
even higher numbers (562 and 586 genes, respectively) (Table 4.5). 
 
Table 4.5 Number of different genes in each strain compared with the LD61 strain      
                 (Reference strain). 
Strains The expressed genes 
      UCMA5713                                                           254 
           LD55                                                                 332 
            S86                                                                   270 
          LL08                                                                  562 
          LL52                                                                  586 
 
In order to analyse the contributions of these individual gene expression 
regulations into the metabolic traits of the different strains, we determined for each 
strain, the over- and under-expressed gene enrichments in the various functional 
categories by the Wilcoxon test on the whole category (p-value < 0.05 significance) as 
previously described by Dressaire et al. (2008). The significantly regulated functional 
(sub)categories compared with the LD61 strain were reported in Table 4.6.  
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Table 4.6 revealed that strong divergence of the five strains compared with 
strain LD61 was observed within many regulated categories distributed all over the 
metabolism. Even if some (sub)categories showed a similar type of regulation for the 
five strains, most of the functional categories exhibited different regulations between 
the strains underlining the large transcriptomic expression variability between the five 
strains. 
In addition, significant differentially regulated genes were observed and shown 
in Table 4.7. The efficient proteolysis of L. lactis LD61 in UF-cheese was reported to 
lead to accumulation of free amino acids (in particular glutamate) and to a low 
expression of the nitrogen metabolism (Cretenet et al., 2011). In our study, after 24 
hours of growth on UF-cheese model, the five strains displayed lower expression 
levels of the amino acid biosynthesis pathways (e.g. aromatic amino acids (aro and 
trp genes), branched chain amino acids (ilv and leu genes) and amino acids of the 
histidine family (his genes)) than the LD61 reference strain. 
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Table 4.6 Significantly  regulated  functional categories in each of the five strains (compared  with  the  LD61  strain)  
     according to Wilcoxon test (P-value < 0.05). Black and gray boxes were higher and lower  gene expression  
     levels than in the LD61 strain, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Functional categories or sub-categories                   UCMA5713               LD55                 LL08                    LL52                   S86 
AMINO ACID BIOSYNTHESIS            
Aromatic amino acid family  
Aspartate family 
Branched chain family  
Histidine family  
          
          
          
          
CELLULAR PROCESSES            
Chaperones  
Transformation  
Protein and peptide secretion  
          
          
          
BIOSYNTHESIS OF COFACTORS, 
PROSTHETIC GROUPS, AND CARRIERS            
Menaquinone and ubiquinone  
Thioredoxin, glutaredoxin and glutathione  
          
          
FATTY ACID AND PHOSPHOLIPID 
METABOLISM            
CENTRAL INTERMEDIARY METABOLISM            
Other           
ENERGY METABOLISM            
Anaerobic  
ATP-PMF conversion  
Fermentation  
Sugars  
TCA cycle  
          
          
          
          
          
OTHER CATEGORIES            
8
3
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Table 4.6 (Continued).  
Functional categories or sub-categories                     UCMA5713            LD55                  LL08                     LL52                    S86 
Adaptations and atypical conditions  
Transposon related functions  
          
          
PURINES, PYRIMIDINES, NUCLEOSIDES 
AND NUCLEOTIDES            
Purine ribonucleotide biosynthesis  
Pyrimidine ribonucleotide biosynthesis  
Salvage of nucleosides and nucleotides  
Sugar-nucleotide biosynthesis and 
interconversions  
          
          
          
          
REGULATORY FUNCTIONS            
AraC-family regulators  
General  
LysR-family regulators  
MarR-family regulators  
Two-component systems 
          
          
          
          
          
REPLICATION            
Degradation of DNA            
TRANSLATION            
Translation factors  
Ribosomal proteins: synthesis and modification  
Amino acyl tRNA synthetases  
          
          
          
TRANSPORT AND BINDING PROTEINS            
Amino acids, peptides and amines  
Anions  
Carbohydrates, organic alcohols and acids  
          
          
          
8
4
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In UF-cheese model, it was shown that LD61 strain induced specific responses 
to counteract different sources of stress including acidic and oxidative stresses and 
carbon limitation (Cretenet et al., 2011). Compared with the LD61 strain, the four 
strains, LL08, LL52, S86 and UCMA5713, exhibited modification of expression of 
genes involved in acidic stress resistance. Several genes involving in the arginine 
deiminase pathway that produced NH3 through the conversion of arginine into 
ornithine were more highly expressed in LL08 strains (arcBC1 and the 
arginine/ornithine antiporter arcD2), LL52 (genes arcABC1) and S86 (arcBC1). In 
the LL08 strain, concomitantly, genes involved in glutamate transport and conversion 
to ornithine (gltQS and argBCDEJ) were more highly expressed than those in the 
LD61 strain. In this strain, the genes citCDEF involved in the citrate metabolism 
which was an alternative acid stress response, were also more highly expressed. In the 
LL52 strain, the genes atpDEH encoding the different subunits of the ATPase were 
expressed at lower levels compared with the LD61 strain. This enzyme catalyzes 
proton expulsion and was thus directly involved in resistance to acidic stress. In the 
plant-associated strain, UCMA5713, a net consumption of protons could be provided 
via the glutamate decarboxylase converting glutamate to the biogenic amine -
aminobutyrate (GABA). The glutamate transporter (gadC coding for a 
glutamate/GABA antiporter) and the glutamate decarboxylase (gadB) expression was 
specifically increased in UCMA5713 strain compared with the other strains. 
Generally, it was found that the lactococcal gadC and gadB genes were maximally 
expressed at low pH (Cotter and Hill, 2003) which were in agreement with the lower 
final pH observed for this particular strain.  
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In response to oxidative stress, the LL52 strain exhibited lower expression of 
genes involved in maintaining a favorable redox balance such as gshR and trxB1 
which coded for glutathione reductase and thioredoxin reductase, respectively. 
Significant higher transcription of gene tpx coding for a peroxidase was observed in 
the S86 strain.  
Concerning carbon limitation, a global over expression of genes involved in 
carbon metabolism and sugar transport was observed in the LD61 strain (Cretenet et 
al., 2011).  Here, all the five strains induced a higher expression of the Leloir pathway 
that was dedicated to lactose assimilation (genes of the gal and lac families) compared 
with the LD61 strain. In addition, expression of several genes involved in alternative 
sugar metabolism such as scrK, ypdBD and yrcA was specifically more highly 
transcribed in the LL08 strain than in the LD61 strain. Consistent with this 
observation, increased expression was observed for genes related to sugar transport 
such as the PTS system for cellobiose (celB, ptcABC) or genes coding for permease, 
binding proteins and transporter (rgpC, ypdA, ypcGH and yngF) involved in general 
carbohydrate transport system for N-galactosides, sugars, and polysaccharides in the 
LL08 strain. In the LL08 strain, increased expression of genes involved in carbon 
transport was consistent with the increased expression of the ldh gene coding for 
lactate dehydrogenase that catalysed the lactate production from pyruvate, the last 
step of carbon catabolism in homolactic bacteria. More surprisingly, the pathway of 
pyruvate conversion into acetolactic acid was also highly expressed with an increased 
transcription of the als gene in the LL08 strain compared with the LD61 strain. 
Inversely, genes involved in central carbon metabolism in the LL52 strain were 
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specifically transcribed to a lower level in this strain, (glycolytic genes, yjhF and 
pgmB, and those involved in the functional category fermentation). 
Finally, some strains exhibited specific traits compared with the LD61 strain. 
The production of biogenic amines (i.e. putrescine) from ornithine was likely in the 
LL08 strain as increased expression of genes potA and potD involved in 
spermidine/putrescine transport was observed. Another important peculiarity in this 
strain was the over-expression of the functional category ribosomal proteins (rpl and 
rps genes) and of the infC gene coding for the translation initiation factor. Cell 
envelop modifications were suggested in both LL08 and LL52 strains since higher 
expressions were observed in the LL08 strain for rgpBEF and ycbBDFHIJ genes 
(potentially involved in biosynthesis, assembly and transport of cell wall 
polysaccharides and important for phage adsorption (Bolotin et al., 2001; Dupont et 
al., 2004; Yamashita et al., 1998) and in the LL52 strain for three genes murA1BC 
involved in amino sugar metabolism. Finally, the significant strain-specific 
expressions of regulators belonging to different families (except for strain 
UCMA5713) could be underlined (Table 4.7). 
 
 
 
 
  
 
 
 
 
 
 
88 
 
 Table 4.7 Differentially  regulated  genes  (Student test, FDR ≤ 7% significance)    
                  sustaining regulated functional categories in the five strains  (compared   
                  with the LD61 strain as shown in Table 4.6). The expression ratios were  
                  listed in the Annex 1. Genes underlined exhibited increased  expression   
                  compared with the LD61 strain, while the genes not underlined showed    
                  lower expression compared with the LD61 strain.  
       Functional categories or        UCMA5713        LD55             LL08               LL52               S86 
              sub-categories   
 
AMINO ACID  
BIOSYNTHESIS 
               
Aromatic amino acid 
Branched chain 
 
Histidine 
    trpA B             aroH              trpAB             aroCDH        aroH 
ilvCD, leuC    ilvD, leuC    ilvBCD, leuBD      ilvBD,       ilvBCDN 
                                                                         leuBC           leuBC 
       hisZ             hisCZ       hisACDGHIKZ    hisDHIZ        hisCZ 
TRANSPORT and ENERGY  
METABOLISM 
Sugars 
 
 
 
 
                              Glutamate / GABA 
 
Glutamate / ornithine 
 
Arginine deiminase pathway 
Biogenic amine synthesis 
 
Citrate metabolism 
                                                   Glycolysis  
 
Fermentation 
 
Alternative sugar metabolism 
 
ATP-PMF conversion 
 
PTS and carbohydrate transport 
   galKMT                galM                bglA, galKMT    galEKMT,       galKM,                                                                                                                                    
glk, lacCZ,                glk,                 gntZ, lacCZ       lacZ, thgA            thgA 
         thgA                     gntZ,                    scrK, thgA              yidC               uxaC 
                                        lacCZ             uxaC, ypdBD,                                   
                                                                                yrcA 
gadC, gadB 
                                                                            gltQS,                                   
        argBCDEJ 
                                                                         arcD2                  arcABC1         arcBC1 
                                                                        arcBC1 
potAD 
citCDEF, icd 
                                            ldh                            yjhF, 
                                                                                 pgmB 
                                                     als                   ackA1A2 
, frdC, butB 
scrK, yrcA 
 ypdBD 
                                                                                atpDEH 
celB, ptcABC,  
rgpC, ypdA,  
yngF ypcGH  
 
BIOSYNTHESIS OF  
COFACTORS, PROSTHETIC  
GROUPS and CARRIER 
Thioredoxin, glutaredoxin and                                                                             gshR, 
glutathione                                                                                                                                                                  trxB1                                                                                                                                                                                         
CELL ENVELOP 
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  Table 4.7 (Continued). 
         Functional categories                    UCMA                 LD55                  LL08           LL52             S86 
            or sub-categories                              5713                                     
ADAPTATIONS and                                                                                                                   tpx 
ATYPICAL CONDITIONS 
Polysaccharide 
 
Peptidoglycan 
  rgpBEF,  
    ycbBDFHIJ 
                                                      murA1BC 
TRANSLATION 
           Ribosomal proteins and                                                     rplBCNT, 
                    translation factors                                                    rpsCDGQS  
                                                                                                    rpmI, rnpA, 
                                                                                                         infC 
REGULATORY FUNCTIONS 
AraC-family regulators 
DeoR-family regulators 
General 
 
 
 
 
 
 
GntR-family regulators 
GTP-binding proteins 
 
LacI-family regulators 
 
LysR-family regulators 
MarR-family regulators 
 
Two-component systems 
xylR 
                         lacR 
                        purR         birA2, rmeD,          argR               glnR 
                                            ydcG, yjaJ          birA1,             rmeB 
                                             ypfD, yrtfA           copR             ymiA          
                                                ysfD            tenA, yabA,       ynaB 
                                                    ybeD, ydcG              
                                                    yecA, ykhI    
                                                  yliA 
                                                                                             rgrB 
                                                                       yphL,            ylqL 
                                                                 yyaL            yyaL 
                             rliB           rliC 
 
                          fhuR 
                         rmaG          rmaA, zitR       rmaC,  
                                                                    rmaIJ 
                                              llrG 
 
4.4 Confirmation of the significant genes by RT-PCR 
In order to verify the array data, the four selected genes (yaiA, feoA, ipd and 
pyrR) were selected to perform RT-qPCR analysis of their expression. The specific 
primers for specific genes were designed with Bio-Rad Beacon Designer software. 
The reverse transcription was performed with mRNA template as described 
previously (Maligoy et al., 2008). The specificities of the primers for the genes of 
interest were controlled by using the L. lactis IL1403 genome with Vector NTI 
software. The pbp2A and smc genes were chosen as internal normalization controls. 
Afterwards, the Pfaffl analysis method was used to calculate the change in transcript 
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levels between strains UCMA5713, LD55, LL08, LL52 and S86 and the reference 
LD61 strain. The results of these studies were shown in Table 4.8. 
The results showed the direct comparison between transcriptomic data and 
quantitative reverse transcription-PCR expressed as ratios in transcript concentrations 
between the strain of interest and the reference strain and corrected by using the 
pbp2A or smc normalization controls. These ratios of transcriptomic data were similar 
to those observed by qPCR analyses. 
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Table 4.8 Comparison of the gene expression ratios between the strain of interest and the reference LD61strain, in the  
                 transcriptomic and the qPCR analyses (corrected
 
in qPCR experiments
 
by using the pbp2A or smc normalization ratios). 
 
Relative gene 
expression 
 Increased  Unchanged  Decreased 
Gene name  feoA feoA feoA yaiA  feoA  ipd Ipd ipd ipd pyrR pyrR 
Strain  UCMA5713 LD55 LL52 LL52  LL08  UCMA5713 LD55 LL52 S86 LL52 S86 
Transcriptomic ratio  3.5 3.3 4.9 5.6  1.0  0.1 0.2 0.1 0.1 0.2 0.3 
qPCR ratio 
normalized with : 
 pbp2A 
smc 
  
 
5.2 
6.8 
 
 
4.7 
4.8 
 
 
1.3 
1.2 
 
 
2.8 
2.7 
  
 
1.0 
1.0 
  
 
0.2 
0.3 
 
 
0.1 
0.1 
 
 
0.1 
0.1 
 
 
0.1 
0.1 
 
 
0.5 
0.4 
 
 
0.1 
0.1 
9
1
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4.5 Physiological characteristics analysis of L. lactis subsp. lactis 
 4.5.1 Nitrogenous bases requirements of the six L. lactis strains 
  The present study was performed to analyse the growth ability of the 
strains on CDM medium with different nitrogenous base composition. The 
experimental conditions were CDM medium without purine base or without 
pyrimidine base or without both bases. All cultures were grown in the test tube for 24 
h at 30 
o
C. The resulting maximal growth rate in each growth condition was compared 
with the one observed in classic CDM medium (Table 4.9). The results showed that 
all the strains were growing slower in the CDM medium without purine or without 
pyrimidine. In addition, when removing both bases from CDM medium, growth was 
even more reduced for all strains (with the exception of the LD61 strain). In 
conclusion, no major phenotypic difference could be detected between the strains at 
the level of nitrogenous base metabolism. 
Table 4.9 Maximal growth rate of L. lactis subsp. lactis strains in CDM media with  
                 different nitrogenous bases composition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         *Classic  CDM  medium:  CDM  medium  with all bases; Without purine: CDM      
          medium without purine; Without pyrimidine: CDM medium without pyrimidine 
         ; without both bases: CDM medium without purine and pyrimidine. 
Strains Maximal specific growth rate (h
-1
) 
       *classic CDM        without purine        without         without                                                                                                      
                                                                   pyrimidine      both bases                                   
 
UCMA5713               1.66±0.02             1.16±0.02          1.32±0.04             0.87±0.04 
        LD55                  1.29±0.01             1.00±0.02          1.22±0.01             0.89±0.03 
        LD61                  1.32±0.02             0.98±0.07          1.14±0.04             1.28±0.01 
        LL08                  1.37±0.07             1.07±0.09          1.18±0.03             0.81±0.03 
        LL52                  1.37±0.04             1.20±0.17          1.21±0.06             1.00±0.01 
          S86                   1.19±0.09             0.89±0.01          1.11±0.07             0.68±0.06 
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4.5.2 Branched chain amino acid (BCAA) requirements of the six L. lactis 
strains 
  To determine the branched chain amino acid requirements of the six L. 
lactis strains, the strains were cultivated in CDM medium under various conditions 
defined as follows; without isoleucine or without leucine or without valine or without 
all BCAAs. The control contained all branch chain amino acids (classic CDM 
medium).  The results of these studies were shown in Table 4.10. It revealed that the 
two strains, LL08 and LL52, had significant growth rate in the media without Ile or 
Leu or Val in the medium, as well as in the absence of BCAAs. In addition, they 
harbored only slightly reduced maximal growth rate in these conditions compared 
with the reference CDM medium. On the contrary, the two other strains, UCMA5713 
and S86, were not able to grow in both medium without Leu or Val and in the absence 
of BCAAs. The LD55 strain showed no growth ability in the medium without Val or 
without all BCAAs while the LD61 strain could not grow only in the medium without 
Val.  
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Table 4.10 Maximal growth rate of L. lactis subsp. lactis strains in CDM media with  
                   different branched chain amino acid (BCAA) composition. 
 
Strains Maximal specific growth rate (h
-1
) 
*classic CDM     without Ile       without Leu       without Val      remove all   
                                                                                                            BCAAs 
UCMA5713        1.66±0.02          0.99±0.02               -                       -                       - 
       LD55            1.29±0.01          1.11±0.01          0.97±0.02             -                       - 
       LD61            1.32±0.02          1.16±0               1.17±0.02             -             0.95±0.14 
       LL08            1.37±0.07           0.99±0.02          0.92±0.01     0.77±0.04     0.83±0.01 
       LL52            1.37±0.04           1.04±0.09          1.03±0.04     0.83±0.04     0.97±0.03 
         S86             1.19±0.09           0.26±0.04                -                      -                        - 
 
     *Classic CDM medium: CDM medium with all BCAA; 
     Without Ile: CDM medium without Isoleucine; 
     Without Leu: CDM medium without Leucine; 
     Without Val: CDM medium without Valine; 
     Remove all BCAAs: CDM medium with no BCAAs = no significant growth. 
          
In conclusion, the behavior of the six L. lactis strains with regard to the BCAA 
requirement was strongly strain dependent. All the tested strains were able to grow 
only in the absence of isoleucine, while the S86 strain could slightly grow on the 
medium without isoleucine. 
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CHAPTER V 
DISCUSSION 
 
The importance of strains belonging to the species Lactococcus lactis in the 
manufacture of fermented dairy products is well known. Generally, it occupies in a 
niche related to plant or animal surfaces and the animal gastrointestinal tract 
(Wegmann et al., 2007).  The current literatures reveal L. lactis strains could be 
models for study on metabolism, physiology, genetics, and molecular biology of lactic 
acid bacteria (LAB), especially in two subspecies strain as lactis and  cremoris 
(Bolotin et al., 2001) since the diversity was found within these species.  
Recently, physiological properties and genetics of lactococci have 
considerably changed (Van Hylckama et al., 2006). To assess the intra-subspecies 
diversity of L. lactis subsp. lactis, therefore, the present study performed comparisons 
at the phenotypic, genomic and transcriptomic levels of the six strains of L. lactis 
subsp. lactis. The six strains of L. lactis subsp. lactis isolates representative of the 
dairy diversity of the Génoferment collection were selected. One strain, UCMA5713, 
was a plant-associated strain whereas the other five strains LD55, LD61, LL08, LL52 
and S86, were found in dairy fermentations. The phenotypic analysis of L. lactis 
strains on UF-cheese model was firstly investigated. Their ability of strains to grow 
and acidify in UF-cheese was compared for all along the cheese repining by growing 
these strains on skimmed raw milk ultrafiltration (UF) retentate. From such result, no 
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significant difference in terms of growth rate and final cell density was observed 
between the strains during growth in UF-cheese. However, phenotypic differences 
were detected when comparing final cheese pH, since a 0.3 pH unit variation can lead 
to different cheese quality such as cheese flavor, cheese texture and cheese safety 
(Pandey et al., 2003). In addition, De Giori et al. (1985) found that variations in pH 
had a strong influence on casein hydrolysis in streptococci more than in lactobacilli. 
Strains were also tested for their ability to grow with other sugars, like glucose 
as carbon source on media that it is commonly used in laboratories. Since chemically 
defined medium (CDM) is a synthetic medium that contains 18 amino acids, 12 
vitamins and 6 bases, and can support growth of the bacteria at a constant specific 
growth rate (Novak et al., 1997), therefore, CDM medium was selected for further 
study. From the results, strains exhibited only weak differences in the final cell 
population (1.21 to 1.83 x 10
9
 CFU/ ml) and pH (4.12 to 4.57). It was LL52 strain that 
reached the low final pH value of 4.12.  
From the previous experiment, the result showed that the synthetic medium 
(CDM) containing glucose supplemented with high amino acids, vitamins, and bases 
could be used as the growth media for these strains. The other types of media which 
were complex medium (M17) and modified synthetic medium (M13), were also 
studied for their ability to grow and acidify. From the results, strains could grow in 
M17 medium since this complex medium was formulated by including ingredients of 
natural origin (Zhang and Greasham, 1999) while none of the six strains were able to 
grow on M13 medium because of the lacking in 12 amino acids, 7 vitamins, and all 
nitrogenous bases.  Novak et al. (1997) showed that the biomass was detected from 
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the culture grown in M17 medium was higher than the other media (MS10, MS13, 
and MS14, respectively) which was correlated with glucose consumption.  
Since the genomes of the six strains of L. lactis subsp. lactis exhibiting a dairy 
phenotype were not sequenced, their similar genomic contents (core genome) were 
compared by using array-based comparative genome hybridization during growth on 
M17 medium. The genome of the sequenced strain L. lactis subsp. lactis IL1403 was 
used as a reference strain. DNA array technology has recently been used for the 
analysis of genome variability among bacterial species or closely related bacteria 
(Vijayendran et al., 2007). Array-based comparative genome hybridization is 
commonly used to determine the genomic content of bacterial strains. It is applied 
frequently to study the genomic content of closely related microorganism (Van Hijum 
et al., 2008). Detection of genomic variation between related organisms can elucidate 
relations between genotypic and phenotypic traits of organisms (Bayjanov et al., 
2009). In present study, open reading frames (ORFs) were predicted in the assembled 
draft genome sequences of the six strains. The genome of the sequenced strain L. 
lactis subsp. lactis IL1403 was used for microarray platform design. In consideration 
of genome content, the six strains shared a large core genome of 1,915 genes 
corresponding to more than 99% of the IL1403 ORFs spotted on the membranes. In 
addition, significantly lower core genome values were obtained for other species 
(Rasmussen et al., 2008). Due to the represent of genome content in all dairy L. lactis 
strains, here, the core genome could be named a “dairy” core genome since it was 
representative of the very homogeneous group of strains sharing a dairy phenotype 
(growth on UF-cheese model and high acidification rate). However, we could not 
exclude a certain genomic variability between the strains related to their accessory 
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genomic content notably for the LL52 strain harbouring an additional 260 kb 
compared with the IL1403 strain. According to CGH analysis, the accessory genome 
(or non-core) of the IL 1403 strain (defined as genes present in the IL1403 strain but 
not in all strains) was able to analyse. The results showed that fourteen genes 
constituting part of the accessory genome could be divided into two groups. First 
group was in the mobilome or mobile DNA that invaded or left the unnecessary 
genome and then added to the fitness of the strain such as phage-related genes. The 
diversity region involved in the strain specific fitness (genes involved in citrate 
metabolism citR and surface polysaccharides pspB) was grouped to the second one. 
This small accessory genome did not contain any genes unique to the IL1403 strain.  
 Due to an attention in gene expression of LAB, various specific techniques 
that fall under the rubric of omics and bioinformatics approaches were used for 
monitoring the global changes in phenotype of transcripts, proteins, and metabolites 
(Downs, 2006). The expression of the common genes to the six studied strains was 
compared in UF-cheese model conditions using DNA arrays corresponding to the 
IL1403 genome. The comparison was performed at 24 hours of growth since the 
dynamic study of LD61 strain under similar conditions has shown that the number of 
differentially expressed genes did not change thereafter (Cretenet et al., 2011). To 
establish the relationships of the different strains, the expression data set of the 1,915 
core genome gene of the five strains (S86, LD55, LL08, LL52 and UCMA5713) was 
classified by a hierarchical clustering. From the strain dendrogram, based on gene 
expression ratios, showed the strains grouping between the LD55 and UCMA571 
strains. In contrast to the LL08 strain, which was the most divergent compared with 
the other four strains. Moreover, the diversity between the six strains at the level of 
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gene expression of their core genome (1,915 genes) was demonstrated. Such a level of 
regulation was already reported in the literature between two species E. coli/Shigella 
(in adaptation to their environment) or two closely related E. coli K12 sub-strains 
(during growth) (Le Gall et al. (2005), Vijayendran et al. (2007)). Variation in gene 
expression was present between plant- and dairy-associated strains, but more 
interestingly, also between strains of the same dairy origin (starters and raw milk).  
 Classification by functional categories revealed that gene products involved in 
the formation of the translation complex and in the general metabolism constituted the 
largest groups of identified proteins (Schrtl et al., 2005) and it has been also used in 
this present study. The specific gene regulation in the plant-associated UCMA5713 
strain was mainly restricted to the increased expression of genes involved in the 
glutamate uptake and conversion to GABA. These genes involved in the function of 
controlling pH by combination between amino acid decarboxylation and amino acid 
antiport (Sanders et al., 1998). Nomura et al. (1998) showed the relationship between 
the pH values and the production of gamma-aminobutyric acid during cheese ripening 
that gamma-aminobutyric acid increased linearly in the experimental cheeses as the 
pH of the cheese decreased. Siezen et al. (2010) did not report modification of the 
genomic content of the two L. lactis plant isolates, KF147 and KF282, related to 
GABA metabolism even if two polyamine transporter systems were present in these 
strains. Recently, a GABA-producing Lactococcus lactis strain grown in the medium 
supplemented with or without glutamate was studied using the combined 
transcriptome/proteome analysis (Mazzoli et al., 2010). It was found that most 
glutamate-induced responses consisted in under-expression of metabolic pathways, 
with the exception of glycolysis where either over- or under-expression of specific 
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genes was observed. In addition, the energy-producing arginine deiminase pathway, 
the ATPase, and also some stress proteins were down-regulated, suggesting that 
glutamate was not the only an alternative means to get energy, but also a protective 
agent against stress for the strain studied. Although being a plant associated strain, the 
UCMA5713 strain exhibited a dairy phenotype and it was closely related to the dairy 
origin strains (expression dendrogram, Figure 4.3). This could be explained by the 
observation that UCMA5713 strain was isolated from grassland neighbouring a dairy 
factory, not excluding the fact that the UCMA5713 strain was not a real grassland 
strain but a strain with a dairy origin found on the plant. Recently, Passerini et al 
(2010) revealed that the gene-based phylogeny was not fully consistent with the 
traditional classification into dairy and non-dairy strains but supported a new 
classification based on ecological separation between the environmental strains and 
the domesticated strains. Among the dairy origin strains, the LL08 strain displayed the 
largest transcriptomic divergence as shown by its separated branch in the dendrogram 
and its large amount of strain-specific transcriptomic features. Increased expression of 
genes involved in central metabolism, glutamate consumption, ribosomal protein 
synthesis and translation factors and the stronger induction of the alternative sugar 
metabolism and transport indicated that this strain was still able to maintain metabolic 
activity even after 24 hours of growth in UF-cheese. From the industrial point of 
view, the potential capabilities of the LL08 strain to produce diacetyl, a butter flavor 
compound, and polysaccharides potentially involved in cheese texture, were 
interesting properties even if the concomitant synthesis of the undesired biogenic 
amines was also possible.  
  
 
 
 
 
 
 
101 
 
We have tried to link the different observation levels, phenotype (growth on 
UF-cheese matrix and acidification capability), genomic content and transcriptomic 
profile. After 24 hours of growth on UF-cheese model, the transcriptomic profiles 
(common for the five strains or strain-specific) were in agreement with the genomic 
content of the strains and corresponded to the responses previously observed for the 
LD61 strain (Cretenet et al., 2011), i.e. acid and oxidative stresses and carbon but not 
nitrogen limitation. In the case of citrate utilization a discrepancy was however 
observed. Even if citrate was present in the cheese matrix, the five strains 
(UCMA5713, LD55, LL08, LL52 and S86) should not be able to metabolise citrate 
since they do not belong to the biovar diacetylactis. The absence of the citR gene in 
the five strains was consistent with this observation. However, more surprisingly, a 
citDEF operon was present in all these five strains and increased expression of the 
citDEF was observed in the LL08 strain compared with the LD61 strain belonging to 
the biovar diacetylactis. In addition, we observed using PCR (results not shown) that 
neither the citP gene (coding for the citrate permease) nor the citM-citRCDEFGX 
region was present in the UCMA5713, LD55, LL08, LL52 and S86 strains. One 
explanation could be the presence of cross-hybridization of other genes (plasmid-
borne genes) with the microarray probes designed against the IL1403 citDEF genes.   
Despite the strong similarity of the core genome between the strains, a large 
transcriptomic polymorphism was observed. We had reconfirmed that there was no 
significant bias in expression-change determination linked to low hybridization 
efficiencies. In addition, for each tested strain, we showed that genes declared as 
divergence was not over represented in the group of genes differentially regulated 
compared with the LD61 strain. The strain-specific expression of a similar core 
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genome could be related to the ability of the accessory genome expression to interact 
with the core genome expression. However the strain with the largest chromosome 
(LL52) and the potentially largest accessory genome was not the most divergent strain 
at the transcriptomic level. The discrepancy between genomic similarity and 
transcriptomic diversity could more probably reveal strain-dependent regulatory 
networks. This conclusion was supported by variable regulations within the functional 
category regulatory functions between the strains, related to 37 regulatory genes 
exhibiting strain-specific expression differences. 
Nucleotides are obligatory metabolites in all organisms. They are substrates 
for RNA and DNA synthesis, and serve as the main energy donors for cellular 
processes. Some nucleotides are constituents of coenzymes in central metabolic 
pathways (Martinussen and Hammer, 1998), while others are used for activation of 
precursors in polysaccharide and lipid synthesis. In addition, nucleotides serve an 
important role in the regulation of numerous cellular processes from the metabolic 
level to the level of gene expression (Kilstrup et al., 2005). Most bacteria are able to 
produce nucleotides de novo, while others including some lactic acid bacteria, require 
addition of either purines or pyrimidines to the growth medium. Milk does not contain 
sufficient levels of purine compounds to support the growth of L. lactis even a 
pyrimidine source is present in milk but only some strains of the lactic acid bacteria 
can utilize it. Therefore, de novo biosynthesis is necessary (Bolotin et al., 2001). 
Recently, Bolotin et al. (2001) showed that L. lactis has sufficient and fairly active 
capacities for biosynthesis and also for salvage of nucleic acid compounds. Therefore, 
the growth ability of the strains on the modified bases CDM medium was studied. 
After cultivating of strains in CDMs medium containing no purine base, no 
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pyrimidine base or without both bases, the results showed that all the strains were not 
grown well in the missing of at least one of these bases in the CDM medium. 
Recently, additional of purines to L. lactis MG1363 grown in chemically defined 
GSA medium was demonstrated to stimulate the growth rate by approximately 15% 
while pyrimidine had no effect (Martinussen et al., 2003). Hence, the addition of 
exogenous purines to the growth medium led to the repression of the purine 
biosynthetic genes in L. lactis as well as de novo pyrimidine synthesis was also 
inhibited due to repression of the expression of the pyrimidine biosynthetic genes 
encoded by the pyr operon when uracil was present in the culture medium (Arsène-
Ploetze et al., 2006). In addition, Martinussen et al. (1994) showed that hypoxanthine, 
adenine, and guanine facilitate growth of a purine-requiring mutant. It had been 
shown that all pyrimidine derivatives except cytosine could be metabolized, 
demonstrating permeability for these compounds as well as BmpA-NupABC recently 
was found to be an ABC transporter with the ability to actively transport all common 
nucleosides, whereas UriP was shown to be responsible for the uptake of only uridine 
and deoxyuridine (Martinussen et al., 2010). 
Generally, LAB use amino acids not only to synthesize proteins but also use as 
an energy source to obtain the optimal internal pH under an acid environment. In 
addition, this source is used to regenerate co-substrates, and also for biosynthesis 
(Ardö, 2006). Besides the limited capacity for biosynthesis of amino acids, Lactococci 
require essential amino acids for growth, and the number of essential amino acids is 
strain-dependent (Van Kranenburg et al., 2002). Branch chain amino acids (BCAA) 
was selected to test for growth requirements of strains since these amino acids are 
highly relevant to substrates for cheese flavor development. Besides the essential 
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growth of L. lactis in at least the six amino acids such as glutamate, leucine, 
isoleucine, valine, histidine, and methionine (Wegmann et al., 2007), synthetic 
medium (CDM) was used as growth medium.  Although in most cases complex and 
semi-defined media provided greater biomass yields than these of CDM medium. For 
this reason, the CDM that supports reasonable cell growth can be very useful in 
studies of gene regulation, protein expression, and metabolic fluxes (Zhang et al., 
2009). Moreover, CDM medium are usually preferred in laboratory research since 
they permit one to determine the specific requirements for growth and product 
formation by systematically adding or eliminating chemical species from the 
formulation, with minimal complicated medium interactions and reproducible culture 
conditions. Defined media are thus well suited for fundamental studies of metabolism 
(Zhang and Greasham, 1999). Strains were cultivated in CDM medium under various 
kinds of BCAAs as following; without isoleucine, without leucine, without valine, 
and without all BCAAs. The different kinds of BCAAs in the CDM medium were 
carried out to investigate the growth requirements for amino acids in the five strains 
compared with the LD61 strain which was the reference strain. The results showed 
that all these strains could grow at least in the modified CDMs medium. However, 
these results showed no correspondence between the physiological characteristics and 
global gene expression. Therefore, the physiological characteristics analysis and the 
global transcriptome led to the conclusion that the genome expression and 
physiological characteristics analysis should not link with these closely related sub-
strains of L. lactis subsp. lactis. However, the growth requirement for specific amino 
acids could result from either the absence of the functional specific biosynthesis genes 
(Godon et al., 1993) or from the specific regulatory mechanisms (Chopin, 1993) or 
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the difference of the environment such as medium that used to cultivate the strains 
that may affect the growth ability. 
From the study of comparative genomic hybridization and gene expression in 
the six L. lactis strains, the strains exhibited different gene expression under acidity 
condition, oxidative stress, and carbon limitation. These results showed that some 
strains could grow under the acidity condition and inhibit the pathogenesis since this 
strain was used for cheese manufacturing or dairy fermentation.  
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CHAPTER VI 
CONCLUSIONS AND RECOMMENDATIONS 
 
         The six strains of Lactococcus lactis subsp. lactis isolates form the Génoferment 
collection were selected. They were isolated from various sources, and all of them 
showed a dairy phenotype. After these L. lactis strains were grown on skimmed raw 
milk ultrafiltration (UF) retentate, it was found that no significant difference in the 
final cell density was observed between the strains during growth in UF-cheese. 
However, phenotypic differences were detected when final cheese pHs were 
compared, since a 0.3 pH unit variation could lead to different cheese quality such as 
cheese flavor, cheese texture and cheese safety (Pandey et al., 2003). The other types 
of media which were synthetic medium (chemically defined medium; CDM), 
complex medium (M17) and modified synthetic medium (M13), were also studied for 
their ability to grow with glucose as a carbon source on media commonly used in 
laboratories. Strains also exhibited only weak differences in the final cell density and 
pH whereas none of the strains was able to grow on M13 medium. 
According to the scanning of a whole genome for variations in DNA copy 
number, CGH analysis was used to determine the core genome (similar genomic 
content) of the six strains of L. lactis subsp. lactis exhibited a dairy phenotype. After 
CGH experiments and signal normalization, the intensities ratios were calculated 
between the tested strain and IL1403 strain in order to evaluate the genomic 
divergences between the strains. It was found that only a few genes had low ratios, 
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indicated strong similarities between the sequences of the six strains. The sequence of 
the reference LD61 strain was close to the sequence of IL1403 strain, while the five 
other strains shared diversity in the same regions. From the calculation with three 
statistical methods, PCR experiment and comparing of genome content, it was found 
that the six strains shared a large core genome of 1,915 genes, corresponding to more 
than 99% of the IL1403 ORFs spotted on the membranes. 
         The expression of the genes common to the six studied strains was compared 
under UF-cheese model conditions using DNA arrays corresponding to the IL1403 
genome. After signal normalization, evaluative statistical significance of expression 
ratios using false discovery rate (FDR) calculations and a statistical threshold of 7%, 
the expression changed at the level of the functional (sub) categories was then further 
determined. The number of genes differentially expressed was observed for each 
strain. This investigation showed that a total of 968 different genes were differentially 
regulated in at least one of the five strains compared with the LD61 strain. For each 
strain, genes were equally partitioned between higher and lower expression levels 
compared with the reference strain. From the calculation of over- and under-expressed 
gene enrichments in the different groups using the Wilcoxon test, it was found that 
strong divergence of the five strains compared with the LD61 strain was observed 
within many regulated categories distributed throughout metabolism. Even if some 
(sub)categories showed a similar type of regulation for the five strains, most of the 
functional categories exhibited different regulation between the strains, underlining 
the large transcriptomic expression variability between the five strains. After a 
hierarchical clustering analysis of the expression data set of the 1,915 core genome 
genes of the five strains (S86, LD55, LL08, LL52 and UCMA5713), the strain 
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dendrogram based on gene expression ratios showed the strains grouping between the 
LD55 and the UCMA571 strains. In contrast to the LL08 strain, which was the most 
divergent compared with the other four strains.  
To determine the physiological characteristics, therefore, the six of                  
L. lactis strains were investigated for the nitrogenous bases and branched chain amino 
acids (BCAAs) requirements in CDM medium under various conditions as described 
above. Results showed that no major phenotypic difference could be detected between 
the strains at the level of base metabolism. The behaviour of the strains with regards 
to the BCAA requirement was strongly strain dependent. All the tested strains were 
able to grow in the absence of isoleucine, except the S86 strain could slightly grow on 
the medium without isoleucine. 
Recommendation for further studies 
The expression of the genes in the six studied strains was compared in UF-
cheese model condition in order to establish the relationships of the different strains 
with the clustering analysis. However, it will be interesting to compare the gene 
expression and the clustering groups of the strains after cultivation in the CDM 
medium and compare them with the former results. This study will enable better 
understanding of the gene expression and the clustering analysis after the strain grown 
in the UF-cheese model compared with that in CDM medium.    
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APPENDIX A 
CULTURE MEDIA AND REAGENTS 
 
1.  Culture media for growth of L. lactis subsp. lactis strains 
 1.1 Chemically defined media (CDM)  
 CDM was used for the cell cultivation and physiological characteristics 
analyse. All compounds were weighted individually and prepared with distilled water. 
All solutions were mixed in the order indicated (Solution 1 to Solution 8). The pH was 
maintained at 6.6 and the final volume was adjusted with distilled water. Afterwards, 
the culture media were sterilized by filtering through the membrane (0.2 µm; 
Sartorius). The culture media were prepared as described by Otto et al. (1983) and 
modified by Poolman & Konings (1988). It has composition as follows: 
. 
  1.1.1 Solution 1: Sugars and Salts1 
  Composition per liter (concentration 1X): 
  Glucose     10 g 
  Sodium acetate       1 g 
  Ammonium citrate   0.6 g 
  KH2PO4       9 g 
  K2HPO4    7.5 g 
 
  This solution was prepared at concentration 10X . 
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  1.1.2 Solution 2: Salt2 
  Composition per liter (concentration 1X): 
  MgCl26H2O       0.2 g 
  FeSO27H2O                      0.011 g 
  CaCl2 2H2O                           0.05 g 
  ZnSO4 7H2O                     0.005 g 
  CoCl2 6H2O                   0.0025 g 
 
  This solution was prepared at concentration 50X. 
 
  1.1.3 Solution 3: Amino acids 
  Composition per liter (concentration 1X): 
  Alanine                0.24 g 
  Arginine     0.12 g 
  Asparagine     0.34 g 
  Glutamine     0.51 g 
  Glycine     0.17 g 
  Histidine     0.11 g 
  Isoleucine       0.2 g 
  Leucine     0.47 g 
  Lysine      0.35 g 
  Methionine     0.12 g 
  Proline      0.68 g 
  Serine      0.34 g 
  Threonine     0.23 g 
  Tryptophane     0.05 g 
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  Valine      0.33 g 
 
  This solution was prepared at concentration 20X. 
 
  Preparation of medium: To determine the growth ability of bacterial 
strains in the medium with and without branch chain amino acids, therefore, branch 
chain  amino acids such as isoleucine, leucine or valine, were individually added.  
 
   1.1.4 Solution 4: Phenylalanine 
  Composition per liter (concentration 1X): 
  Phenylalanine     0.28 g 
 
  This solution was prepared at concentration 20X. A few drops of 37% 
HCl  were added. 
 
  1.1.5 Solution 5: Tyrosine 
  Composition per liter (concentration 1X): 
  Tyrosine      0.29 g 
 
  This solution was prepared at concentration 20X. A few drops of 10N 
KOH were added. 
 
  1.1.6 Solution 6: Bases 
  Composition per liter (concentration 1X): 
  Adenine     0.01 g 
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  Guanine     0.01 g 
  Inosine              0.005 g  
  Thymidine              0.005 g  
  Uracile     0.01 g  
  Xanthine     0.01 g 
 
  This solution was prepared at concentration 50X. A few drops of 10N 
KOH  were added. 
  Preparation of medium: To determine the growth ability of bacterial 
strains in the medium with and without bases, therefore, purine bases (adenine, 
guanine, xanthine, and inosine) or pyrimidine (uracile and thymidine) were 
individually removed from the solution. 
 
  1.1.7 Solution 7: Vitamins 
  Composition per liter (concentration 1X): 
  para-aminobenzoic acid   0.01 g 
  Biotine     0.01 g 
  Cyano-cobalamine (B12)            0.001 g 
  Folic acid              0.001 g 
  Nicotinic acid              0.001 g 
  Orotic acid                         0.005 g 
  Calcium-pantothenate             0.001 g 
  Pyridoxamine              0.005 g 
  Pyridoxine              0.002 g 
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  Riboflavine (B2)             0.001 g 
  Thiamine              0.001 g 
  DL-6,8-thioctic acid            0.0025 g 
 
  This solution was prepared at concentration 20X. 
 
  1.1.8 Solution 8: Cysteine 
  Cysteine     0.17 g 
 
  This solution was prepared at concentration 20X. 
 
 1.2 M13 medium 
 M13 medium is a synthetic medium. All compounds were weighted 
individually and prepared with distilled water. All solutions were mixed in the order 
indicated (Solution 1 to Solution 3). The pH was maintained at pH 6.6 and the final 
volume was adjusted with distilled water. Afterwards, the culture media were 
sterilized by filtering through the membrane (0.2 µm; Sartorius). The culture media 
were prepared as described by Cocaign-Bousquet et al. (1995). It has composition as 
follows: 
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  1.2.1 Solution 1: Sugars and Salts1 
  Composition per liter (concentration 1X): 
  Glucose                       5 g 
  KH2PO4                    4.5 g 
  K2HPO4                              3.75 g 
 
  This solution was prepared at concentration 10X . 
 
  1.2.2 Solution 2: Salt2 
  Composition per liter (concentration 1X): 
  MgCl2.6H2O      0.1 g 
 
  This solution was prepared at concentration 50X. 
 
  1.2.3 Solution 3: Amino acids 
  Composition per liter (concentration 1X): 
  Glutamic acid     0.05 g 
  Isoleucine       0.1 g 
  Leucine              0.235 g 
  Methionine     0.06 g 
  Serine      0.17 g 
  Valine               0.165 g 
 
  This solution was prepared at concentration 20X. 
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  1.2.4 Solution 4: Vitamins 
  Composition per liter (concentration 1X): 
  Biotine      0.1 g 
  Nicotinic acid               0.01 g 
  Calcium-pantothenate              0.01 g 
  Pyridoxamine               0.05 g 
  Riboflavine (B2)              0.01 g 
   
  This solution was prepared at concentration 20X. 
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2. Reagents for gel electrophoresis 
     2.1 Agarose agar: 1.5% of agarose agar. 
     2.2 Loading buffer: 0.25% bromphenol blue, 0.25% Xylene cyanol FF and 40%     
           (w/v) sucrose was diluted in Milli Q water. 
     2.3 Lysis buffer: 50 mM glucose, 25 mM Tris-HCl, and 10 mM EDTA 
     2.4 Phenol, TE saturated.  
           Dissolved phenol was transferred to 10 mM Tris-HCl, pH 8.0 and 1 mM   
           EDTA, pH8 
     2.5 TE buffer: Ten mL of 1 M Tris-HCl, pH 8.0 was mixed with 0.2 mL of 0.5 M    
           EDTA, pH 8.0 and made up volume to 1.0 L. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
152 
 
APPENDIX B 
 FORMULAR 
 
 The volume of inocula was determined to obtain an initial optical density at 
600 nm of 0.1 as described by the follow formulas, 
     ODi = ODf/e
µt
 ………………………….(1) 
 ODi = the initial OD600 unit of the culture 
 ODf = the final OD600 unit of the culture 
 µ      = specific growth rate of the interest culture (h
-1
) 
 t    = the different of time between initial and final OD600 unit of the culture 
     ViODi = VfODf …………………………(2) 
 Vi   = the initial volume of the fresh culture 
 ODi = the initial OD600 unit of the culture 
 Vf   = the final volume of the needed culture 
 ODf = the final OD600 unit of the culture 
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                                         APPENDIX C 
 
Table C1 Sequences of primer pairs for qPCR experiments table. 
Gene 
Sequences (5’ - 3’) 
 
 Forwards Reverses 
feoA TCAGACGCCGCTTGATGGAC AGTTCAAGAGGGTCGCCAAGTG 
yaiA CAGAAGAAGATGGGCATGGAGC GTCGGTACACGGAATGAAGCAC 
pyrR GACCGTGGACATCGTGAATTGC CATTGCCATCGTGTTCAGACATTTG 
ipd TGGCTGATGGCTATGCTCGTAC CGGCGTAACTTCCTGCTAATCC 
pbp2A TGGAGCAGTCACAGGCAGATAC GTCAGACCATACTTGCGTTCCG 
smc CGCAGTTGTCGGTCCAAATGG ACGAAGTGCTTTAGCCGATTGC 
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APPENDIX D 
 
Table D1 Expression ratios of the 1,915 genes of the core genome. 
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
accB 1.53 3.56 3.52 2.43 4.14 
accC 1.2 1.12 1.06 0.91 1.08 
accD 1.11 1.13 1.2 0.96 1.04 
ackA1 0.6 0.58 0.62 0.56 0.71 
ackA2 0.71 0.82 1.11 0.7 1.17 
acmA 1.28 0.94 1.18 1.56 1.21 
acmB 0.84 0.84 0.75 0.63 0.88 
acmC 1.28 1.02 1.16 1.37 0.99 
acmD 0.84 0.74 0.48 0.92 0.67 
acpA 1.17 0.93 0.79 0.74 1.14 
acpD 1.47 1.06 1.08 1.03 1.15 
adaA 1 0.9 0.77 0.81 0.61 
add 1.18 0.95 0.7 0.77 0.85 
adhA 1.45 1.18 0.45 0.83 1.15 
adhE 1.48 1.2 0.47 1.24 1.27 
adk 0.7 0.71 0.58 0.63 0.73 
ahpC 0.93 0.71 0.65 0.84 1.09 
ahpF 1.1 0.86 0.79 0.96 1.26 
ahrC 1.89 1.6 1.34 1.65 1.66 
alaS 1.11 1.16 0.83 0.9 0.87 
aldB 1.04 1.05 1.28 0.69 1.16 
aldR 1.14 1.6 1.47 1.09 1.59 
als 1.1 1.26 2.35 0.91 1.18 
amtB 0.94 1.1 0.55 0.68 0.51 
amyL 1.13 1.04 1.1 1.11 1.51 
ansB 1.05 0.92 0.89 1.12 1.31 
apbE 1.16 0.83 1.23 1.02 1.08 
apl 1.21 1 0.82 1.19 1.31 
apt 1.15 0.87 1.01 1.06 1.04 
apu 0.73 0.65 0.64 0.74 0.71 
araT 0.62 0.56 0.92 0.49 1 
arcA 1.12 0.58 0.89 1.77 1.18 
arcB 1.49 0.93 1.28 2.51 1.32 
arcC1 1.57 1.25 1.46 1.35 1.84 
arcC2 1.2 1.05 1.06 1.11 1.13 
arcC3 1.23 1.1 0.93 0.92 1.16 
arcD1 1.12 0.91 0.94 1.19 1.29 
arcD2 0.97 0.86 1.39 0.86 1.01 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
arcT 1.13 0.87 0.92 1.08 1.19 
argB 1.18 1.6 3.32 1.4 1.44 
argC 1.46 1.07 8.29 1.46 1.46 
argD 1.43 1.44 2.65 1.24 1.45 
argE 0.53 0.5 2.36 0.65 0.55 
argF 1.05 0.96 1.03 1.06 1.42 
argG 0.51 0.47 0.48 0.44 0.4 
argH 0.42 0.57 0.47 0.45 0.33 
argJ 0.99 1.65 7.18 1.51 1.09 
argR 0.84 0.9 1.1 0.48 0.97 
argS 0.82 0.67 0.99 0.68 0.66 
aroA 1.01 1 1.15 0.82 0.87 
aroB 1.2 0.85 0.89 1.06 1.19 
aroC 0.95 0.83 1.16 0.61 1.14 
aroD 0.82 0.86 1.02 0.6 0.91 
aroE 1.33 1.07 1.14 1.15 1.16 
aroH 0.48 0.43 0.71 0.43 0.48 
arsC 0.69 1.29 0.96 0.96 1.29 
asd 0.78 0.88 0.78 0.75 0.73 
asnB 1 0.83 0.76 0.8 0.88 
asnH 1.09 0.88 0.77 0.98 0.93 
asnS 0.86 0.86 1.08 0.78 0.91 
aspB 0.88 0.77 0.99 0.81 0.9 
aspC 0.88 0.73 1.03 0.87 1.06 
aspS 0.82 0.71 0.93 0.87 0.95 
atpB 0.8 0.87 0.82 0.81 0.99 
atpD 0.66 0.76 0.81 0.65 1.03 
atpE 0.89 0.8 0.89 0.74 0.99 
atpF 0.89 1.07 0.95 0.78 0.94 
atpG 0.86 0.87 0.68 0.78 1 
atpH 0.74 0.81 0.9 0.66 0.96 
bacA 1.09 1.03 1.13 1.11 1.01 
bar 1.21 1.04 0.91 0.98 1.56 
bcaT 0.79 0.64 0.89 0.63 0.68 
bglA 1.22 1.12 1.64 1.04 1.41 
bglH 0.65 0.62 0.87 0.51 1.14 
bglR 0.38 0.35 0.29 0.4 1.16 
bglS 1.23 1.18 1.29 1.02 1.33 
birA1 1.22 1.25 0.95 1.37 1.21 
birA2 1.02 1.17 0.75 0.87 1.09 
blt 1.15 1.16 0.91 0.78 0.67 
bmpA 0.77 0.67 0.55 1.02 0.9 
busAA 0.72 0.92 0.7 0.61 0.75 
busAB 0.6 0.8 0.78 0.67 0.84 
busR 0.93 1.01 0.94 0.82 0.96 
butA 0.92 1.01 1.34 0.56 0.74 
butB 0.43 0.53 0.64 0.32 0.65 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
cadA 0.41 0.51 1.46 0.49 1.23 
carA 0.3 0.39 0.69 0.24 0.38 
carB 0.74 0.49 0.59 0.47 0.52 
cbr 1.28 1.2 1.53 1.59 1.26 
ccpA 0.88 1.01 1.14 1.08 0.75 
cdd 1.2 1.47 1.22 1.25 1.14 
cdsA 1.48 1.38 0.98 1.53 0.71 
celB 1.66 1.32 2.8 0.93 1.97 
ceo 0.67 0.93 0.58 0.43 1 
chiA 1.25 1.97 2.54 0.8 1.77 
choS 0.84 0.8 1.04 0.7 1.49 
citB 1.37 1.08 1.38 1.03 0.98 
citC 1.2 1.14 3.8 1.17 1.19 
citD 1.28 1.5 9.16 1.63 1.57 
citE 0.84 1.02 8.03 1.18 1.03 
citF 0.94 0.85 5.73 1.06 0.87 
clpB 1.02 1.54 0.76 1.43 1.12 
clpC 1.07 1.11 0.98 0.76 1.24 
clpE 0.74 0.85 0.78 0.63 0.91 
clpP 0.65 0.95 0.81 0.51 0.94 
clpX 1 0.83 1.02 0.9 1.21 
clsA 0.77 0.75 0.98 0.7 1.09 
clsB 0.94 0.88 1.1 0.75 1.13 
cmk 1.22 0.95 0.83 0.97 1.05 
coaA 0.77 0.82 1.01 0.94 0.79 
cobC 1.02 1.01 1.04 1.23 1.01 
cobQ 1.04 0.9 0.97 1.06 0.93 
codY 0.91 0.88 0.93 0.93 0.96 
codZ 1.26 1.13 0.91 1.16 1.08 
coiA 1.99 3.2 2.11 2.53 1.46 
comC 1.2 1.32 1.16 1.16 1.18 
comEA 0.88 0.91 0.74 0.93 0.95 
comEC 0.93 0.94 0.72 0.83 1.02 
comFA 1.28 1.07 0.95 1.1 1.47 
comFC 0.95 1.54 1 1.16 1.97 
comGA 1.17 0.87 0.97 0.97 1.42 
comGB 0.92 0.93 0.85 0.97 1.1 
comGC 0.89 0.83 0.76 1.03 1.07 
comGD 1.03 0.77 0.71 1.2 1.26 
comX 0.89 0.91 0.81 0.83 1.45 
copB 5.61 1.6 2.84 0.99 2.06 
copR 1.03 0.94 0.79 0.61 1.15 
cpo 1.04 0.83 0.91 0.7 1.06 
cpsM 1.4 0.99 1.08 1.17 1.18 
crtK 1.59 1.84 2.47 1.01 3.02 
cshA 0.99 0.92 1.18 0.78 0.94 
cspE 1.22 1.03 0.84 0.92 1.09 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
cstA 3.24 3.74 5.37 2.86 1.45 
ctrA 1.18 1.1 0.78 0.8 0.86 
ctsR 0.91 1.09 0.85 0.79 1.34 
cydA 0.81 0.88 0.57 0.61 0.82 
cydC 1 1.22 1.01 0.82 0.96 
cydD 1.25 1.45 1.24 1.03 1.02 
cysD 1.74 1.46 1.09 1.78 1.12 
cysE 1.1 1.02 1.02 0.96 1.06 
cysK 1.89 1.49 2.12 1.69 1.55 
cysM 1.12 1.01 1.78 0.95 0.71 
cysS 1.01 0.86 0.89 1.09 0.94 
dacA 1.3 0.93 0.86 1.32 1.27 
dacB 1.03 0.97 1.23 1 0.86 
dal 1.09 1.19 0.9 1.12 1.05 
dapA 1.26 1.22 0.99 1.26 1.31 
dapB 0.93 0.94 0.75 0.87 0.99 
dcdA 1.05 0.94 0.92 1.13 0.97 
ddl 1.29 1.28 1.23 1.09 1 
def 1.38 1.49 0.95 1.11 1.35 
deoB 0.97 0.99 1.09 0.8 1.06 
deoC 1.06 0.95 1.07 0.86 0.91 
deoD 1.11 1.08 1.72 0.86 1.08 
dexB 1.13 0.92 0.95 1.18 1.2 
dfpB 1.01 0.99 1 0.99 1.17 
dfrA 0.81 0.8 0.95 0.93 0.79 
dgkA 1.06 0.99 0.98 1.14 1.1 
dhaK 0.96 1 1.07 0.89 0.96 
dhaL 0.52 0.32 0.93 0.38 1.15 
dhaM 0.67 0.58 0.76 0.63 1.03 
dinF 0.93 0.96 1.25 0.97 0.86 
dltC 0.32 0.35 0.5 0.27 0.46 
dnaC 0.96 1.12 0.97 0.77 0.84 
dnaD 1.34 1.32 1.11 1.69 0.97 
dnaE 0.96 1.1 1.44 1.02 0.9 
dnaH 1.38 1.11 1.07 1.33 1.34 
dnaJ 1.21 0.96 0.85 1.11 0.93 
dnaK 2.41 2.67 1.32 2.28 1.27 
dnaN 0.74 0.68 0.82 0.72 0.82 
dnaQ 1.06 0.97 0.83 1.08 0.83 
dpsA 1.31 1.15 1 1.1 1.23 
dukA 0.99 0.9 0.92 0.97 1.03 
dukB 0.78 1 0.85 0.71 0.82 
dut 1.05 1.22 1.08 0.84 1.13 
dxsA 1.07 1.05 0.87 0.99 1.15 
dxsB 1.44 1.59 1.58 1.11 0.9 
ecsB 0.93 1.02 1.06 0.87 0.82 
efp 0.92 0.81 1.02 0.96 0.81 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
enoA 1.17 0.96 1.09 1.28 1.19 
enoB 1.31 1.16 1 1.4 1.15 
eraL 0.93 0.77 0.85 1.27 0.78 
exoA 1.21 1.1 1.13 0.66 0.89 
ezrA 0.88 0.82 0.95 0.84 0.67 
fabF 1.36 1.41 1.46 0.91 1.44 
fabG1 1.38 1.07 1.16 0.95 1.09 
fabG2 0.92 0.96 1.13 1.12 1.31 
fabI 1.12 0.99 0.94 1.06 0.96 
fabZ1 1.14 0.98 1.02 1.52 1.02 
fabZ2 0.95 1.05 1.12 0.95 1.21 
fadA 1.02 1.05 1.25 1.86 1.65 
fadD 1.35 1.28 1.07 1.73 1 
fbaA 1.2 0.96 0.84 1.09 1.03 
fbp 0.75 0.96 0.97 0.85 0.95 
femD 1.21 1.22 0.98 1.11 1.02 
feoA 3.5 3.27 1.05 4.92 0.98 
feoB 2.17 1.88 0.89 2.12 0.92 
fer 0.65 0.71 0.65 0.94 0.75 
ffh 1.17 0.8 0.99 0.91 0.97 
fhs 0.65 0.7 0.8 0.73 0.82 
fhuB 1.11 0.79 0.73 1.35 0.91 
fhuD 1.38 1.23 1.01 1.22 1.16 
fhuG 1.3 1.12 0.84 1.17 0.98 
fhuR 0.85 0.71 0.81 0.84 0.82 
fmt 1.46 1.5 1.18 1.62 1.46 
folB 1.01 0.94 0.93 0.94 0.86 
folC 1.22 0.87 0.76 1.04 1.02 
folD 1.28 0.95 1.12 1.43 1.01 
folE 1.19 1.17 1.03 0.83 1 
folP 1.01 1.05 1.04 0.67 0.9 
frdC 0.84 0.64 0.89 0.68 0.89 
frr 1.15 0.88 0.88 1 0.83 
ftsA 1.04 0.85 0.89 1.04 0.82 
ftsE 1.06 0.88 0.85 1.14 0.8 
ftsH 1.34 0.98 0.88 1.07 1 
ftsW1 1 1.14 0.79 1.08 0.87 
ftsW2 0.19 0.19 0.58 0.39 0.88 
ftsX 1.18 1.11 0.99 1.07 0.79 
ftsY 1.12 1.05 1.01 0.87 1.07 
ftsZ 0.95 0.99 0.99 0.94 0.79 
fur 1.02 1.02 1.14 0.85 1.03 
fusA 1.06 0.93 1.01 0.97 1.06 
gadB 1.49 0.86 0.7 0.89 0.91 
gadC 1.48 0.71 0.41 0.73 0.95 
gadR 1.18 1 1.14 1.08 1.06 
galE 1.31 0.76 1.33 1.45 1.02 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
galK 2.72 1.45 3.97 3.05 2.3 
galM 2.34 1.69 3.58 2.3 3.57 
galT 1.63 1 2.1 1.68 1.26 
gapA 1.51 1.73 1.27 1.12 1.66 
gapB 1.42 1.36 1.32 1.54 1.27 
gatB 1.11 1.08 1.24 0.87 0.92 
gatC 0.9 0.91 1.18 0.84 0.98 
gcp 1.26 1.16 0.99 1.21 0.95 
gidA 0.89 1.15 1.05 0.81 0.75 
gidB 2.23 1.71 1.49 2.06 1.25 
gidC 0.88 0.94 0.82 0.73 0.7 
glgA 0.59 0.64 0.58 0.43 0.57 
glgC 0.55 0.61 0.75 0.4 0.54 
glgD 0.69 0.69 0.84 0.36 0.75 
glgP 0.48 0.58 0.53 0.4 0.61 
glk 1.46 1.26 0.91 1.27 0.83 
glmS 0.69 0.83 1.61 0.7 0.69 
glmU 1.01 0.99 0.96 1.01 0.96 
glnA 1.03 0.84 0.66 0.87 0.56 
glnB 1.01 1.26 0.85 0.78 0.7 
glnP 0.94 0.97 0.94 0.7 0.66 
glnR 0.71 0.66 0.5 0.75 0.47 
glpD 0.69 0.89 0.67 0.58 0.79 
glpF1 0.71 0.76 1.04 0.94 0.84 
glpF2 0.73 0.84 0.73 0.82 0.96 
glpK 0.74 0.88 0.69 0.79 0.88 
glpT 0.59 0.58 0.5 0.61 0.58 
gltA 1.09 0.92 1.25 1 0.74 
gltD 0.99 1.17 0.66 0.97 1.18 
gltQ 0.92 0.92 1.84 0.87 0.68 
gltS 0.43 0.36 2.15 0.38 0.32 
glyA 1.02 1.06 1 0.87 0.83 
glyS 1.39 1.32 1.02 1.28 0.69 
gnd 1.46 1.38 1.28 1.41 1.07 
gntK 1.07 1.15 1.31 1 1.11 
gntR 0.99 1.14 1.26 0.94 1.11 
gntZ 1.03 1.47 1.42 1.13 0.98 
gpdA 0.92 0.87 1.03 1.06 0.87 
gpo 0.86 0.73 1.08 0.77 1.38 
greA 1.55 1.39 2.81 1.2 1.26 
groES 1.46 1.23 0.7 1.03 1.24 
grpE 2.2 2.24 1.09 1.59 1.08 
gshR 0.83 0.96 1.02 0.54 0.85 
guaA 1.25 1.19 1 1.23 0.74 
guaB 1.04 0.93 0.82 0.93 0.54 
guaC 0.57 0.55 0.48 0.96 0.65 
gyrA 1.08 0.91 0.8 1.22 0.85 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
gyrB 0.91 0.91 0.8 1.18 0.72 
hemH 0.88 0.78 0.93 1.03 0.66 
hemK 1.06 1.21 1.09 0.74 0.88 
hemN 0.99 1.06 1.27 1.03 0.83 
hexA 0.84 0.88 0.99 0.97 0.92 
hexB 1.03 1.05 1.04 1.13 0.8 
hflX 1.4 1.41 1.42 1.43 0.94 
hisA 0.88 0.81 0.58 0.77 0.64 
hisB 0.77 0.68 0.66 0.89 0.93 
hisC 0.6 0.56 0.3 1.04 0.56 
hisD 0.86 0.79 0.65 0.64 0.92 
hisG 0.85 0.9 0.64 0.67 0.83 
hisH 0.87 0.99 0.81 0.72 0.93 
hisI 0.73 0.76 0.67 0.63 0.89 
hisK 0.65 0.78 0.59 0.7 0.76 
hisS 1.02 1.18 0.99 1.13 0.73 
hisZ 0.66 0.71 0.52 0.61 0.59 
hly 0.77 0.88 0.95 0.82 0.66 
hmcM 1.84 2.28 2.17 1.86 1.27 
holB 1.24 1.06 0.9 1.27 0.84 
hom 0.96 1.1 0.84 0.89 0.56 
hprT 1.11 1 0.95 1.11 0.96 
hpt 1.17 0.95 0.82 1.29 0.92 
hrcA 1.38 1.57 0.96 1.22 1.18 
hsdM 0.34 0.39 1.58 0.33 0.3 
hsdR 0.97 0.8 0.94 0.75 0.72 
hsdS 0.77 1.45 2.24 1.03 0.43 
hslA 0.92 0.7 0.89 0.87 1.02 
hslB 2.17 1.72 1.01 0.99 1.15 
htrA 0.78 0.84 0.67 0.75 0.59 
icaA 0.84 1.62 0.85 0.83 0.82 
icaC 0.91 1.32 0.96 1.01 0.62 
icd 1.43 1.28 1.6 0.93 0.93 
ileS 1.41 1.35 0.81 1.35 0.85 
ilvB 0.83 0.85 0.75 0.8 0.61 
ilvC 0.48 0.7 0.66 0.55 0.49 
ilvD 0.37 0.54 0.46 0.32 0.4 
ilvN 0.73 0.83 0.77 0.79 0.66 
infA 0.83 0.81 0.97 1.07 1.03 
infB 1.1 1.11 1.26 1.06 0.76 
infC 1.1 1.07 1.68 1.21 0.81 
ipd 0.14 0.21 0.43 0.15 0.1 
ispA 1.22 1.19 1.07 1.38 0.89 
ispB 1.52 1.18 0.93 1.31 0.9 
kdgA 0.7 0.72 0.89 0.72 1.03 
kdgK 1.07 0.99 0.82 1.27 1 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
kdtB 1.11 1.1 0.92 0.82 0.95 
kinA 1.03 1.31 1.07 1.02 1 
kinB 0.78 0.9 1.06 0.74 0.71 
kinC 1.14 1.12 0.93 1.13 1.03 
kinD 1.26 1.13 1.13 1.28 0.89 
kinE 0.96 0.96 0.96 1.2 0.95 
kinF 2.28 2.28 1.89 1.58 0.77 
ksgA 1.63 1.27 1.23 1.54 1.16 
kupA 0.72 1.11 1.19 0.88 0.83 
kupB 1.12 1.51 0.81 1.16 0.99 
lacC 2.2 3 2.75 1.78 1.9 
lacR 1.2 1.78 1.86 1.16 1.08 
lacZ 1.82 1.45 2.4 2.07 1.76 
lcnC 0.5 0.32 0.65 0.61 0.66 
lcnD 0.44 0.57 0.83 0.47 0.85 
lctO 0.77 0.78 0.78 0.86 0.92 
ldh 1.16 1.43 2.15 1.3 1.11 
ldhB 1.03 0.94 0.95 1.14 0.8 
ldhX 1.16 1.14 1.16 1.31 1.03 
lepA 0.88 0.98 0.92 0.91 0.66 
leuB 0.6 0.65 0.65 0.52 0.52 
leuC 0.45 0.41 0.58 0.33 0.41 
leuD 0.62 0.57 0.68 0.75 0.76 
leuS 1.11 1.32 1.11 1.25 0.72 
lgt 1.07 1.41 1.51 1.33 1.01 
ligA 0.5 0.46 0.58 0.62 0.58 
llrA 1.08 1.21 1.23 0.77 1.04 
llrB 0.65 1 1.1 0.82 0.73 
llrC 0.76 0.84 0.97 0.92 0.71 
llrD 1.44 1.31 1.12 1.49 0.99 
llrE 0.77 0.86 0.91 1.07 0.78 
llrF 1.62 2 1.55 1.27 1.08 
llrG 1.03 1.2 0.93 0.81 0.83 
llrH 0.71 0.29 0.3 0.69 0.58 
lmrA 0.71 0.77 0.59 0.77 0.67 
lnbA 0.99 0.77 0.8 0.75 0.85 
lplL 1.66 1.44 2.96 1.89 1.18 
lspA 0.84 0.89 1 0.97 0.87 
lysA 0.65 0.69 0.69 0.51 0.69 
lysP 0.85 0.83 0.78 0.75 0.88 
lysQ 0.4 0.37 0.73 0.25 0.42 
lysS 0.67 0.74 1.11 0.92 0.9 
mae 1.04 0.98 2.98 1.22 1.19 
malQ 1.24 1 1.12 0.88 1.08 
menB 1.17 1.15 0.95 1.15 1.09 
menD 1.2 1.23 1.16 0.95 1.26 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
menE 0.98 1.13 0.92 1.16 1.11 
menF 1.2 1.36 1.26 0.91 1.18 
menX 1.52 1.66 1.8 1.24 1.37 
mesJ 1.8 1.38 0.93 1.91 1.25 
metB1 1.05 0.93 1.23 0.98 1.52 
metB2 1.9 1.71 2.52 1.45 1.38 
metE 0.48 0.46 0.28 0.37 0.54 
metF 0.42 0.52 0.37 0.48 0.59 
metK 0.95 1.09 1.41 0.98 1.13 
metS 0.7 0.73 0.8 0.67 0.77 
mgtA 0.43 0.35 0.47 0.36 0.34 
miaA 0.7 0.53 0.66 0.59 0.65 
mleR 0.91 0.8 0.77 0.89 0.86 
mleS 1.15 1.22 1.38 0.77 1.2 
mreC 1.05 0.87 0.88 1.14 1.03 
mreD 0.89 1.02 0.82 0.84 0.84 
mscL 1.72 2.07 1.9 1.28 2.1 
msmK 1.12 1.14 1.16 0.79 0.97 
mtlD 0.91 1.29 0.97 0.8 0.84 
mtlF 0.93 1.01 0.85 0.81 1.15 
mtlR 0.92 0.99 1.02 0.98 1.14 
mtsA 2.12 2.14 0.65 2.43 1.46 
mtsB 1.7 1.6 0.64 2.35 1.32 
mtsC 2.21 2.57 0.56 2.6 1.44 
murA1 1.26 1.18 1.03 1.42 1.29 
murA2 0.98 0.81 0.82 1.06 1.01 
murB 1.35 1.22 1.05 1.4 1.14 
murC 1.55 1.28 1.06 1.28 1.16 
murD 1.13 1 0.93 0.92 1.04 
murE 0.98 0.92 0.84 0.92 0.98 
murF 1.05 1.13 1.07 1.09 1.04 
murI 0.76 0.71 0.62 0.83 0.84 
mutM 1.46 0.95 1.37 0.92 1.35 
mutS 1.31 1 1.27 1.38 1.24 
mutX 1.09 0.88 1.06 1.04 1.14 
mvaA 1.33 0.89 0.75 1.28 1.02 
mycA 1.2 1.71 1.1 1.48 1.06 
nadE 1.29 1.23 1.31 0.8 1.01 
nadR 1.1 1.1 1.13 1.04 1.32 
nagA 1.54 1.34 1.06 1.32 1.17 
nagB 1.14 1.27 0.89 1 1.32 
nah 0.88 0.94 1.1 0.85 1.19 
napB 1.07 0.97 1.26 0.82 1.09 
napC 0.63 0.51 0.57 0.85 0.74 
ndrH 0.7 0.88 0.75 0.39 0.8 
ndrI 0.63 0.74 0.71 0.45 0.75 
nifS 0.92 0.95 0.83 0.92 0.89 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
nifU 0.9 0.91 0.73 0.85 0.87 
nifZ 1.28 1.4 0.9 1.55 1.13 
noxA 0.9 0.78 0.8 0.72 0.62 
noxB 1.25 1.06 0.87 1.2 0.77 
noxC 1.74 1.74 0.92 1.58 1.38 
noxD 1.8 2.14 1.15 1.71 0.92 
noxE 1.25 1.03 0.33 1.62 1.38 
nrdD 0.63 0.55 0.61 0.5 0.63 
nrdE 0.77 0.83 0.72 0.53 0.76 
nrdF 0.88 0.85 0.75 0.78 0.89 
nrdG 1.07 0.92 1.07 0.86 0.7 
nth 2.28 2.11 1.3 3.23 1.63 
nucA 0.64 0.77 0.68 0.54 0.71 
nusA 0.94 0.91 0.86 0.86 0.81 
nusB 1.54 1.43 1.42 1.28 1.08 
nusG 1.05 1 1.23 0.94 0.88 
obgL 1.05 1.18 0.92 1.27 1.06 
ogt 0.83 0.86 0.76 0.81 0.76 
oppA 0.52 0.69 0.49 0.36 0.78 
oppB 0.74 0.71 0.71 0.54 1.24 
oppC 0.74 0.75 0.72 0.55 1.13 
oppD 0.65 0.65 0.83 0.71 1.05 
oppF 0.82 0.86 0.71 0.66 1.1 
optA 1.46 1.09 0.61 0.88 0.93 
optB 0.86 1 0.52 0.7 0.82 
optC 0.53 0.78 0.42 0.5 0.74 
optD 0.83 1.19 0.54 0.68 0.75 
optF 0.71 1.03 0.44 0.62 0.72 
optS 1.16 1.1 0.79 1.02 0.97 
osmC 0.79 0.85 0.45 0.8 1.16 
otcA 1.13 1.38 1.09 1.47 1.95 
pabB 1 0.95 0.78 1.02 1.07 
pacB 0.93 0.85 0.83 0.97 0.93 
pacL 0.97 0.89 0.76 0.99 1.14 
panE 0.98 0.97 0.67 0.75 1.44 
papL 0.9 0.93 0.89 0.98 0.92 
parA 1.79 1.84 1.02 1.47 1.02 
parC 1.14 1.2 0.99 1.08 0.83 
parE 1.08 0.88 1.15 0.73 0.8 
pbp1B 0.92 0.97 1.11 0.97 1 
pbp2A 1.1 1 1.04 0.96 1.13 
pbp2B 1.3 0.93 1 1.24 1.26 
pbpX 1.4 1.08 0.85 1.23 1 
pbuX 0.64 0.72 0.55 0.61 0.6 
pcaC 1.28 1.08 0.92 1.27 1.38 
pcrA 0.84 0.83 0.85 0.9 0.69 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
pdc 0.83 0.97 0.85 0.68 0.95 
pdhA 0.54 0.74 0.93 0.65 0.9 
pdhB 1.07 1.19 1.26 0.92 1.07 
pdhC 0.7 0.92 1.1 0.75 1.01 
pdhD 0.87 1 1.11 0.91 1.12 
pdp 1.1 1.07 1.19 0.98 1.2 
pepC 0.73 0.73 1 0.8 0.8 
pepDA 1.11 0.68 0.91 0.99 0.98 
pepDB 1.52 1.31 1.37 0.98 1.36 
pepF 1.19 1.35 1.11 1.07 0.92 
pepM 0.96 0.97 0.99 1.09 0.93 
pepN 0.9 0.94 0.93 0.92 1.12 
pepO 0.58 0.75 0.63 0.5 0.81 
pepP 0.84 0.95 1.21 0.57 1 
pepT 1.63 1.28 1.34 1.3 1.57 
pepV 0.82 0.96 0.96 0.64 0.86 
pepXP 2.41 2.13 2.45 1.87 1.16 
pfl 0.68 0.62 0.69 0.71 0.54 
pflA 1.13 0.93 0.96 1.03 0.93 
pfs 1.03 1.21 0.88 1.25 1.15 
pgk 1.14 1.04 1.03 0.91 1.08 
pgmB 0.79 0.88 0.86 0.7 0.87 
pgsA 1.16 1.1 1 0.9 0.78 
pheA 1.14 1.25 0.89 0.8 0.85 
pheS 1.13 1.24 1.01 0.93 1.17 
pheT 1.33 1.21 1.11 1.1 1.06 
phnA 3.01 2.39 1.05 2.52 1.12 
phnB 0.86 0.72 0.84 0.84 0.93 
phnC 0.64 0.52 0.69 0.72 0.66 
phnE 0.64 0.6 0.89 0.72 0.7 
phoL 0.99 1.02 1.04 0.99 0.87 
phoU 1.11 1.17 1.1 0.87 1.13 
pi101 1.6 1.26 2.41 1.01 2.73 
pi102 1.14 0.92 2.88 1.93 1.06 
pi103 1.17 1.29 1.98 1.37 0.91 
pi104 1.24 0.86 0.77 1.22 1.05 
pi105 1.32 1.01 0.91 0.88 3.35 
pi106 0.69 0.78 1.01 0.95 0.82 
pi107 1.15 1.13 2.19 1.13 1.3 
pi108 1.56 1.21 1.15 1.38 1.52 
pi109 1.19 0.97 1.54 1.24 1.52 
pi110 1.24 1.01 0.81 1.1 1.04 
pi111 1.29 1.31 1.09 1.3 1.14 
pi113 1.52 0.83 0.95 1.03 1.33 
pi114 1.22 1 0.89 1.22 1.1 
pi115 1.16 0.91 0.93 1.25 1.22 
pi116 1.12 0.89 0.75 1.21 1.42 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
pi117 0.57 0.51 0.44 0.44 0.58 
pi118 1.08 1.08 1.03 0.95 0.92 
pi120 0.5 0.54 0.45 0.47 0.56 
pi122 0.9 1.06 1.04 0.88 0.86 
pi123 0.69 0.71 1 0.77 0.75 
pi124 1.15 0.8 0.91 0.88 0.94 
pi125 0.07 0.05 2.01 0.06 0.07 
pi127 0.73 0.6 0.96 0.7 1.08 
pi128 1.4 1.08 1.48 1.28 1.63 
pi129 1.54 1.42 1.13 1.55 1.43 
pi130 1.02 0.91 1.16 0.87 1.02 
pi133 1.52 1.12 0.91 1.31 1.37 
pi135 1.22 0.99 0.93 1.07 1.21 
pi137 0.79 0.9 0.87 0.77 0.86 
pi138 0.96 0.89 1.01 1.01 0.96 
pi139 1.19 1.17 1.1 1.27 1.44 
pi140 1.01 0.97 0.86 0.93 0.97 
pi141 1.13 1.22 1.19 1.4 1.44 
pi142 1.46 0.83 0.77 1 1.33 
pi143 1.09 0.99 1.03 1.12 1.21 
pi144 1.12 1.08 0.95 1.03 1.1 
pi145 1.11 1.18 3.47 0.9 0.82 
pi205 0.85 1.08 1.25 1.05 0.85 
pi208 0.09 0.1 0.47 0.9 0.46 
pi209 0.78 1.14 0.78 0.78 0.87 
pi210 0.25 0.37 0.31 0.28 0.37 
pi211 0.49 0.65 0.94 0.59 0.68 
pi215 0.8 0.93 0.56 0.85 1.1 
pi216 0.84 1.03 1 1 0.85 
pi217 1.09 0.95 0.85 1.05 1.06 
pi218 1.05 0.77 0.74 1.09 1.19 
pi222 0.49 0.56 0.52 0.47 0.67 
pi223 0.72 0.8 1.2 0.73 0.86 
pi224 1.05 1.02 1.17 1.16 1.27 
pi227 1.15 1.23 1.38 1.12 1.28 
pi228 1.45 1.12 0.95 1.11 1.07 
pi229 1.1 1.06 0.98 1.38 0.93 
pi230 0.98 0.89 0.91 1.17 1.15 
pi231 1.14 1.15 0.88 1.3 0.88 
pi232 1.22 1.27 1.08 1.14 0.98 
pi233 1.27 1.08 0.85 1.39 1.44 
pi234 1.04 0.8 0.8 1.03 1.27 
pi235 1.41 1.03 0.96 0.99 1.09 
pi236 1.14 1.01 0.99 1.24 1.18 
pi237 1.55 1.37 1.1 1.35 0.82 
pi238 0.89 1.12 1.07 1 0.95 
pi239 1.3 1.22 1.09 1.14 1.27 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
pi240 1.01 0.98 0.94 0.97 1.07 
pi241 1.29 1.05 0.85 1 1.13 
pi242 1.06 1.11 1.22 1.04 1.11 
pi243 1.46 1.18 1.15 1.52 1.46 
pi244 1.12 1.11 1.22 1.47 1.45 
pi245 1.33 1.13 0.9 1.56 1.3 
pi246 1.12 1.08 0.9 1.34 0.97 
pi247 0.98 0.75 0.76 1 0.88 
pi248 1.09 1.2 1.07 1.03 1.05 
pi249 1.05 0.95 1.1 1.15 1.46 
pi251 1.03 1.07 1.24 0.81 1.3 
pi301 0.54 0.62 0.59 0.63 0.6 
pi302 0.82 0.87 0.86 0.74 0.97 
pi303 1 0.66 0.86 1.07 1.47 
pi307 1.26 1.27 1.02 1.1 0.79 
pi308 1.07 1.05 1.09 0.84 1.32 
pi316 0.81 0.78 0.72 0.78 0.83 
pi317 1.08 0.93 1 1.22 1.2 
pi318 1.18 0.97 0.88 1.34 1.21 
pi319 1.18 1 1.01 1.46 1.65 
pi320 1.16 1.21 1 1.43 1.39 
pi321 1.05 1.18 1.04 1.02 1.35 
pi322 1.18 1.31 1.11 1.3 1.64 
pi323 1.19 1.08 0.99 1.14 1.31 
pi324 1.2 1.21 1.11 1.32 1.22 
pi325 1.02 0.97 0.8 0.93 0.85 
pi326 1.13 1.16 0.91 1.04 0.75 
pi327 1.13 1.07 1.19 1.01 1.25 
pi328 1.1 1.18 0.97 1.02 1.18 
pi329 1.11 1.16 1.21 1.38 1.38 
pi330 1.17 0.95 0.9 1.12 1.11 
pi331 1.22 1.02 0.98 1.37 1.13 
pi333 0.7 0.94 0.76 0.86 1.06 
pi334 1.04 0.86 0.8 1.03 1 
pi336 0.75 1.19 0.84 0.72 0.93 
pi337 0.6 0.57 0.55 0.59 0.64 
pi338 1.15 1.07 0.83 1.35 1.18 
pi339 0.95 1 0.83 0.98 1.27 
pi341 0.8 0.94 1.03 0.88 1.05 
pi343 1.31 0.94 0.82 0.99 0.96 
pi345 0.99 1.08 0.88 1.13 1.07 
pi347 1.03 1.16 1.03 0.95 1.14 
pi348 0.52 0.55 0.56 0.59 0.6 
pi349 0.35 0.35 0.29 0.33 0.39 
pi350 0.94 1.09 0.88 1.09 0.95 
pi353 0.4 0.38 0.39 0.41 0.53 
pi354 0.91 1.01 0.85 1.11 1.47 
 
  
 
 
 
 
 
 
167 
 
Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
pi355 1.21 1.73 1.19 1.6 1.01 
pi356 0.96 0.65 0.65 1.14 1.12 
pi357 1 0.87 0.81 1.29 1.06 
pi358 1.93 1.33 1.82 3.27 1.37 
pi359 0.14 0.16 0.17 0.15 0.16 
pi360 0.84 1 0.98 3.79 2.02 
pip 1.04 1.17 1.4 1.03 0.72 
pknB 1.2 1.06 0.88 1.23 0.82 
plpA 1.26 1.14 1.51 1.12 0.73 
plpB 1.49 1.49 1.78 1.16 1 
plpC 1.43 1.46 1.49 1.22 0.97 
plpD 1.19 1.07 1.24 1.21 0.96 
plsX 1.08 0.99 0.99 0.89 1.15 
pmg 0.95 0.78 0.79 0.84 0.73 
pmpA 0.71 0.79 0.86 0.81 0.55 
pmrA 1.09 1.25 0.79 0.91 1.08 
pmsR 0.85 0.89 1.22 0.71 0.94 
pmsX 1.34 1.37 1.19 1.06 1.53 
pnpA 1.37 0.95 1.11 1.26 0.74 
pnuC2 1.25 1.25 0.92 1.27 0.95 
polA 1.26 1.19 1.06 1.14 1.4 
polC 0.91 1.01 1.14 1.01 1 
ponA 1.25 1.01 1.08 0.92 1.02 
potA 1.24 1.11 1.33 1.08 0.88 
potB 1.12 0.98 1.3 0.98 0.9 
potC 0.8 0.89 1.08 0.67 0.62 
potD 1.19 1.14 1.7 0.82 0.93 
poxL 0.58 0.51 0.47 0.52 0.96 
ppiA 0.82 0.78 0.91 0.79 0.56 
ppiB 1.57 1.14 0.78 1.57 1.77 
preA 1.15 1.17 0.84 0.68 1.25 
prfA 1.43 1.33 1.11 1.43 1.08 
prfB 1.01 0.98 1.26 1.06 1.11 
prfC 0.99 1.05 1.16 0.97 0.73 
prmA 1 0.9 0.98 0.86 0.98 
proA 0.91 0.89 0.99 0.72 0.7 
proB 0.84 0.72 0.85 0.76 0.63 
proC 0.94 1.09 0.93 0.65 0.82 
proS 0.94 0.98 1.04 0.97 0.76 
prsA 1.11 1.13 0.87 1.34 0.92 
prsB 1.13 0.85 0.89 1.22 0.88 
ps101 1.37 1.17 1.13 1.78 1.39 
ps102 0.98 1.35 1.36 1.43 0.75 
ps104 1.13 1.3 1.05 1.14 1.22 
ps105 1.25 1.15 0.81 1.14 0.99 
ps106 1.18 1.81 0.85 1.26 1.18 
ps107 1.16 1.9 1.11 1.13 1.06 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ps108 0.89 0.62 0.56 0.92 0.94 
ps109 1.05 0.93 0.86 0.98 1.2 
ps110 1.1 0.99 0.9 1.02 1.31 
ps111 0.92 1.07 0.92 1.14 1.33 
ps112 1.34 1.39 1.22 1.44 1.22 
ps113 1.09 1.09 1.02 1.21 1.14 
ps114 1.33 1.07 1.03 1.22 1.06 
ps115 1.03 1.15 1.13 1.52 1.22 
ps116 1.5 1.38 1.27 1.79 1.62 
ps117 0.72 0.84 2.17 1.64 1.09 
ps118 5.76 2.46 1.86 3.79 3.68 
ps119 1.32 1.15 1.51 1.55 1.52 
ps120 0.92 1.03 1.76 1.33 1.44 
ps121 2.05 2.08 1.61 1.55 1.46 
ps122 1.21 1.23 1.17 1.42 0.84 
ps123 1.23 1.13 0.96 1.07 0.57 
ps201 1.76 1.38 1.62 1.92 2.2 
ps202 2.04 1.09 1.98 1.16 1.08 
ps203 0.72 0.3 0.7 0.2 0.91 
ps205 1.51 1.25 1.6 1.39 1.28 
ps206 1.1 0.87 1.01 0.95 1.13 
ps207 1.46 0.98 0.88 1.23 1.51 
ps209 1.06 1.72 0.85 0.95 1.04 
ps211 0.99 1.16 0.85 1 1.15 
ps212 0.99 0.88 0.9 1.01 1.29 
ps213 1.51 1.29 1.43 1.08 1.21 
ps214 1.22 1.05 0.96 1.14 0.93 
ps216 1.2 1.15 0.99 1.25 1.11 
ps218 1.26 1.79 1.01 1.57 0.99 
ps219 1.24 1.06 0.88 1.43 1.17 
ps220 1.61 1.21 1 1.93 1.34 
ps301 0.89 0.92 6.19 0.89 0.74 
ps302 1.04 0.89 9.14 0.89 1.08 
ps303 0.57 0.28 0.69 0.78 1.02 
ps304 1.1 0.99 0.98 1.04 1.16 
ps306 1.13 1.11 0.99 0.96 1.54 
ps307 0.88 1.32 0.9 1 1.81 
ps308 0.88 0.95 0.86 0.76 1.17 
ps309 0.97 1.11 1 1.08 0.96 
ps311 0.94 1.25 0.92 0.73 0.75 
ps312 0.97 1.1 1.17 0.97 1.01 
ps314 0.86 1.01 0.92 1.13 1.09 
ps316 0.25 0.24 1.56 0.41 0.37 
pstA 1.01 0.9 1.02 0.87 0.82 
pstB 0.99 0.96 0.97 0.81 0.8 
pstC 0.96 1.04 1.27 0.84 0.8 
pstE 2.22 1.13 1.99 0.77 1.22 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
pstF 2.61 0.96 2.7 0.48 1.13 
pta 0.77 0.78 0.89 0.89 0.77 
ptbA 0.32 0.31 0.3 0.19 0.77 
ptcA 1.31 0.92 3.06 0.99 1.12 
ptcB 1.11 0.72 1.72 0.9 0.66 
ptcC 1.41 1.16 1.88 0.94 0.93 
ptk 0.74 0.96 0.97 0.65 1.07 
ptnAB 0.58 0.64 0.82 0.64 0.74 
ptnC 1.24 1.31 1.61 1.33 0.68 
ptnD 1.14 1.25 1.39 1.16 0.8 
ptpL 0.59 0.81 0.63 1.06 0.63 
ptsH 0.96 0.83 0.87 1 0.93 
ptsI 0.99 1.21 0.93 1.17 0.74 
ptsK 0.73 0.87 0.91 0.77 0.63 
purB 0.8 0.8 0.9 0.89 0.6 
purC 0.74 0.7 0.87 1.02 0.49 
purD 0.81 0.74 0.92 1.13 0.58 
purE 0.95 0.97 1.03 1.23 0.58 
purF 0.74 0.66 0.62 0.57 0.64 
purH 0.82 0.74 0.7 1.09 0.55 
purK 0.82 0.79 0.92 1.01 0.47 
purL 0.48 0.66 0.72 0.62 0.48 
purM 0.73 0.7 0.83 0.95 0.72 
purN 0.92 0.84 1.09 1.02 0.77 
purR 0.64 0.57 0.93 0.82 0.69 
pycA 0.9 0.99 0.75 0.82 0.7 
pydA 0.63 0.62 0.5 0.55 0.6 
pydB 0.61 0.47 0.62 0.31 0.3 
pyk 1.21 1.22 1.08 1.08 0.82 
pyrB 0.36 0.43 0.63 0.19 0.34 
pyrC 0.56 0.42 0.66 0.39 0.32 
pyrE 0.81 0.43 0.5 0.47 0.32 
pyrF 0.54 0.7 0.77 0.42 0.39 
pyrG 1 0.92 0.89 0.77 0.79 
pyrH 1.02 0.57 0.84 1.07 0.82 
pyrR 0.45 0.47 0.66 0.26 0.31 
pyrZ 0.49 0.22 0.4 0.22 0.21 
qor 1.25 1.51 1.26 2.03 1.1 
queA 1.22 1.26 1.07 1.3 0.78 
racD 1.31 1.29 1.04 1.21 0.8 
radA 1.15 1.29 1.11 1.08 1.02 
radC 1.09 1.08 1.26 1.19 1.14 
rarA 0.82 0.59 0.71 0.81 1.2 
rbfA 1.17 1.07 1.19 1.11 0.88 
rbsA 1.7 1.47 1.35 1.58 1.08 
rbsB 1.25 1.45 1.64 1.66 1.29 
rbsC 1.46 1.61 1.32 1.55 0.96 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
rbsD 0.86 1.07 1.01 1.15 0.79 
rbsK 1.98 1.87 1.2 1.39 1.37 
rbsR 1.01 0.95 0.78 1.71 0.86 
rcfA 1.03 1.12 0.88 1.21 0.9 
rcfB 1.15 0.97 0.85 1.21 1.1 
rdrA 1.09 1.05 0.91 1.12 0.81 
rdrB 1.11 1.33 0.66 1.01 0.88 
recA 0.94 0.93 0.86 1.11 0.81 
recD 0.96 1.58 0.82 0.85 0.91 
recJ 1.83 1.79 1.8 1.68 1.7 
recM 1.31 0.99 0.89 1.17 1.17 
recN 1.76 1.4 1.17 1.63 1.71 
recQ 1.28 1.09 0.86 1.17 1.03 
relA 0.76 0.73 0.91 0.85 0.82 
rexA 1.09 1 0.89 1.01 1.09 
rexB 0.95 0.95 0.83 0.97 1.24 
rgpA 0.96 0.78 0.92 0.84 0.81 
rgpB 0.77 0.62 1.49 0.62 0.67 
rgpC 1.04 0.89 5.35 0.84 1 
rgpE 1.08 0.87 1.52 1.15 1.37 
rgpF 1.06 1.13 5.46 0.9 1.04 
rgrA 1.1 1.02 0.99 0.99 1.24 
rgrB 0.94 0.84 0.79 0.73 0.66 
rheA 1.5 1.06 0.64 1.47 1.59 
rheB 1.06 0.88 0.87 1.11 0.88 
ribA 1.18 0.87 0.8 1.1 1 
ribC 1.24 0.97 0.89 1.19 1.21 
ribH 0.93 0.97 0.95 1.13 1.52 
rimM 1.02 0.89 1.1 0.99 0.85 
rliA 1.09 0.72 0.76 1.09 1.1 
rliB 1.01 0.95 1.24 1.1 0.9 
rliC 1.29 1.39 0.96 1.76 1.51 
rliDB 1.08 1.02 0.71 0.93 1.27 
rlrA 0.8 0.83 0.85 0.96 0.7 
rlrB 0.84 0.84 0.98 1.36 1.3 
rlrC 0.57 0.54 0.48 0.56 0.48 
rlrD 0.4 0.55 0.7 0.75 1.14 
rlrG 0.92 0.96 1.31 0.89 1.29 
rluA 1.18 0.9 1 0.95 1.34 
rluB 1.42 1 0.98 1.31 1.44 
rluC 1.61 1.63 1.85 1.76 1.24 
rluD 1.05 0.93 1.02 1.03 1.02 
rmaA 1.05 0.92 2.37 1.11 1.26 
rmaB 0.71 0.56 0.32 0.6 0.53 
rmaC 1 1.23 0.73 0.64 1.1 
rmaD 1.07 1.08 0.98 1.07 1.11 
rmaE 1.16 0.94 0.86 1.09 1.15 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
rmaF 0.56 0.49 0.49 0.56 0.56 
rmaG 1.05 0.72 0.88 0.94 1.03 
rmaH 1.02 0.85 0.81 1.07 1.1 
rmaI 1.33 1.03 0.97 1.59 1.06 
rmaJ 1.02 0.52 0.77 1.75 0.91 
rmeA 1.12 0.86 0.78 1.27 1.36 
rmeB 0.95 0.97 0.85 0.92 1.58 
rmeC 1.05 0.74 0.67 1.15 1.32 
rmeD 1.42 1.34 1.66 1.25 1.19 
rmlA 1.25 1.29 1.5 1.19 1.2 
rmlB 1.35 1.17 1.31 1.07 0.94 
rmlC 1.16 0.88 1.19 1.14 0.91 
rnc 1.02 0.85 0.92 1.04 1.08 
rnhA 0.99 0.98 1.53 1.11 1.03 
rnhB 1.15 0.95 1.52 1.23 1 
rnpA 1.22 0.83 1.36 1.37 1.18 
rpe 1.08 1.08 1.24 1.21 1.23 
rpiA 1 0.77 0.72 0.94 0.91 
rplA 1.13 0.96 1.03 1.13 0.85 
rplB 1.51 1.54 1.99 1.43 1.31 
rplI 1.09 1 0.99 0.7 0.98 
rplM 1.17 0.99 1.01 0.97 0.85 
rplN 1.06 1.35 1.65 1.3 1.39 
rplO 1.05 0.86 0.82 0.91 0.87 
rplQ 0.8 0.75 0.78 1.02 0.99 
rplR 1.24 1.38 1.43 1.29 1.02 
rplS 1.17 1.2 1.23 1.11 1.1 
rplT 1.67 1.23 2.47 1.48 1.03 
rplU 0.99 0.88 1.03 0.8 0.8 
rplV 1.11 1.2 1.52 1.14 1.08 
rplX 0.88 0.77 1.23 0.87 1.15 
rpmA 1.15 0.87 1.18 0.92 0.99 
rpmB 0.99 0.89 0.95 0.79 1.05 
rpmD 1.19 0.85 0.9 1.26 1.18 
rpmE 1 0.79 0.98 1.09 1.04 
rpmF 0.76 0.69 0.81 0.97 0.72 
rpmGA 0.96 1.19 1.15 0.9 1.11 
rpmGB 0.76 0.64 0.89 0.85 0.9 
rpmGC 0.78 0.96 0.72 0.95 0.78 
rpmH 1.2 1.39 0.91 1.29 1.13 
rpmI 1.55 1.25 2.09 1.55 1.07 
rpmJ 1.01 0.91 0.97 1.05 1.02 
rpoA 1 0.88 1.06 1.42 1.07 
rpoB 0.99 0.95 1 0.95 0.81 
rpoC 0.85 0.87 0.99 0.76 0.83 
rpoD 0.99 0.87 0.91 0.93 1.11 
rpoE 1.11 0.92 0.96 1.23 0.86 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
rpsA 1.24 1.22 1.08 1.2 1.08 
rpsB 0.94 0.77 0.8 1.03 0.83 
rpsC 0.99 1.23 1.62 0.99 1.02 
rpsD 1.14 0.96 1.3 0.99 0.85 
rpsE 0.96 0.83 1.17 1.04 1.08 
rpsF 0.86 0.81 1.15 0.79 0.95 
rpsG 1.16 0.88 1.25 0.96 1.03 
rpsH 0.89 1.01 1.2 1.23 0.92 
rpsI 1.23 1.08 1.07 1.05 0.83 
rpsJ 0.96 1.25 1.44 1.2 0.87 
rpsK 0.81 0.91 1.01 1.09 0.86 
rpsL 0.86 0.87 1.08 0.91 0.72 
rpsM 0.92 1.23 1.18 1.11 0.79 
rpsN 1.14 0.87 1.26 0.93 1.13 
rpsN2 1.01 0.82 1.02 0.6 0.91 
rpsO 0.84 0.78 1 0.78 0.84 
rpsP 0.66 0.55 0.59 0.65 1.09 
rpsQ 1.23 1.15 1.65 1.46 1.22 
rpsR 1.04 0.92 0.91 1.2 0.99 
rpsS 1.2 1.14 1.46 1.41 0.77 
rpsT 0.97 0.99 0.79 0.9 0.88 
rpsU 1.25 0.97 0.94 1.09 1.04 
rsuA 1.91 1.34 0.87 1.76 1.18 
ruvA 0.95 1.02 0.95 1.01 1.19 
ruvB 0.88 0.79 0.95 1.06 1.09 
sbcC 1.14 1.18 1.19 1.19 2.54 
sbcD 0.86 0.96 1.04 0.79 2.53 
scrK 1.24 1.04 2.02 0.88 1.39 
sdaA 1.42 1.07 1.24 1.06 1.37 
sdaB 0.86 0.77 0.76 0.93 0.72 
secA 0.75 0.84 0.89 1.04 0.79 
secE 1.21 0.95 0.93 1 1.33 
secG 0.91 0.82 0.65 0.69 1.02 
secY 0.73 0.65 0.7 0.73 0.69 
serA 1.06 0.97 0.86 0.83 0.71 
serB 1.17 1.22 1.03 1.03 0.74 
serC 1.08 0.74 0.84 0.9 0.78 
serS 1.01 1.02 0.84 1.02 1.03 
sigX 0.56 0.59 0.71 0.49 0.81 
sipL 0.95 0.94 1.1 0.78 0.92 
smc 1.06 0.99 1.01 0.92 1.04 
smpB 0.98 0.84 0.83 0.88 0.97 
snf 1.13 1.26 1.08 0.97 0.96 
sodA 0.88 1.12 0.98 0.77 0.91 
ssbA 0.95 1.02 0.69 1.86 1.83 
ssbB 0.57 0.61 0.86 0.69 0.82 
sugE 1 1.13 1.02 1.12 1.12 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
sunL 0.88 0.74 0.87 0.96 0.64 
tag 1.09 1.01 0.94 0.82 0.95 
tagB 0.45 0.44 0.44 0.31 1.12 
tagD1 0.92 0.93 5.4 1.02 0.99 
tagD2 1.7 1.22 1.11 1.26 1.49 
tagF 1.42 0.98 1.01 0.98 2.64 
tagH 1 0.97 0.89 0.91 1.38 
tagR 0.94 0.99 0.92 1.04 0.93 
tagX 0.93 0.91 0.76 1.03 1.15 
tagY 0.81 1.01 0.58 0.68 0.9 
tagZ 0.63 0.99 0.81 0.61 1.08 
tenA 1.17 1.18 0.86 1.36 1.08 
thdF 0.98 0.93 0.84 0.68 1.02 
thgA 1.86 1.18 2.02 1.88 2.03 
thiD1 0.78 0.73 0.96 0.74 0.98 
thiD2 1.19 1 1.33 1.11 1.05 
thiE 1.18 0.94 0.95 0.98 1.33 
thiL 0.99 0.89 0.67 1.23 0.83 
thiM 0.67 0.75 0.7 0.79 0.75 
thrA 0.66 0.77 0.79 0.8 0.66 
thrB 1.24 1.05 0.92 1.04 1.2 
thrC 0.9 0.83 0.8 0.97 0.85 
thrS 0.95 1.04 0.88 0.91 0.85 
thyA 0.99 0.85 0.93 1.13 0.79 
tig 1.5 1.05 0.82 1.19 0.85 
tkt 0.97 0.94 1.21 0.96 1.04 
topA 0.67 0.71 0.86 0.61 0.66 
tpiA 1.03 1 0.92 0.97 1.11 
tpx 1.11 1.19 1.15 0.95 1.42 
tra1077B 1.81 1.38 5.12 2.69 1.76 
tra904A 1.81 1.47 2.14 0.3 1.06 
tra905 1.19 0.93 0.76 1.26 1.48 
tra981C 1.13 1.3 1.14 1.16 0.77 
tra983L 1.38 1.22 2.37 1.6 1.12 
trmD 1.09 1.13 0.92 0.96 0.79 
trmU 1.3 1.08 0.94 1.35 0.97 
trpA 0.58 0.73 0.6 0.94 0.69 
trpB 0.5 0.7 0.59 0.81 0.75 
trpC 0.63 1.22 0.92 0.82 0.72 
trpD 0.74 1.23 0.88 0.92 0.83 
trpE 0.72 0.95 1.17 1.06 0.56 
trpF 1.07 1.29 0.88 1.05 1.2 
trpG 0.47 1.07 1.13 0.7 0.37 
trpS 1.19 1.7 2.24 1.92 0.8 
truA 0.94 0.91 1.35 1.01 0.99 
truB 0.77 0.89 0.92 0.8 0.77 
trxA 0.87 1 0.91 0.8 1.06 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
trxB1 0.83 1.08 1.05 0.6 1.03 
trxB2 1.25 1.41 0.84 0.94 1.38 
trxH 0.77 0.91 0.98 0.73 0.76 
tsf 1.03 0.96 1.05 1.14 0.92 
tuf 0.88 0.93 0.82 1.14 0.89 
typA 1.11 1.06 0.96 1.14 0.94 
tyrA 1.06 1.21 0.84 0.75 0.86 
tyrS 0.69 0.8 0.7 0.77 0.56 
udk 1.14 1.23 1.05 0.93 1.32 
udp 0.68 0.84 0.86 0.63 0.9 
umuC 0.57 0.6 0.51 0.5 0.75 
ung 1.55 1.4 1.38 1.56 1.3 
upp 1.03 0.77 0.77 0.88 0.81 
usp45 0.87 0.69 0.78 1 0.7 
uvrA 1.39 1.34 1.7 1.43 1.25 
uvrB 1.36 1.36 1.16 1.37 1.23 
uvrC 1.02 1.2 1.11 1.04 1.12 
uxaC 1.28 1.2 1.28 1.08 1.68 
uxuA 0.97 1.04 1.06 0.98 0.95 
uxuB 1.12 1.07 0.93 1.08 0.84 
uxuT 1.59 1.53 1.52 1.02 1.17 
vacB1 1.15 1.07 0.99 1.05 1.36 
vacB2 0.9 0.88 1.22 0.93 0.8 
valS 1.41 1.33 1.27 1.35 1.06 
xerD 1.29 1.13 1.17 1.4 1.43 
xpt 0.68 0.68 0.66 0.83 0.66 
xseA 1.36 1.14 1.3 1.4 1.13 
xylA 0.65 0.69 1.26 0.75 1.03 
xylB 0.98 0.98 0.91 0.98 1.02 
xylH 0.86 0.82 0.89 0.76 1.06 
xylM 1.41 0.87 0.8 1.29 1.27 
xylR 0.88 0.8 0.57 0.91 0.91 
xylT 1.25 1.08 0.98 1.35 1.08 
xylX 1.13 1.08 1.01 1.11 1.18 
xynB 1.21 1.33 1.5 1.34 0.93 
xynD 0.89 0.76 1.02 0.76 0.7 
xynT 1.08 0.94 0.98 0.86 0.94 
yabA 1.01 1.19 1.06 1.74 1.3 
yabB 1.27 1.13 1.09 1.29 1.2 
yabC 0.29 0.33 0.35 0.27 0.4 
yabD 0.37 0.42 0.67 0.46 0.57 
yabE 1.33 1.02 0.84 1.4 1.37 
yabF 1.01 0.94 0.88 1.1 0.98 
yacB 0.81 0.82 0.85 1.14 0.73 
yacC 1.02 0.96 1.09 1.35 0.81 
yacG 1.07 1.05 0.79 1.23 0.89 
yacI 0.47 0.47 0.48 0.44 0.5 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
yafB 0.38 0.39 0.26 0.39 0.32 
yafC 0.96 0.85 0.8 0.93 0.97 
yafD 0.37 0.35 0.89 0.3 0.85 
yafE 1.8 1.35 0.67 2.53 1.72 
yafF 2.11 1.23 0.89 2.21 2.57 
yafJ 0.67 0.62 0.64 0.56 0.71 
yagA 1.49 2.21 3.76 1.68 1.2 
yagB 1.13 1.74 2.52 1.96 0.84 
yagE 0.5 0.66 0.52 0.72 1.02 
yahA 1.51 1.2 1.35 1.44 1.07 
yahB 0.89 0.92 0.64 0.83 1.03 
yahC 0.56 0.48 0.53 0.51 1.28 
yahD 4.18 3.6 2.15 4.04 3.14 
yahG 0.86 0.76 0.81 0.9 0.78 
yahI 1.5 1.56 1.17 1.43 1.06 
yaiA 6.58 5.39 3.48 5.63 4.86 
yaiB 4.39 3.7 2.98 3.71 4.57 
yaiE 1.09 1.11 1.29 0.9 0.78 
yaiF 0.9 0.79 1.38 0.88 0.97 
yaiG 1.09 1.05 1.04 1.14 1.37 
yaiI 1.19 1.14 0.95 1.04 0.97 
yajB 0.67 0.85 1.49 0.79 1.42 
yajE 1.47 1.78 1.66 1.77 1.1 
yajH 1.44 1.08 0.97 1.71 1.49 
ybaA 1.04 1.03 0.97 1.28 1.4 
ybaB 1.07 0.85 1.01 0.89 1.01 
ybaC 0.71 0.76 1.01 0.92 1.05 
ybaD 0.96 1.03 1.46 0.95 1.11 
ybaF 1.32 1.43 1.3 1.18 0.9 
ybaG 1.21 1.15 1.11 1.07 0.86 
ybaH 0.93 0.97 0.86 1.05 0.75 
ybaI 0.82 0.78 0.81 1.14 0.9 
ybbA 1.14 1.19 1.02 1.12 1.17 
ybbB 0.9 1.12 0.91 0.76 1.08 
ybbC 1.34 1.11 1.45 1.18 0.78 
ybbE 1.22 0.95 1.06 1.3 1.01 
ybcC 1.4 1.42 0.9 1.5 1.41 
ybcG 1.19 1.13 0.92 1.27 1.08 
ybcH 1.05 1.06 1.16 0.67 0.61 
ybdA 1.03 0.91 0.68 1.37 0.9 
ybdC 1.15 1 0.95 1.22 0.89 
ybdD 1.38 1.19 1.04 1.28 0.9 
ybdG 0.28 0.28 0.37 0.29 0.99 
ybdH 0.35 0.26 0.4 0.41 0.59 
ybdI 0.62 0.68 0.62 0.63 0.95 
ybdJ 0.77 0.87 0.82 0.66 1.01 
ybaH 0.93 0.97 0.86 1.05 0.75 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ybaI 0.82 0.78 0.81 1.14 0.9 
ybbA 1.14 1.19 1.02 1.12 1.17 
ybbB 0.9 1.12 0.91 0.76 1.08 
ybbC 1.34 1.11 1.45 1.18 0.78 
ybbE 1.22 0.95 1.06 1.3 1.01 
ybcC 1.4 1.42 0.9 1.5 1.41 
ybcG 1.19 1.13 0.92 1.27 1.08 
ybcH 1.05 1.06 1.16 0.67 0.61 
ybdA 1.03 0.91 0.68 1.37 0.9 
ybdC 1.15 1 0.95 1.22 0.89 
ybdD 1.38 1.19 1.04 1.28 0.9 
ybdG 0.28 0.28 0.37 0.29 0.99 
ybdH 0.35 0.26 0.4 0.41 0.59 
ybdI 0.62 0.68 0.62 0.63 0.95 
ybdJ 0.77 0.87 0.82 0.66 1.01 
ybdK 0.49 0.74 0.98 0.32 0.81 
ybdL 1.05 1.31 2.93 1.42 1.23 
ybeA 0.92 0.99 1.02 0.94 0.93 
ybeB 1.1 0.97 0.95 1.14 0.99 
ybeC 1.09 1.1 0.94 0.96 0.97 
ybeD 1.14 1.28 0.96 1.84 1.04 
ybeF 0.88 1.88 0.65 5.88 0.8 
ybeH 1.03 1.1 0.65 1.19 1.13 
ybeI 1.45 1.23 1.31 1.67 1.71 
ybeM 1.05 1.02 0.93 1.03 1.07 
ybfA 1.31 1.4 1.75 0.86 1.21 
ybfB 0.94 1.02 0.9 1.11 0.94 
ybfC 3.68 2.07 2.22 1.66 2.05 
ybfD 1.6 1.64 0.88 1.45 1.52 
ybfE 1.18 1.19 1.29 0.9 1 
ybgA 5.05 2.9 2.21 3.22 2.87 
ybgD 0.86 0.89 1.01 0.81 1.26 
ybgE 1.13 1.14 0.97 0.87 1.07 
ybhA 1.09 1.03 0.93 0.85 0.86 
ybhB 0.96 0.84 0.72 0.94 0.81 
ybhC 1.11 0.98 0.88 1.36 1 
ybhD 0.86 0.92 1.23 1 0.92 
ybhE 1.42 1.35 1.86 1.44 1.49 
ybiB 1 1.02 0.93 1.35 1.18 
ybiC 1.43 1.26 1.01 1.37 1.12 
ybiD 1.12 1.05 1 1.15 0.82 
ybiE 0.75 0.73 1.04 0.77 0.73 
ybiG 1.16 1.29 1.08 0.79 1.09 
ybiH 0.59 0.67 0.5 0.61 0.4 
ybiI 0.59 0.59 0.55 0.55 0.55 
ybiJ 0.54 0.45 0.58 0.52 0.49 
ybiK 1.81 1.19 1.01 1.69 1.55 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ybjA 1.43 1.72 1.5 1.21 1.09 
ybjB 1.58 1.7 1.23 1.48 1.52 
ybjD 1.22 0.89 1.13 1.02 0.82 
ybjJ 1.09 1.11 0.89 1.01 0.89 
ybjK 1.09 1.04 0.84 1.19 1 
ycaF 1.14 0.93 2.19 1.25 1.17 
ycaG 0.84 1.09 5.91 1.09 1.05 
ycbA 1.05 1.05 4.99 1.04 0.81 
ycbB 0.87 0.96 4.9 0.79 0.93 
ycbC 1.1 1.02 3.16 1.06 1.15 
ycbD 1.31 1.09 1.64 1.14 1.08 
ycbF 0.99 1.13 2.07 0.99 0.85 
ycbH 0.88 1.53 4.77 1.13 0.97 
ycbI 1.13 1.47 3.26 1.14 0.93 
ycbJ 1.03 1.17 4.46 1.02 1.07 
yccB 0.85 0.92 1.84 0.77 0.67 
yccE 1.35 1.52 1.63 1.67 1.38 
yccF 1.27 1.11 1.18 1.25 0.84 
yccG 1.4 1.36 1.63 1.37 1.16 
yccH 1.39 1.3 1.67 1.28 1.18 
yccI 1.5 1.49 1.63 1.4 1.32 
yccJ 1.11 1.16 1.29 1.06 1.06 
yccK 1.2 1.39 0.88 1.4 1.36 
yccL 1.12 1.1 0.93 1.02 1.1 
ycdA 0.49 0.6 0.94 0.56 0.5 
ycdB 1.02 0.89 0.84 1.01 0.79 
ycdC 1.05 1.12 0.94 1.23 0.7 
ycdE 0.95 1.09 0.94 1.09 1.07 
ycdF 1.08 1.03 0.92 1.12 1.25 
ycdG 0.86 0.89 0.98 0.85 0.92 
ycdH 1.16 1.17 1.03 1.17 1.2 
yceA 1.23 0.98 0.88 1.3 0.87 
yceD 1.79 1.67 1.41 1.77 1.23 
yceE 1.13 1.23 1.13 1.43 1.23 
yceG 1.28 1.92 1.9 1.67 1.14 
yceJ 0.56 0.52 0.87 0.52 1.06 
ycfA 0.95 1.02 1.08 1.02 0.81 
ycfB 0.84 0.71 0.88 0.71 0.71 
ycfD 0.76 0.73 1 0.83 0.67 
ycfF 0.95 1.05 1.19 0.95 0.99 
ycfG 1.07 1.24 1.12 1.34 1.2 
ycfH 0.96 0.96 0.88 0.91 1.11 
ycfI 0.63 1.24 1.03 1.36 0.88 
ycgA 0.95 1.55 1.22 1.17 1.03 
ycgB 0.83 1.31 1.25 1.2 1.29 
ycgC 0.67 0.86 1.23 0.54 0.92 
ycgD 1.26 1.22 1.12 1.23 1.06 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ycgE 0.91 0.96 0.88 0.91 0.81 
ycgF 0.93 1.21 1 0.82 1.01 
ycgG 1.07 1.15 0.98 0.91 0.93 
ycgH 0.95 0.94 0.81 0.87 0.82 
ycgI 0.71 0.72 0.92 0.73 0.76 
ycgJ 0.93 0.83 0.79 0.86 0.95 
ychC 1.46 1.33 1.23 1.56 0.97 
ychD 1.07 1.01 0.89 1.33 0.81 
ychE 1.3 1.1 1.1 1.47 1.04 
ychG 0.98 1.04 1.03 0.87 0.75 
yciA 0.54 0.57 0.98 0.69 0.55 
yciC 1.1 1.26 1.16 1.41 0.98 
yciD 1.23 1.29 1.12 1.34 0.98 
yciF 0.7 0.72 0.63 0.73 0.71 
yciG 0.54 0.8 0.56 0.47 0.57 
ycjA 0.86 1.01 0.81 0.89 0.91 
ycjB 1.01 1.53 1.15 1.27 0.76 
ycjC 1.25 1.01 0.96 1.18 0.87 
ycjD 1.11 1.16 0.95 1.18 0.98 
ycjG 0.63 0.74 0.84 0.82 0.89 
ycjH 0.8 0.79 0.8 0.85 0.78 
ycjI 0.65 0.45 0.41 0.98 0.43 
ydaE 1.18 1.8 1.64 1.35 1.18 
ydaF 0.64 0.88 0.88 0.54 0.77 
ydaG 0.78 1.04 1.14 0.66 0.49 
ydbA 0.85 1.08 0.98 0.69 0.64 
ydbC 1.93 1.21 1.42 1.56 1.53 
ydbD 0.67 0.88 0.87 0.85 0.6 
ydbE 1.11 1.09 1.12 0.82 0.98 
ydbF 0.8 1.16 1.13 0.99 0.93 
ydcB 1.34 1.05 1.2 0.89 1.08 
ydcD 0.98 1.14 1.05 1.03 0.9 
ydcE 1.03 1.06 1.09 0.96 0.95 
ydcF 0.6 0.97 0.93 0.6 0.78 
ydcG 1.16 0.81 0.59 1.28 0.97 
yddA 0.89 1.21 1.06 1.21 1.31 
yddB 0.89 1.13 0.85 0.94 0.9 
yddC 0.89 1.02 1.14 0.87 0.92 
yddD 0.82 1.02 1.06 0.93 0.78 
ydgB 0.55 0.94 0.63 0.69 0.67 
ydgC 0.46 0.65 0.49 0.75 0.48 
ydgD 0.64 0.68 0.78 0.72 0.71 
ydgE 0.76 0.9 0.84 0.88 0.86 
ydgF 0.69 0.81 0.75 1.14 0.83 
ydgG 0.72 0.82 0.81 0.76 0.83 
ydgH 0.81 0.85 0.77 1.25 1.34 
ydgI 0.75 0.83 0.99 0.66 0.59 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ydhB 1.02 1.17 1.02 1.1 0.81 
ydhF 1.69 1.35 1.31 1.39 0.97 
ydiA 0.42 0.42 1.36 0.65 0.52 
ydiB 1.18 1.13 1.17 1.21 0.66 
ydiC 0.9 1.17 1.07 1.2 1.1 
ydiD 0.9 1.12 0.85 1.07 0.77 
ydiE 0.73 0.82 0.71 0.88 1.29 
ydiF 0.86 1.06 0.59 0.95 0.99 
ydiG 0.91 1.41 0.88 0.93 1.09 
ydjB 0.86 0.73 1.01 0.73 1.04 
ydjD 0.73 0.86 0.76 0.7 0.83 
yeaA 0.36 0.39 0.8 0.3 0.31 
yeaC 1.2 1.29 1.33 1.1 1.27 
yeaD 0.78 0.64 1.07 0.67 0.58 
yeaF 1.34 1.74 1.38 1.51 1.84 
yeaG 1.08 0.92 0.92 1.06 0.96 
yeaH 1.56 1.1 1.35 1.39 1.19 
yebB 0.69 0.6 0.4 0.2 0.28 
yebE 1.01 0.73 0.75 0.94 0.92 
yebF 1.13 0.95 1.06 1.31 1.22 
yecA 0.99 0.9 1.06 0.77 1.29 
yecD 0.18 0.17 0.23 0.2 0.48 
yecE 1.04 1.08 1.17 0.88 1.14 
yedA 1.11 1.01 0.83 0.99 1.16 
yedE 0.9 0.66 0.8 0.74 0.75 
yedF 1.22 0.91 0.92 1.02 1.01 
yeeC 1.28 1.26 1.04 1.11 1.2 
yeeD 1.25 1.28 1.17 1.14 1.31 
yeeF 1.24 0.93 0.86 1.2 1.16 
yeiD 0.52 0.61 0.25 1.12 0.6 
yeiE 1.26 1.24 1.09 0.77 1.25 
yeiF 0.79 0.72 0.66 0.62 0.93 
yeiG 1.35 1.14 1.14 1.03 0.76 
yejC 0.82 0.83 0.82 0.71 0.62 
yejD 1.27 1.14 0.94 1.24 1.08 
yejE 2.11 0.72 1.67 1.12 1.17 
yejI 0.95 0.46 0.72 1.06 1.02 
yfaA 1.06 0.85 1.36 0.93 1.05 
yfbB 0.84 1.45 0.84 1.05 1.03 
yfbG 0.37 0.45 0.42 0.61 0.92 
yfbI 1.02 0.96 1.13 0.85 1.12 
yfbJ 1.29 1.15 1.16 1.21 1.5 
yfbK 1.12 1.22 1.58 1.17 1.9 
yfbM 1.98 2.02 2.15 1.6 3.09 
yfcB 2.16 2.71 2.56 1.46 4.05 
yfcF 1.25 0.99 1.03 1.1 1.32 
yfcI 0.82 0.68 0.87 0.95 0.93 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
yfdA 0.84 0.65 0.95 0.95 0.82 
yfdB 1.71 0.8 0.97 1.22 0.91 
yfdD 0.93 0.95 0.94 1.28 1.22 
yfdE 0.58 0.42 0.44 0.66 0.73 
yfeA 1.44 1.26 1.31 1.34 1.5 
yffA 1.24 0.97 0.82 1.06 1.05 
yffB 0.76 0.85 0.73 0.57 0.93 
yffD 0.91 1.03 0.67 0.75 0.75 
yfgC 1.08 1.03 0.77 0.99 0.84 
yfgG 1.04 0.78 0.84 1.05 0.93 
yfgH 0.6 0.64 0.89 0.79 0.86 
yfgL 1.19 0.98 0.9 1.4 1.37 
yfhA 1.42 1.7 0.9 2.22 1.37 
yfhF 0.82 1.17 0.8 1.07 1.08 
yfhH 1.27 1.67 1.26 1.35 1.46 
yfhI 0.97 0.95 7.36 1.17 9.81 
yfhJ 1.16 0.79 6.42 0.95 7.46 
yfhK 1.37 1.52 0.93 1.11 1.36 
yfhL 1.23 1.2 1.25 1.24 1.42 
yfiC 1.06 0.74 0.93 0.96 1.03 
yfiE 1.79 1.71 1.76 1.62 2.66 
yfiG 0.57 0.6 0.63 0.72 0.79 
yfiH 0.77 0.63 0.64 0.72 0.76 
yfiJ 0.84 1.01 1.05 0.82 0.9 
yfiL 1.43 1.52 1.23 1.33 1.52 
yfjA 1.09 1.3 1.59 0.99 1.07 
yfjC 1.1 1.01 1.07 0.99 1.04 
yfjD 1.18 1 1.47 0.9 1.58 
yfjF 1.87 1.16 1.75 1.71 1.53 
ygaB 0.47 0.36 1.1 0.46 0.4 
ygaC 0.47 0.4 0.76 0.53 0.42 
ygaD 0.96 0.93 1.05 1.16 0.96 
ygaE 1.35 1.2 1.03 1.13 1.2 
ygaF 0.5 0.67 0.76 1.02 0.73 
ygaI 1.24 1.19 1.19 0.99 1.22 
ygaJ 1.79 1.09 3.68 1.03 1.22 
ygbB 1.21 0.99 1.23 1.26 0.95 
ygbD 1.36 1.05 1.28 1.21 1.04 
ygbE 1.26 1.19 1.12 1.03 1.3 
ygbF 1.99 1.84 2.18 2.37 2.31 
ygcA 0.97 0.83 1.14 0.92 1.26 
ygcC 1.29 0.97 1 1.13 1.32 
ygdC 1.41 1.2 1.2 1.77 1.51 
ygdD 0.87 0.82 0.95 0.81 1.03 
ygdE 1.2 1.21 1.2 1.52 0.99 
ygdF 1.6 1.75 1.69 1.6 1.67 
ygeB 0.27 0.23 0.39 0.24 0.28 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ygeC 0.7 0.67 0.74 0.62 0.74 
ygeD 1.02 0.98 0.71 1.39 0.99 
ygfA 1.16 1.16 0.95 1.22 1.04 
ygfB 2.77 3.16 2.2 2.71 2.01 
ygfC 1.66 2.31 1.64 1.65 1.84 
ygfE 0.96 0.88 1.3 0.77 1.2 
yggA 0.91 1.38 0.95 1.02 1.05 
yghB 1.15 1.27 1.56 0.96 1.25 
yghC 0.81 0.79 0.79 0.83 0.73 
yghD 1.51 1.3 1.37 1 1.37 
yghE 1.32 1.28 1.33 1.17 1.24 
yghG 0.94 1.06 0.74 0.99 0.94 
ygiC 0.9 1.28 0.95 1.1 1.09 
ygiG 0.49 0.46 0.45 0.46 1.38 
ygiI 1.04 0.98 0.82 1.13 0.99 
ygiJ 1.56 1.38 1.37 1.31 1.21 
ygiK 1.6 1.25 1.09 1.18 1.07 
ygjB 1.03 0.85 1.01 0.87 0.87 
ygjD 0.63 0.9 1.49 0.52 0.8 
yhbE 0.58 0.45 0.35 0.49 0.54 
yhbH 0.95 0.86 0.74 1.04 1.03 
yhcA 2.62 1.53 1.57 1.62 1.35 
yhcB 3.04 2.69 1.71 5.76 2.66 
yhcC 1.15 1.03 1.04 1.26 1.34 
yhcE 1.18 1.05 2.2 1.31 1.31 
yhcH 0.84 0.96 0.95 0.9 1.24 
yhcI 0.94 1.16 1.01 0.88 1.09 
yhcK 1.06 1.05 0.68 1.52 1.18 
yhdA 1.12 1.71 1.46 1.5 1.18 
yhdB 1.09 1.31 1.12 1.22 1.03 
yhdC 0.67 0.81 1.04 1.09 0.86 
yheA 1.08 0.9 1.41 1.02 1.2 
yheB 1.17 1.01 1.27 1.05 1.01 
yhfB 0.67 0.78 0.81 0.76 0.82 
yhfC 0.93 1.08 0.88 0.95 0.8 
yhfD 1.15 1.17 1.02 1.09 1.03 
yhfE 1.27 1.05 0.94 1.13 1.05 
yhfF 1.42 1.25 1.03 1.25 1.11 
yhgA 1.25 1.18 0.8 1.45 0.99 
yhgB 1.67 1.61 1.48 1.88 1.81 
yhgC 0.69 0.67 0.7 0.72 0.82 
yhgD 1.27 1.06 0.91 1.19 1.36 
yhgE 1.1 0.8 0.79 1.02 1 
yhhA 1.14 1.06 0.94 0.97 0.97 
yhhB 1.37 1.18 1.01 1.14 1.17 
yhhD 0.94 0.99 1.07 0.93 1.03 
yhhE 1.08 0.86 0.87 0.85 0.99 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
yhhG 1.17 1.15 1.31 0.95 0.98 
yhjA 1.53 1.59 1.14 1.05 1.75 
yhjB 1.75 1.51 1.05 1.97 1.68 
yhjC 1.92 1.51 1.09 1.72 1.68 
yhjE 1.31 1.11 1.03 1.11 0.93 
yhjF 1.84 1.3 1.11 1.81 1.28 
yhjG 1.07 1.14 1.38 0.98 1.15 
yiaA 0.74 0.77 0.94 0.7 0.79 
yiaB 0.82 0.84 0.91 0.81 0.88 
yiaC 0.93 0.86 0.86 1 0.78 
yiaD 1.03 1.61 2.08 0.93 1.74 
yibB 1.23 1.44 1.17 1.18 1.23 
yibC 1.22 1.13 1.13 1.23 1.14 
yibD 1.43 1.83 1.36 1.13 0.77 
yibE 1.52 1.67 1.1 1.43 1.45 
yibF 1.17 1.06 0.92 1.01 0.78 
yibG 3.37 3.06 1.18 0.99 1.29 
yicA 1.25 1.58 1.4 1.57 1.29 
yicB 0.93 1.13 1.29 1.01 0.94 
yicC 1.1 1.21 1.22 1.21 1.11 
yicE 1.17 0.99 0.83 1.92 0.81 
yidA 1.68 1.53 1.59 1.64 1.35 
yidB 1.11 0.92 0.99 1.22 1.23 
yidC 1.36 1.31 1.28 1.29 1.63 
yidE 1.09 0.97 0.91 0.99 1.03 
yieF 0.93 0.94 1.07 0.81 1.54 
yieH 1.86 2.01 0.91 2.52 1.24 
yifA 1.81 1.73 0.73 1.77 1.07 
yigC 1.95 1.8 3.04 1.58 1.89 
yihA 1.33 1.21 1.02 1.33 2.1 
yihB 1.12 1.06 0.94 1.19 2.02 
yihD 1.19 1.19 1.09 1.2 1.74 
yihF 1.22 1.11 1.34 1.18 1.37 
yiiB 1.45 1.38 1.17 1.54 1.26 
yiiD 1.07 0.92 0.78 1.1 0.89 
yiiE 0.71 0.82 0.76 1.04 0.81 
yiiF 0.84 0.89 0.64 0.89 0.78 
yiiG 1.04 0.98 0.69 1.13 1.01 
yiiH 0.93 0.79 0.71 0.99 0.73 
yiiI 0.89 0.73 0.58 0.77 0.74 
yijB 1.36 1 1.08 1.07 1.29 
yijC 1.58 1.09 1.01 1.09 0.96 
yijD 1.63 1.29 1.12 1.27 1.32 
yijE 1.01 1.02 1.17 0.86 0.97 
yijF 1 1.12 0.98 1.08 1 
yijG 0.96 0.84 0.73 0.93 0.97 
yijH 3.32 3.52 3.59 3.01 2.06 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
yjaB 1.8 1.33 1.03 0.91 1.31 
yjaD 0.92 0.83 1.02 0.98 0.75 
yjaE 1.06 0.9 0.85 0.78 1.05 
yjaF 0.87 0.8 0.61 1.02 0.84 
yjaH 0.5 0.5 0.65 0.56 0.75 
yjaI 0.89 0.82 0.78 0.91 1.06 
yjaJ 0.79 0.45 0.48 0.82 0.84 
yjbB 1.62 1.37 1.58 1.48 1.01 
yjbC 1.81 1.16 1.21 1.55 1.34 
yjbE 1.73 1.3 1.14 1.52 1.57 
yjbF 1.45 1.43 1 1.5 1.42 
yjcA 1.62 2.03 1.55 1.07 1.08 
yjcD 0.76 0.99 1.01 0.99 0.93 
yjcE 0.64 0.59 0.82 0.94 0.7 
yjcF 1.09 0.89 0.84 1.31 0.85 
yjdA 1.5 2.19 1.24 1.5 1.52 
yjdB 2.54 2.89 2.25 3.02 1.89 
yjdE 0.72 0.95 0.84 0.5 0.56 
yjdI 0.79 0.96 0.93 0.86 1.06 
yjdJ 0.91 0.9 0.87 1.1 0.95 
yjeA 1.43 1.22 1 1.26 1.14 
yjeD 0.73 0.83 0.67 0.42 0.84 
yjeF 1.16 0.98 1.09 1.07 1 
yjeG 0.91 1.17 0.97 0.91 1.85 
yjfB 1.12 1.24 1.24 1.22 1.41 
yjfG 0.86 1.02 1.27 0.77 1.13 
yjfI 0.79 0.73 0.79 0.76 1.41 
yjfJ 0.68 0.64 0.69 0.49 1.07 
yjgB 0.71 0.6 0.42 0.94 0.96 
yjgC 1.49 1.41 2.17 1.18 0.96 
yjgD 1.17 1.18 1.37 0.97 0.78 
yjgF 1.23 1.23 1.29 1.26 1.26 
yjhA 1.25 1.11 1.24 1.15 1.04 
yjhB 1.02 1.1 0.9 0.99 1.01 
yjhC 0.98 0.94 1.25 0.88 0.86 
yjhD 0.87 0.91 1.79 0.76 0.56 
yjhF 0.75 0.85 1.57 0.75 0.65 
yjiB 2 2.16 1.43 2.58 1.27 
yjiE 1.13 1.11 0.99 0.94 0.91 
yjjA 1.2 1.12 1.14 0.96 1.02 
yjjB 1.06 0.92 0.89 1.14 0.98 
yjjC 1.07 1.25 1.91 1.1 1.46 
yjjD 1.4 1.19 1.95 1.02 1.79 
yjjE 0.91 1.05 0.92 0.88 0.98 
yjjF 0.84 0.91 0.85 0.81 0.85 
yjjH 0.83 0.81 1.18 0.92 1.12 
ykaE 0.87 0.96 1.02 1.2 0.94 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ykaF 1.14 0.81 0.89 1.26 0.86 
ykbA 1.18 0.9 0.89 1.19 1.06 
ykbC 0.4 0.33 0.43 0.4 0.26 
ykbE 0.68 0.56 0.57 0.68 0.68 
ykbF 0.58 0.59 0.47 0.59 0.59 
ykcA 0.51 0.45 0.48 0.67 0.52 
ykcB 0.43 0.61 0.62 0.71 0.62 
ykcC 0.8 0.77 0.7 0.89 0.94 
ykcF 0.54 0.71 0.84 0.64 0.66 
ykcG 1.27 1.03 0.99 1.59 1.31 
ykdA 1.28 1.06 1.16 1.47 1.05 
ykdB 1.28 1.08 1.05 1.46 1.11 
ykhE 1.23 1.26 2.02 1.49 0.7 
ykhF 0.99 0.88 0.96 1.13 0.95 
ykhG 0.98 1.33 1.32 1.21 0.8 
ykhI 1.22 1.3 1.03 2.07 1.12 
ykhJ 0.81 1.07 1.07 0.96 1.17 
ykhK 1.33 1.42 1.19 2.26 1.12 
ykiC 1.88 1.75 1.14 2.41 1.44 
ykiD 1.8 2 1.29 2.89 1.54 
ykiF 0.95 0.95 0.95 0.93 0.81 
ykiG 0.86 0.87 0.93 0.81 0.94 
ykiH 0.85 0.94 1.2 0.79 0.8 
ykjA 1.3 1.37 1.2 1.2 0.85 
ykjB 0.81 1.4 0.89 0.73 3.87 
ykjC 1.1 1.09 0.67 0.94 2.27 
ykjE 1.1 0.98 1.08 0.96 1.01 
ykjF 1.05 0.96 1.09 0.89 0.93 
ykjH 1.19 1.49 1.21 1.21 1 
ykjJ 1.35 1.4 1.35 1.53 1.25 
ylaC 0.91 1.03 1.09 0.95 0.98 
ylaE 1.83 1.47 1.16 1.71 1.05 
ylbA 1.1 1.23 1.46 1.16 1.19 
ylbB 1.22 1.26 1.58 1.09 1.44 
ylbD 1.02 0.91 1.05 0.96 0.83 
ylbE 1.08 1.01 1.16 0.77 0.96 
ylcA 1.37 1.35 1.22 0.95 1.17 
ylcC 0.34 0.39 0.32 0.27 0.61 
ylcD 0.51 0.53 0.35 0.51 0.51 
ylcE 0.81 0.75 0.59 0.79 0.75 
ylcF 0.59 0.59 0.38 0.68 0.59 
yldA 1.13 1.04 0.96 1.16 1.11 
yldC 0.96 1.21 1.35 0.78 1.27 
yldE 1.28 1.72 1.79 1.29 1.51 
yleB 1.27 1.19 1.64 3.44 1.07 
yleE 1.08 1.25 1.07 1.15 1.03 
yleF 1.14 1.21 1.28 1.28 1.15 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ylfA 1.15 1.43 1.24 1.46 0.99 
ylfB 0.82 0.79 0.56 0.79 0.64 
ylfC 0.68 0.67 0.59 0.78 0.56 
ylfD 0.68 0.67 0.55 0.86 0.55 
ylfF 1.21 0.95 1 1.01 0.62 
ylfH 1.41 1.09 1.08 0.78 0.82 
ylfI 1.16 1.5 1.58 1.16 1.36 
ylgB 1.31 1.47 1.15 1.68 1.38 
ylgC 0.85 0.93 0.65 1.13 0.92 
ylgG 1.12 1.08 1.09 0.72 0.9 
ylhB 1.54 2.08 1.96 1.18 2.08 
yliA 0.91 0.82 0.89 0.71 1.04 
yliC 1.28 1.15 0.84 1.29 0.97 
yliD 1.15 1.11 1.03 1.28 0.82 
yliE 0.95 1.04 0.97 1.16 1.04 
yliF 0.88 0.97 0.95 0.79 1.23 
yljB 1.18 1.07 1.1 1.05 1.12 
yljC 1.1 0.98 1.18 0.94 1.11 
yljD 0.97 0.9 0.83 0.81 0.91 
yljE 0.71 0.89 0.9 0.97 0.72 
yljF 1.08 1.17 1.06 1.04 0.78 
yljG 1.15 1.25 1.34 1.13 0.77 
yljH 0.86 1.14 0.9 0.87 0.95 
yljI 0.91 1.23 0.82 0.95 0.77 
yljJ 1.01 1.26 1.04 1.17 0.73 
ylqL 1.05 0.86 0.91 1.02 0.71 
ylxQ 1.19 1.03 1.06 1.08 0.88 
ymaB 0.93 0.96 1.01 0.84 1.03 
ymbC 1.11 1.03 0.96 1.26 0.94 
ymbD 1.36 1.17 1.01 1.2 1.35 
ymbG 0.93 1.03 1.04 0.79 0.96 
ymbJ 0.98 1.06 1.14 1.21 1.03 
ymbK 1.63 1.61 1.17 1.98 0.91 
ymcA 1.02 1.25 1 1.15 0.96 
ymcB 0.8 1.36 1.02 0.9 0.67 
ymcC 1.08 1.35 0.98 1.16 0.97 
ymcF 1.27 1.18 0.99 1.24 1.21 
ymdC 0.47 0.57 0.47 0.41 0.43 
ymeB 0.44 0.58 0.87 0.34 0.39 
ymfD 0.84 1.06 0.69 1.3 0.84 
ymfE 1.16 0.95 0.93 1.15 0.94 
ymgB 1.13 1.16 1.1 1.2 1.81 
ymgC 1.49 1.53 1.62 1.52 1.49 
ymgF 1.72 1.97 1.54 1.37 2.86 
ymgG 0.6 0.75 0.46 0.95 0.69 
ymgH 0.62 0.56 0.43 0.86 1.04 
ymgI 0.64 0.67 0.45 0.97 0.77 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ymgJ 0.51 0.84 0.62 0.86 0.81 
ymgK 0.4 0.52 0.37 0.4 0.93 
ymhC 1.44 1.03 1.01 1.33 2.35 
ymhG 0.47 0.76 0.77 0.6 0.59 
ymiA 0.73 0.94 0.85 0.82 0.58 
ymjE 1.24 1.78 1.17 2.32 1.04 
ymjF 1.13 1.73 1.19 2.18 0.85 
ynaA 1.1 0.91 0.84 1.18 1.17 
ynaB 0.85 0.89 0.76 0.92 0.5 
ynaC 0.83 0.98 1.13 1.06 0.64 
ynaD 0.9 0.78 0.69 1.16 0.71 
ynaE 0.92 0.93 0.65 0.97 0.86 
ynaG 1.43 1.48 1.17 1.2 0.97 
ynbA 1.22 1.23 1.49 1.24 0.95 
ynbB 1 1.06 1.1 1.1 0.96 
ynbC 0.96 1.06 0.97 1.03 0.7 
ynbD 0.89 0.86 0.75 1.03 0.66 
ynbE 0.78 1.01 0.88 1.02 0.86 
yncA 0.7 0.91 1.06 0.68 0.66 
yncB 0.87 0.83 0.66 0.89 0.61 
yndA 0.83 0.95 0.7 0.94 0.59 
yndB 0.97 1.08 1.23 0.87 0.86 
yndC 1.15 1.26 1.2 1.12 1.17 
yndD 1.05 1.08 0.88 1.13 1.12 
yndE 0.94 1.02 0.96 0.9 1.15 
yndF 1.09 1.25 1 1.36 0.99 
yndG 0.77 2.03 0.85 1.01 1.21 
yneB 1.22 0.65 1.26 1.34 1.31 
yneC 1.11 1.2 1.45 1.18 1.44 
yneE 0.73 0.97 0.85 0.83 0.76 
yneF 0.71 0.69 0.6 0.84 0.45 
yneG 4.06 3.37 2.18 4.46 1.3 
yneH 3.65 3.88 2.64 4.3 1.11 
ynfC 0.9 1.15 1.22 0.8 0.85 
ynfD 1.43 1.35 1.29 1.52 2.57 
ynfG 0.22 0.34 0.34 0.22 0.3 
ynfH 1.54 1.14 0.99 1.65 1.02 
yngA 0.79 0.9 0.83 0.72 0.82 
yngB 0.71 0.89 0.85 0.75 0.85 
yngE 1.29 1.58 2.15 1.59 1.09 
yngF 0.96 1.21 1.86 1.14 0.94 
ynhA 1.27 1.38 1.28 1.01 1.19 
ynhC 2.58 2.03 1.7 2.82 1.16 
ynhD 1.95 1.78 1.65 2.18 1.15 
ynhH 0.84 1.11 1.05 1.47 0.93 
ynhI 0.75 1 0.83 1.05 0.66 
yniC 0.73 0.87 0.92 0.68 0.74 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
yniG 1.03 1.27 0.91 1.05 0.91 
yniH 1.41 1.18 1.24 1.4 1 
yniI 1.02 0.49 0.52 0.76 0.56 
yniJ 1.02 1.05 0.85 1.11 1.19 
ynjC 1.64 6.21 1.58 11.21 2.56 
ynjD 1.9 2.36 0.93 3.71 1.12 
ynjE 1.86 1.52 0.92 2.54 1.06 
ynjF 1.41 1.49 0.93 1.8 1.09 
ynjG 1.52 1.06 0.73 2.1 1.47 
ynjH 2.53 2.51 4.58 1.75 1.5 
ynjI 1.6 2.17 2.05 2.33 1.92 
ynjJ 1.9 1.92 1.83 2.22 1.73 
yoaD 1.18 0.82 0.81 1.27 1.03 
yoaG 1.03 1.17 0.99 1.25 0.8 
yoaH 1.03 1.29 0.88 1.2 0.87 
yoaI 0.22 0.65 0.28 0.64 0.72 
yobA 0.09 0.86 0.68 0.75 0.67 
yobC 1.14 0.78 0.75 1.08 1.54 
yofM 0.73 0.56 0.52 0.8 0.83 
yogE 1.22 0.93 1.07 1.1 1.06 
yogG 0.89 0.75 0.84 1 0.92 
yogI 1.17 0.94 1.03 0.9 1.46 
yogJ 1.14 0.77 1.16 0.79 1.42 
yogL 1.03 0.77 0.7 1.13 1.11 
yogM 1.16 0.77 0.9 0.93 1.2 
yohC 0.59 0.63 0.48 0.35 0.84 
yohD 0.95 0.8 0.75 0.8 1.04 
yohH 1.03 1.11 0.81 0.81 1.33 
yohJ 1.09 1.28 1.01 0.83 1 
yoiB 1.18 1.16 0.91 1.25 1.07 
yoiC 0.86 1.09 0.9 1.11 1.19 
yojB 0.69 0.8 0.66 0.82 0.89 
yojC 0.8 1.03 0.93 0.92 1.22 
ypaA 1.11 1.12 0.76 0.63 1.12 
ypaC 0.85 0.78 1 0.68 0.99 
ypaG 0.33 0.27 0.25 0.26 0.47 
ypaH 0.74 0.73 0.83 0.84 0.84 
ypaI 1.13 1.08 1.18 1.06 1.1 
ypbB 0.89 1.02 0.97 0.86 1.19 
ypbC 1.47 2.07 1.49 1.72 0.55 
ypbD 1.49 1.79 1.39 1.3 0.23 
ypcA 1.2 1.02 1.36 0.67 1.06 
ypcB 1 0.83 0.95 0.73 1.07 
ypcC 1.1 0.99 0.88 0.96 1.1 
ypcD 0.76 0.61 0.62 0.85 1.18 
ypcG 1.44 1.21 2.21 0.92 1.27 
ypcH 1.13 1.33 2.83 0.79 1.04 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ypdA 1.1 1.44 3.7 1.03 1.04 
ypdB 1.14 1.35 3.41 1.03 1.34 
ypdC 1.15 1 1.92 1.09 1 
ypdD 1.27 1.3 1.84 1.2 0.81 
ypfD 0.74 0.83 1.38 0.91 0.8 
ypfE 1.77 2.74 2.29 1.75 1.08 
ypfF 1.08 0.9 1.01 0.96 1.21 
ypgB 0.94 0.79 0.88 0.79 1.02 
ypgC 1.29 0.82 0.88 1.17 1.35 
ypgD 1.13 0.73 1.16 1.06 1.09 
yphA 1.3 1.22 1.25 1.16 1.46 
yphC 0.81 0.84 0.84 0.83 0.54 
yphH 1.09 0.82 0.84 1.16 1.09 
yphI 0.96 1.02 1.27 0.97 0.92 
yphJ 1.26 1.21 1.52 1.22 0.95 
yphK 1.08 1.28 1.56 1.21 0.98 
yphL 1.38 1.33 1.01 1.3 1.19 
ypiA 1.34 1.08 1.06 1.3 1.6 
ypiB 1.33 1.27 0.97 1.23 1.25 
ypiE 2.1 1.27 1.21 1.77 1.48 
ypiH 2.04 1.48 1.49 1.93 1.14 
ypiJ 1.65 1.18 1.14 1.44 1.36 
ypiK 1.08 1.13 0.95 1.02 0.95 
ypiL 1.09 1.22 0.74 1.61 0.84 
ypjA 1 0.96 0.89 1.03 1.1 
ypjB 0.96 0.93 0.92 0.96 1.08 
ypjC 1.08 0.78 0.87 1.24 1.1 
ypjF 1 0.96 0.83 1.12 1.22 
ypjH 0.93 0.92 0.95 0.9 0.84 
ypjI 1.06 1.04 0.86 1.03 1.05 
yqaB 0.72 0.6 0.59 0.57 1.02 
yqaC 0.88 0.92 0.69 0.77 0.97 
yqaD 1.05 0.8 0.81 0.77 0.89 
yqaG 0.48 0.38 0.55 0.6 0.65 
yqbA 1.17 0.96 0.8 0.91 1.08 
yqbF 1.03 1.15 1.04 1.21 1.46 
yqbH 0.16 0.18 0.18 0.17 0.2 
yqbI 0.18 0.15 0.16 0.14 0.16 
yqbJ 0.63 0.57 0.63 0.72 0.83 
yqcB 0.2 0.22 0.23 0.23 0.29 
yqcC 0.15 0.17 0.18 0.18 0.2 
yqcD 0.19 0.18 0.22 0.19 0.25 
yqcE 0.73 0.7 0.54 0.74 0.6 
yqcF 1.16 1.2 0.89 0.9 1.02 
yqcG 1.15 0.91 1.18 1.23 1.14 
yqdA 0.92 0.81 0.91 0.66 1.05 
yqeA 0.9 0.81 1.04 0.73 1.28 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
yqeB 0.72 1.08 0.87 0.81 0.89 
yqeD 0.92 0.88 1.02 0.99 0.77 
yqeH 1 0.76 0.87 1.03 1.01 
yqeL 0.95 0.96 0.96 0.99 0.92 
yqfA 0.96 1.01 0.83 1.33 1.07 
yqfC 0.76 0.85 0.79 0.73 0.82 
yqfE 0.97 0.23 1.57 0.66 1.4 
yqfF 0.86 0.72 0.89 0.73 1.4 
yqfG 1.34 1.4 1.03 1.95 1.82 
yqgA 1.22 1.16 1.01 1.12 1.08 
yqgC 1.05 0.99 0.92 0.93 0.88 
yqgE 0.65 0.75 0.66 0.65 1.33 
yqgF 1.55 1.35 1.1 1.73 1.73 
yqgG 1.84 1.62 1.33 2.08 1.92 
yqhA 1.05 1.1 1.23 0.9 1.4 
yqiA 1.07 1.3 1.1 1.42 1.07 
yqjA 0.77 0.81 0.83 0.93 0.9 
yqjB 1.05 0.81 0.9 1.35 0.8 
yqjD 1.29 0.94 1.04 1.21 1.2 
yqjE 0.88 0.91 0.86 1.11 0.63 
yraA 0.91 0.85 1.13 0.97 0.96 
yraB 0.76 0.75 0.88 0.82 0.85 
yraC 1.32 1.05 1.39 1.21 1.35 
yraD 1.25 1.06 1.19 1.11 1.18 
yraE 1.09 1.05 1.02 0.95 0.92 
yraF 0.8 1.06 0.79 1.08 0.96 
yrbA 1.01 0.98 0.99 0.88 0.97 
yrbB 0.97 0.97 0.68 1.76 0.76 
yrbC 0.76 0.69 0.44 1 1.26 
yrbD 1.31 1.16 0.97 1.52 1.57 
yrbE 1.06 1.02 0.82 1.12 0.93 
yrbF 1.31 0.88 0.79 1.48 1.57 
yrbH 1 1.21 0.99 1.15 1.49 
yrbI 1.05 0.91 0.95 0.94 0.98 
yrcA 1.19 1.2 2.08 1.06 1.2 
yrcB 1.19 0.99 0.8 1.14 1.05 
yreB 1.13 0.87 0.83 0.94 1.09 
yreD 1.13 0.97 0.81 1.02 1.14 
yreE 1.1 0.95 0.91 1.06 1.1 
yrfA 0.8 0.75 0.74 0.79 0.88 
yrfB 1.44 2.13 1.93 1.23 1.86 
yrfC 1.18 0.91 0.85 0.99 1.3 
yrfD 1.44 1.35 1.2 1.26 1.11 
yrfE 0.84 0.81 0.94 1.35 0.97 
yrgA 0.85 0.85 1.02 0.9 1.07 
yrgE 0.94 1.11 0.88 1.08 0.97 
yrgF 0.64 0.74 0.85 0.47 0.83 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
yrgG 1.21 1.11 1.02 1.18 1.77 
yrgH 0.91 1.18 1.13 0.74 0.63 
yrgI 0.83 1.06 0.91 0.5 0.59 
yrhH 1.12 0.88 0.83 1.11 1.11 
yriB 1 0.87 1.04 0.87 0.96 
yriC 0.85 0.96 1.12 0.73 0.8 
yrjA 0.68 0.6 0.8 0.55 0.54 
yrjB 0.47 0.59 1.17 0.72 0.79 
yrjC 1.18 1.42 1.15 2.07 1.21 
yrjD 1.48 1.57 1.07 2.66 1.37 
yrjE 2.31 2.15 1.58 2.11 2.01 
yrjF 1.9 1.87 2.35 1.73 1.77 
yrjG 0.76 0.71 0.8 1.06 0.69 
yrjI 0.93 1.19 1.02 0.88 0.98 
ysaA 0.86 1.04 0.94 0.78 1.02 
ysaB 0.3 0.33 0.3 0.23 0.44 
ysaC 0.45 0.38 0.31 0.41 0.64 
ysaD 0.35 0.25 0.2 0.34 0.47 
ysbA 0.79 0.83 1.24 0.6 0.95 
ysbB 0.86 1.1 1.11 0.73 0.94 
ysbC 0.75 0.9 1.03 0.79 1.02 
ysbD 1.25 0.88 0.83 1.14 0.91 
yscA 0.25 0.2 0.7 0.87 0.73 
yscB 0.96 1.23 0.79 1.08 1.08 
yscD 0.84 0.82 0.83 0.8 0.87 
yscE 0.72 0.87 1.03 0.91 1.45 
ysdA 0.91 0.96 1.13 0.71 1.16 
ysdB 1.04 0.86 0.98 0.98 1.23 
ysdC 1.36 1.31 0.99 1.3 1.44 
ysdE 2.92 2.64 3.52 2.09 2.27 
yseA 0.91 0.93 0.95 1.22 1.02 
yseC 1.02 1.11 1.21 1.5 1.36 
yseD 0.81 0.85 0.94 0.96 1.17 
yseE 0.76 1.06 1.41 2.12 1.52 
yseF 0.94 0.9 0.77 1.05 0.82 
yseH 0.91 1.07 0.78 0.95 0.9 
ysfB 0.95 0.99 0.58 0.79 0.73 
ysiA 0.8 0.8 0.73 1.17 0.86 
ysiB 0.51 0.52 0.44 0.66 0.44 
ysiC 1.16 1.16 1.06 0.85 1.07 
ysiD 1.45 1.4 1.37 1.39 1.19 
ysiE 0.98 0.89 1.01 0.88 0.88 
ysiG 1.22 1.2 1.33 1.14 1.24 
ysjA 0.57 0.65 0.7 0.56 0.44 
ysjC 1.43 1.04 1.03 0.91 1.39 
ysjD 1.01 0.86 0.91 0.93 1.22 
ysjE 0.85 0.9 1.1 0.78 1.27 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ysjF 0.35 0.4 0.46 0.5 0.43 
ysjG 1.09 0.97 1.05 1.22 1 
ysjH 1.13 0.86 0.75 1.2 0.95 
ysxL 1.19 1 0.87 1.3 1.32 
ytaA 1.01 1.34 1.22 1.41 1.22 
ytaB 1.14 0.98 0.78 1.22 1.17 
ytaD 0.58 0.58 0.51 0.66 0.55 
ytbA 0.92 0.91 0.92 0.91 0.86 
ytbB 1.25 1.21 1.34 1.16 1.2 
ytbC 1.13 1.16 0.73 0.85 1.53 
ytbD 0.85 0.86 0.95 0.77 1.19 
ytbE 1.21 1.05 1.04 1.37 1.2 
ytcA 1.05 1.03 0.98 1.13 1.06 
ytcB 1.05 0.96 1.12 1.21 0.88 
ytcC 1.19 0.97 0.16 1.32 1.09 
ytcD 1.43 1.48 1.37 1.42 1.6 
ytcE 1.27 0.9 0.78 1.09 1.11 
ytdA 1.16 0.99 0.98 1.09 0.91 
ytdB 1.11 0.93 0.72 1.13 0.96 
ytdC 0.68 0.71 0.66 0.8 0.99 
ytdF 1.1 1.03 0.99 0.98 0.83 
yteA 1.01 0.86 0.87 0.83 0.87 
yteB 1.6 1.94 1.79 1.34 1.79 
yteC 1.16 1.03 1.14 1.03 1.11 
yteD 0.66 0.73 1.11 0.65 1.47 
yteE 1.19 1.09 0.93 1.74 1.65 
yteG 1.35 1.08 1.07 1.44 1.39 
ytfA 1.63 1.25 0.91 1.54 1.53 
ytfB 1.16 0.9 0.83 1.1 1.07 
ytgA 2.34 2.6 2.43 2.67 3.01 
ytgB 2.35 2.43 3.13 2.75 2.97 
ytgC 1.22 0.94 0.91 1.26 1.18 
ytgD 1.24 1.3 1.15 1.23 1.17 
ytgE 1.32 1.17 1.45 1.01 1.27 
ytgF 1.12 0.98 1.17 1.09 0.99 
ytgG 1.53 1.46 1.9 0.93 1.19 
ytgH 2.71 2.28 2.65 2.52 3.03 
ythA 2.47 1.34 0.91 1.93 1.98 
ythB 2.43 1.52 1.06 2.12 2.15 
ythC 2.27 1.64 1.05 1.96 1.78 
ytiA 1.83 2.06 2.09 1.63 2.05 
ytjA 1.3 1.23 1.07 1.1 1.06 
ytjD 0.95 0.92 0.61 0.62 1.6 
ytjE 0.91 1.14 1.2 0.88 0.94 
ytjF 1.19 1.15 0.94 0.87 1.25 
ytjG 0.92 0.83 0.93 0.85 1.01 
ytjH 1.19 1.28 1.2 1.37 1.1 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
yuaA 1.1 1.09 1.3 0.94 1.08 
yuaB 1.13 1.12 1.27 0.92 1.15 
yuaC 1.19 1.01 1.04 1.25 1.19 
yuaD 1.03 0.87 1.17 0.93 1.01 
yuaE 1.12 0.75 0.69 1.06 0.81 
yucF 2.28 1.94 2.38 1.88 1.79 
yucG 1.69 1.96 2.11 1.3 1.41 
yudA 1.2 0.98 0.99 1.11 1.06 
yudB 0.98 0.81 0.81 0.95 0.59 
yudD 1.27 0.97 0.92 1.14 0.79 
yudE 0.87 0.66 0.7 1.2 0.7 
yudF 0.79 0.77 0.73 1.07 0.69 
yudG 1.35 1.21 1.08 0.98 1.51 
yudI 1 0.92 1.03 0.84 1.13 
yudJ 1.18 0.79 0.79 0.96 0.91 
yudK 0.79 0.97 0.77 0.61 0.75 
yudL 0.83 0.91 0.97 0.9 0.81 
yueA 1.12 0.9 0.91 1.15 0.99 
yueB 0.36 0.34 0.3 0.26 0.32 
yueC 0.88 0.61 0.62 0.84 0.79 
yueD 0.9 0.86 0.74 0.88 0.68 
yueE 1.31 1.12 0.9 1.3 1.35 
yueF 1.47 1.24 1.12 1.17 1.34 
yufA 0.93 0.96 1.06 0.99 0.9 
yufC 1.01 0.86 0.64 1.04 0.64 
yugA 1.17 1.05 1.27 1.38 1.29 
yugB 1.62 1.48 1.75 1.63 1.57 
yugC 1.12 1.08 1.43 0.96 1.13 
yugD 0.72 0.8 1.14 0.79 0.94 
yuhA 1.17 1.17 0.93 1.11 1.15 
yuhB 0.94 0.84 0.86 1.08 0.86 
yuhC 0.95 0.87 0.71 1.05 1 
yuhD 0.96 0.89 0.59 0.93 0.75 
yuhE 1.32 1.06 1.01 1.19 0.83 
yuhH 0.84 0.82 0.85 0.89 0.61 
yuhI 0.68 0.95 0.8 0.81 0.92 
yuhJ 0.97 1.1 0.92 1.08 1.31 
yuiA 0.99 0.99 0.84 0.95 1.11 
yuiB 0.88 0.97 2.34 0.53 1.1 
yuiC 0.98 0.94 0.86 1.11 0.96 
yuiD 1.1 1.28 1.02 1.24 0.87 
yuiE 1.57 1.43 1.06 1.15 1.29 
yujA 0.88 1.03 1.29 0.87 1.02 
yujB 1.27 1.38 1.53 1.36 1.34 
yujD 0.97 0.91 0.84 0.95 0.91 
yujE 0.86 0.88 0.89 0.85 0.89 
yujF 1.23 1 0.9 1.19 1.19 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
yujG 1.19 1.08 0.94 1.29 1.31 
yvaA 0.7 0.8 0.87 0.86 0.88 
yvaB 1.16 1.08 0.84 1.25 0.78 
yvaD 1.05 0.83 0.91 1.18 1 
yvcA 1 0.79 0.85 1.15 0.92 
yvcC 1.59 1.29 1.13 1.38 1.23 
yvdB 1.44 1.59 1.01 1.7 1.43 
yvdC 0.74 1.06 1.08 0.67 0.68 
yvdD 0.72 0.7 0.54 0.69 0.65 
yvdE 1.77 2.23 2.07 1.46 0.78 
yvdF 1.03 1.02 1.1 0.58 0.69 
yvdG 0.68 0.67 0.44 0.44 0.47 
yveB 1.07 0.87 1.02 0.81 0.97 
yveC 1.44 0.87 1 1.48 1.39 
yveD 1.88 1.46 1.23 2.36 1.43 
yveE 1.42 1.26 1.09 1.59 1.07 
yveF 1.91 1.6 1.45 2.29 1.37 
yveG 0.98 0.98 0.91 0.78 0.87 
yveH 1.36 1.12 1.02 1.36 1.05 
yveI 0.85 1.12 1.43 0.79 1.08 
yvfA 1.22 1.08 0.86 0.84 0.81 
yvfB 0.96 1.16 0.95 0.71 0.82 
yvhA 1.03 1.14 0.73 1.28 1.13 
yvhB 1.49 1.65 1.25 1.4 1.01 
yviA 2.13 2.29 1.58 1.93 2.03 
yviC 1.8 2.19 1.69 2.28 2.11 
yviH 1.15 1.02 0.93 1.1 1.04 
yviI 1.56 1.28 0.96 1.57 1.4 
yviJ 1.19 0.91 0.93 0.94 0.8 
yvjA 1.21 1.38 0.89 1.17 0.75 
yvjB 0.91 1.06 0.95 1 0.76 
ywaB 0.83 1 0.81 1.02 0.84 
ywaC 0.93 0.95 0.81 0.7 0.94 
ywaD 1.1 1.22 1.37 1.25 1.09 
ywaE 0.77 0.78 0.87 0.81 0.52 
ywaF 0.98 0.95 0.95 1.24 0.84 
ywaG 1.16 1.08 0.95 1.37 0.93 
ywaH 3.22 2.33 0.87 3.99 2.25 
ywaI 1.8 1.53 1.15 1.8 0.99 
ywbA 1.12 1.04 0.7 1.1 0.81 
ywbB 1.07 0.78 0.85 0.74 1.32 
ywcC 0.86 0.83 1.25 0.76 1.1 
ywdA 1.38 0.92 0.68 1.39 1.07 
ywdB 1.48 1.21 1.01 1.26 1.33 
ywdC 1.34 1.73 0.97 1.48 1.1 
ywdD 1.29 1.44 1.11 1.45 1.28 
ywdE 0.95 0.97 0.98 0.94 0.93 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
ywdF 1.08 1.16 1.09 0.94 0.91 
yweA 1.04 1.01 0.78 0.92 0.81 
yweB 0.8 1.09 1.17 0.8 0.74 
yweC 0.65 0.78 1.48 0.59 0.96 
yweD 1.78 1.37 1.48 1.44 1.11 
yweE 1.1 1.03 0.72 1.32 1.38 
yweF 1.08 0.97 1.03 1.35 0.94 
ywfA 1.12 1.37 1.42 1.65 1.17 
ywfB 1.02 1.23 0.91 1 1.02 
ywfC 0.99 0.94 1 1.42 0.89 
ywfD 0.92 1.1 1.09 0.97 0.72 
ywfE 0.8 1.01 1.12 0.97 0.75 
ywfF 0.76 0.8 0.94 1.05 0.63 
ywfH 0.63 1.58 1.33 3.2 0.75 
ywgA 1.17 1.31 0.86 1.68 0.87 
ywhA 1.03 1.1 1.24 1.13 0.85 
ywiA 1.23 1.01 0.83 1.21 0.85 
ywiB 1.48 1.31 1.07 1.67 1.09 
ywiC 1.25 1.14 1.12 1.13 1.21 
ywiD 1.01 1.23 1.11 1.85 1.4 
ywiE 1.32 0.86 0.94 1.24 1.28 
ywiH 1.38 1.75 0.98 1.93 1.5 
ywjA 1.33 1.33 1.01 1.13 0.91 
ywjB 0.7 0.9 0.94 1.04 0.74 
ywjC 1.17 1.06 0.89 1.1 0.98 
ywjD 0.26 0.35 0.79 0.29 0.33 
ywjE 0.35 0.46 1 0.37 3.29 
ywjG 0.84 0.96 0.8 1.07 0.98 
yxaB 1 1.22 0.84 1.73 1.24 
yxaC 1.07 1.07 1.05 1.11 0.71 
yxaF 1.26 1.13 0.85 1.28 1 
yxbA 0.99 1.04 0.9 1.08 0.84 
yxbC 0.87 1.4 1.32 0.79 0.51 
yxbD 0.86 1.1 0.86 0.95 1.12 
yxbE 0.68 0.57 0.74 0.98 0.95 
yxbF 1.04 1.12 0.99 0.91 1.02 
yxcA 0.68 0.87 1.29 0.84 0.87 
yxcB 0.45 0.61 0.68 0.58 0.53 
yxcD 1.12 1.31 0.89 1.61 0.78 
yxdB 0.53 0.5 0.58 0.82 0.55 
yxdC 0.59 0.95 0.79 0.44 0.42 
yxdD 2.63 1.57 1.4 1.44 1.2 
yxdE 1.89 1.31 0.92 1.09 1.2 
yxdF 1.07 1.12 0.83 1.14 1.11 
yxdG 0.91 0.83 1.28 0.79 1.06 
yxeA 2.94 2.73 2.59 2.33 2.27 
yxeB 2.86 3.01 1.89 2.81 1.39 
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Table D1 (Continued).  
Expression ratios between the strains of interest and the reference LD 61 strain  
Gene id UCMA5713 LD55 LL08 LL52 S86 
yxfA 0.47 0.83 0.21 0.51 0.5 
yxfB 0.83 0.9 0.75 0.85 0.75 
yxfC 0.97 1.12 1.1 1.27 1 
yyaL 0.92 0.97 0.96 1.29 0.71 
zitP 1.11 0.97 0.89 1.01 0.76 
zitQ 1.03 1.09 1.04 0.92 0.97 
zitR 0.94 0.88 0.7 0.74 0.84 
zitS 0.56 0.54 0.48 0.57 0.5 
zwf 0.59 0.84 0.94 0.53 0.88 
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Table D2 CGH ratios of the 1,915 genes of the core genome. 
 
 CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
accB 1.09 0.83 0.94 0.88 0.96 
accC 1.06 0.92 0.99 0.95 0.89 
accD 1.16 0.98 1.12 1.07 0.99 
ackA1 1.24 1.18 1.21 1.14 1.19 
ackA2 1.31 1.27 1.27 1.17 1.12 
acmA 1.21 1.04 1.04 1.08 1.06 
acmB 1.47 1.3 1.11 1.06 1.05 
acmC 0.91 0.85 0.98 0.79 0.81 
acmD 1.12 1.12 1 1.04 1.01 
acpA 0.98 0.79 0.84 0.89 0.85 
acpD 0.9 0.82 0.94 0.78 0.81 
adaA 1.27 1.06 1.13 1.15 1.22 
add 1.27 1.02 1.09 0.96 0.96 
adhA 1.23 1.15 1.11 1.19 0.95 
adhE 1.24 1.09 1.23 1.06 1.13 
adk 1.01 0.93 1.04 0.93 0.94 
ahpC 1.39 1.24 1.26 1.08 1.13 
ahpF 1.4 1.32 1.23 1.13 1.1 
ahrC 0.85 0.82 0.81 0.77 0.75 
alaS 1.03 1.11 1.06 1.04 1 
aldB 1 0.88 1.02 0.83 0.94 
aldR 0.97 0.71 1 0.96 0.95 
als 0.96 0.85 0.89 0.8 0.92 
amtB 1.12 0.89 0.95 0.94 0.89 
amyL 1.09 0.85 1.04 0.95 0.98 
ansB 1.24 1.14 1.19 1.12 1.19 
apbE 1.01 0.95 0.98 0.89 0.89 
apl 1.12 1.08 1.06 0.97 1.03 
apt 1.21 1.15 1.13 1.05 1.1 
apu 0.98 1.02 1.05 0.88 0.99 
araT 1.04 0.98 1.12 0.9 1.01 
arcA 1.04 1.08 1.1 0.97 1.03 
arcB 1.2 1.02 1.08 0.99 1.21 
arcC1 1.05 0.92 0.9 0.88 0.98 
arcC2 1.2 1.1 1.16 1.1 1.07 
arcC3 1.11 1.03 1.07 1 0.98 
arcD1 1.36 1.3 1.26 1.2 1.2 
arcD2 1.14 1.13 1.07 1.03 1.12 
arcT 1.12 1.1 1.1 0.99 0.99 
argB 1.36 1.37 1.29 1.18 1.22 
argC 1.02 1.03 1.06 0.91 1.01 
argD 0.91 0.95 0.97 0.86 0.92 
argE 1.17 1.16 1.28 1.06 1.18 
argF 1.12 1.11 1.05 1.07 1.12 
argG 1.21 1.02 1.16 1.12 1.2 
argH 1.09 1.07 1.04 1.09 1.12 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
argJ 1.19 1.07 1.11 1.06 1.06 
argR 1.16 1.07 1.09 1.05 1.09 
argS 1.11 1.14 1.14 1.08 1.04 
aroA 1.11 1.05 1.02 1.03 0.95 
aroB 1 0.98 0.98 0.95 0.96 
aroC 1.05 1.09 0.96 1.01 0.92 
aroD 1.43 1.37 1.29 1.33 1.41 
aroE 1.09 1.08 1 0.94 0.98 
aroH 0.78 0.76 0.99 0.8 0.83 
arsC 0.89 0.45 0.87 0.89 0.88 
asd 1.04 0.92 0.99 1.01 0.96 
asnB 1.08 1.09 1.09 1.05 1.02 
asnH 1.34 1.23 1.27 1.25 1.25 
asnS 1.41 1.35 1.28 1.36 1.3 
aspB 1.08 1.07 0.98 1.03 0.97 
aspC 1.06 1.06 1 1.02 0.93 
aspS 1.3 1.32 1.2 1.16 1.18 
atpB 0.81 0.93 0.91 0.82 0.82 
atpD 0.98 1.14 1.09 1.02 1.15 
atpE 0.86 0.88 0.86 0.84 0.9 
atpF 1 0.93 1.07 1 0.96 
atpG 1.03 1.01 1.02 1 0.96 
atpH 1.11 1.03 1.11 1.04 1 
bacA 1.03 0.99 0.98 0.94 0.93 
bar 1.08 1.11 1.01 1.11 1.06 
bcaT 0.96 1.09 1.01 1.04 0.99 
bglA 1.08 1.05 0.96 0.96 1 
bglH 1.31 1.24 1.15 1.14 1.09 
bglR 0.79 1.06 1.03 1 0.97 
bglS 1.07 1.07 1.15 1.03 1.04 
birA1 1.18 1.09 1.25 1.12 1.09 
birA2 1.05 1.08 1.11 1.03 1.01 
blt 1.24 1.09 1.22 1.1 1.13 
bmpA 1.07 0.97 0.98 0.9 0.95 
busAA 0.98 0.94 0.99 0.99 0.92 
busAB 1 0.95 0.91 1.03 0.87 
busR 1.14 1.16 1.05 1.2 1.07 
butA 1.11 1.02 1.06 1.06 0.98 
butB 1.09 1.04 1.08 1.03 1.01 
cadA 1.26 1.22 1.17 1.04 1.12 
carA 1.11 1.19 1.19 1.13 1.06 
carB 0.86 0.88 0.96 0.87 0.82 
cbr 1.1 1.06 1.23 1.05 1.05 
ccpA 1.15 1.19 1.15 1.17 1.26 
cdd 1.07 0.93 1.19 0.94 1.11 
cdsA 1.3 1.13 1.26 1.08 1.03 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
celB 1.24 1.19 1.13 1.17 1.22 
ceo 1.64 1.14 1.13 1.53 1.47 
chiA 1.16 1.17 1.16 1.19 1.09 
choS 1.04 0.98 1 0.88 0.92 
citB 1.15 1.09 1.16 1.03 0.98 
citC 0.66 0.68 0.99 0.58 0.59 
citD 0.7 0.5 0.98 0.58 0.51 
citE 0.48 0.41 1.05 0.37 0.4 
citF 0.58 0.53 1.15 0.54 0.58 
clpB 1.05 0.95 1.02 0.94 0.98 
clpC 0.92 0.9 0.96 0.94 0.91 
clpE 1.38 1.37 1.23 1.29 1.21 
clpP 1.17 1.17 1.13 1.25 1.09 
clpX 1.14 1.09 1.06 1.01 0.98 
clsA 1.16 1.16 1.14 1.11 1.11 
clsB 1.04 0.98 1.08 0.9 0.88 
cmk 0.75 0.89 0.86 0.72 0.73 
coaA 0.98 0.95 1.02 0.89 0.86 
cobC 1.06 1.06 1.09 1.01 1.03 
cobQ 1.01 0.95 1.09 1 1 
codY 0.98 1.02 0.97 0.99 1.02 
codZ 0.94 0.79 0.79 0.71 0.92 
coiA 1.34 1.22 1.18 1.17 1.07 
comC 1.17 1.15 1.06 1.15 1.12 
comEA 1.02 1.04 0.96 1.04 0.93 
comEC 0.89 0.97 0.91 0.95 0.9 
comFA 1.07 1.08 1.05 0.97 1 
comFC 1.06 1.07 1.15 0.89 0.94 
comGA 1.09 1.05 1.07 0.86 0.96 
comGB 0.9 0.93 0.96 0.82 0.87 
comGC 0.81 0.79 0.83 0.76 0.82 
comGD 0.74 0.74 0.65 0.56 0.74 
comX 0.7 0.8 0.83 0.8 0.78 
copB 1.2 2.61 1.81 1.09 1.2 
copR 0.87 0.88 0.88 0.96 0.9 
cpo 0.97 0.93 0.95 0.99 0.9 
cpsM 0.86 0.85 1.04 0.96 0.96 
crtK 1.04 1.05 1.02 0.94 0.94 
cshA 1.39 1.38 1.51 1.17 1.29 
cspE 0.91 0.76 0.83 0.83 0.75 
cstA 1.16 1.09 1.12 0.9 0.95 
ctrA 1.09 0.99 1.07 0.9 0.96 
ctsR 1.08 1.05 1.19 0.96 1.05 
cydA 0.87 0.86 0.93 0.83 0.89 
cydC 1.05 1.05 1.02 1.17 1.2 
cydD 1.28 1.18 1.26 1.15 1.16 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
cysD 1.07 1.1 1 1.07 1.06 
cysE 1.13 1.09 0.9 1.08 1.06 
cysK 1.08 1.07 0.94 1.02 1.05 
cysM 0.86 0.97 0.92 0.99 0.88 
cysS 1.02 1.07 0.92 0.99 1.01 
dacA 0.84 0.86 0.89 0.85 0.84 
dacB 1.04 0.96 0.9 0.84 0.86 
dal 1 0.84 0.95 0.9 0.89 
dapA 0.96 0.88 0.97 0.98 0.96 
dapB 1.17 1.07 1.15 1.04 0.96 
dcdA 0.96 1.02 1.05 0.97 0.95 
ddl 1.14 1.2 1.06 1.07 1.12 
def 1.25 1.3 1.12 1.24 1.18 
deoB 0.96 1.01 0.93 0.99 0.95 
deoC 0.99 0.93 0.82 0.96 0.91 
deoD 0.98 1.08 1.02 0.99 1 
dexB 0.78 0.83 0.86 0.84 0.73 
dfpB 1.02 1.04 1.12 0.97 0.99 
dfrA 0.93 0.89 1.13 0.87 0.99 
dgkA 0.71 0.76 0.72 0.82 0.84 
dhaK 1.09 1.01 1.1 1.01 1.12 
dhaL 1.09 1.16 0.93 1.1 1.11 
dhaM 1.24 1.24 1.24 1.28 1.24 
dinF 1.12 1.22 1.08 1.17 1.13 
dltC 1.11 0.83 1.14 1.07 1.04 
dnaC 1.22 1.1 1.16 1.13 1.12 
dnaD 1.01 1.04 1.02 1 1 
dnaE 1.09 1.2 1.15 1.14 1.12 
dnaH 1.07 1.13 1.06 1.11 1.12 
dnaJ 0.9 1.12 1.05 1.05 1.03 
dnaK 1.04 1.03 1.08 1.13 1.01 
dnaN 1.08 1.13 1.08 1.12 0.99 
dnaQ 0.92 0.92 0.95 0.83 0.85 
dpsA 0.96 0.93 0.9 0.94 0.86 
dukA 1.12 1.09 1.07 1.04 1.04 
dukB 0.93 0.94 0.9 0.9 0.99 
dut 1.08 0.98 1.08 1.05 1.1 
dxsA 1 1.01 0.89 1.01 0.97 
dxsB 1.15 1.18 1.14 1.23 1.16 
ecsB 0.87 1.07 1 1 0.94 
efp 1.17 1.25 1.35 1.27 1.26 
enoA 1.1 1.17 1.22 1.11 1.05 
enoB 1.13 1.09 1.13 1.09 1 
eraL 1.23 1.22 1.3 1.15 1.12 
exoA 1.04 1.02 1.05 1.05 1.02 
ezrA 1.03 1.03 1.11 1.06 1.07 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
fabF 1.07 1.01 1.04 1.03 1.09 
fabG1 1.06 1.05 1.06 1.1 1.04 
fabG2 1.06 1.13 1.1 1.08 1.07 
fabI 0.99 1.05 1.08 1.03 0.96 
fabZ1 0.93 1.09 1.18 1.04 0.99 
fabZ2 0.96 0.98 1.02 0.94 0.93 
fadA 1.24 1.31 1.3 1.23 1.2 
fadD 1.27 1.24 1.35 1.24 1.15 
fbaA 1.28 1.2 1.15 1.16 1.1 
fbp 1.24 1.13 1.27 1.23 1.24 
femD 1.15 1.09 1.13 1.13 1.11 
feoA 0.93 0.95 0.89 0.78 0.85 
feoB 1.24 1.22 1.19 1.09 1.19 
fer 0.91 0.83 0.95 0.94 0.88 
ffh 1.05 1.1 1.02 1.14 1.03 
fhs 1.09 1.13 1.19 1.23 1.14 
fhuB 0.95 1.04 0.95 0.88 0.94 
fhuD 1.01 1.11 1.1 1.02 1.05 
fhuG 1.14 1.22 1.3 1.05 1.11 
fhuR 1.25 1.27 1.35 1.08 1.14 
fmt 0.89 0.95 0.95 0.91 0.86 
folB 1.02 0.96 1.08 1.05 0.96 
folC 0.89 0.91 1.08 0.94 0.9 
folD 1.06 1 1.14 1.05 1.04 
folE 1.03 0.99 1.03 1.04 0.91 
folP 1.04 1.01 1.02 1.04 0.99 
frdC 1.01 1.07 1 1.04 1.02 
frr 0.86 0.99 0.86 0.92 0.91 
ftsA 1.13 1.09 1.13 0.99 1.03 
ftsE 1.06 0.96 1.06 0.89 0.94 
ftsH 1.15 1.17 1.16 0.96 1.13 
ftsW1 1.03 1.05 1.12 1.07 1.01 
ftsW2 0.98 0.92 0.9 0.91 0.97 
ftsX 1 0.92 1.07 1.05 0.99 
ftsY 1.03 1 0.99 1.01 0.93 
ftsZ 1.05 1.19 1.12 1.16 1.07 
fur 0.94 1.17 1.16 1 1.12 
fusA 0.93 1.1 1.09 1.06 1.09 
gadB 0.86 0.95 0.94 0.9 0.89 
gadC 0.92 0.97 0.95 0.93 0.9 
gadR 0.9 1.02 1.04 0.96 0.95 
galE 1.18 1.17 1.75 1.16 1.13 
galK 1.04 1.14 1.13 1.15 1.07 
galM 0.92 0.97 1.03 0.95 0.99 
galT 0.94 1.03 1.02 0.98 0.97 
gapA 1.04 1.01 1.03 1.11 0.98 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
gapB 1.09 1.21 1.05 1.14 1.05 
gatB 0.94 1.13 1.14 1.06 1.17 
gatC 0.81 0.97 0.98 0.88 0.93 
gcp 1.02 1.1 1.04 1.02 1.13 
gidA 1.06 1.14 1.03 1.04 1.07 
gidB 1.04 1.06 1.08 1.06 1.03 
gidC 0.97 1.01 1.14 0.98 1 
glgA 1.1 1.09 1.14 1.14 0.99 
glgC 0.89 0.97 0.98 0.93 0.9 
glgD 0.97 1.01 1.05 0.95 1.01 
glgP 1.16 1.1 1.09 1.06 1.24 
glk 1.16 1.09 1.08 1.07 1.12 
glmS 0.91 0.94 1 0.92 0.93 
glmU 1.11 1.18 1.07 1.11 1.11 
glnA 1.2 1.34 1.18 1.05 1.31 
glnB 0.92 0.91 0.92 0.96 0.99 
glnP 1.08 1.19 1.02 1.1 1.05 
glnR 1 1.1 0.96 0.98 1.01 
glpD 0.82 0.9 1 0.96 0.9 
glpF1 0.91 1.02 1 1.06 1.02 
glpF2 0.82 0.87 0.89 0.81 0.89 
glpK 0.8 0.84 0.91 0.89 0.9 
glpT 1.03 1.03 1.03 1.07 0.99 
gltA 1.05 1.15 1.15 1.15 1.16 
gltD 0.76 0.81 0.91 0.81 0.78 
gltQ 0.93 1.02 0.98 0.89 0.93 
gltS 0.96 1.07 1.02 1 1.04 
glyA 1.01 1.1 1.07 1.03 1.08 
glyS 0.81 0.89 0.99 0.87 0.9 
gnd 0.84 0.87 0.92 0.92 0.86 
gntK 0.95 1.07 1.12 0.97 1.04 
gntR 1.12 1.16 1.18 1.06 1.25 
gntZ 1.25 1.13 1.19 1.25 1.21 
gpdA 0.69 0.73 0.8 0.79 0.75 
gpo 0.83 0.9 0.95 0.88 0.91 
greA 0.94 1.07 1.02 1.05 1.05 
groES 1.05 0.62 1 0.94 0.91 
grpE 0.95 1 0.99 0.93 0.95 
gshR 0.95 1.02 0.97 0.97 0.99 
guaA 0.99 0.99 0.94 1.03 1.01 
guaB 1.11 1.26 1.25 1.18 1.11 
guaC 0.89 0.88 0.94 1.02 0.93 
gyrA 0.78 0.78 0.72 0.76 0.79 
gyrB 0.83 0.9 0.94 0.86 0.88 
hemH 0.84 0.95 0.87 0.91 0.95 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
      
hemK 0.92 1.13 1.07 1.03 1.02 
hemN 0.92 0.98 1.01 0.93 0.99 
hexA 1.16 1.29 1.19 1.08 1.25 
hexB 0.97 1.09 1.06 0.99 1.08 
hflX 1.18 1.13 0.95 0.98 1.05 
hisA 0.95 0.97 1.01 0.92 0.96 
hisB 0.87 0.89 0.84 0.87 0.89 
hisC 0.99 0.93 0.95 1.02 0.94 
hisD 0.89 0.9 0.88 0.94 0.93 
hisG 0.86 0.87 1.03 0.87 0.96 
hisH 0.96 0.97 1.13 0.95 0.97 
hisI 0.83 0.93 0.93 0.94 0.92 
hisK 0.87 1.01 0.98 0.93 0.98 
hisS 0.82 0.97 0.94 0.88 0.94 
hisZ 0.79 0.85 0.88 0.85 0.85 
hly 1.13 1.16 1.04 1.06 1.11 
hmcM 0.91 0.93 0.86 0.9 0.85 
holB 0.83 0.94 0.91 0.89 0.86 
hom 0.76 0.84 0.85 0.89 0.83 
hprT 0.98 1 1.03 0.98 0.89 
hpt 0.81 0.84 0.91 0.94 0.83 
hrcA 0.99 1.04 1.04 1.04 1.02 
hsdM 0.64 0.65 1.06 0.91 0.67 
hsdR 0.83 0.94 1.13 0.99 0.85 
hsdS 0.64 0.67 1.19 0.71 0.75 
hslA 0.96 0.89 0.96 0.89 0.93 
hslB 0.75 0.86 0.91 0.85 0.87 
htrA 1.12 1.2 1.13 1.09 1.14 
icaA 1.04 1.02 0.93 0.96 1.01 
icaC 0.95 1.02 0.96 0.99 0.99 
icd 1 1.01 0.94 1.03 1.01 
ileS 0.93 1.04 0.95 0.95 0.94 
ilvB 0.89 0.94 0.95 0.85 0.88 
ilvC 0.95 1.02 1.04 1.06 0.98 
ilvD 0.79 0.88 0.96 1 0.92 
ilvN 0.72 0.8 0.88 0.8 0.77 
infA 1.03 0.97 0.96 0.96 0.93 
infB 0.9 0.99 0.98 1.02 1.02 
infC 0.88 1.03 1.04 1 0.99 
ipd 0.87 0.98 0.95 0.94 0.97 
ispA 0.95 0.93 1.02 1.01 0.97 
ispB 0.84 0.92 0.93 0.92 0.94 
kdgA 0.9 0.91 0.72 0.94 0.89 
kdgK 0.81 0.87 0.78 0.84 0.87 
kdtB 1.1 1.22 1.11 1.08 1.1 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
kinA 0.94 1.01 1 0.97 0.94 
kinB 0.8 0.9 0.94 0.9 0.85 
kinC 0.98 1.08 1.04 1.07 1.06 
kinD 0.74 0.83 0.9 0.83 0.84 
kinE 0.92 0.94 1.01 0.96 0.97 
kinF 0.94 0.96 0.94 0.76 0.78 
ksgA 0.97 1.01 0.99 1.07 1.01 
kupA 0.89 0.97 0.91 0.98 0.87 
kupB 0.92 0.94 0.93 0.9 0.93 
lacC 0.94 0.99 0.93 0.89 1.07 
lacR 0.95 1.06 1.01 0.77 0.99 
lacZ 1.01 1.12 1.09 0.96 1.04 
lcnC 0.51 0.6 1.05 0.94 1.05 
lcnD 0.33 0.41 1.16 1.03 1.17 
lctO 0.86 0.94 1 0.91 0.93 
ldh 0.84 0.97 1.02 0.98 1 
ldhB 0.88 0.87 0.99 0.95 0.97 
ldhX 0.82 0.93 1.05 0.88 0.98 
lepA 0.74 0.87 0.87 0.83 0.78 
leuB 0.81 0.87 0.88 0.85 0.81 
leuC 0.86 0.92 0.97 0.97 0.99 
leuD 0.87 0.96 0.97 0.89 0.93 
leuS 1.06 1.14 1.09 0.96 1.1 
lgt 0.79 0.94 1.01 0.95 0.97 
ligA 0.91 1.05 1.17 1.06 1.01 
llrA 0.91 1.04 1.07 1.03 1.08 
llrB 0.86 0.99 1.12 0.98 0.93 
llrC 1.19 1.28 1.27 1.24 1.29 
llrD 0.79 0.87 0.94 0.84 0.87 
llrE 0.88 0.96 1.07 0.9 0.96 
llrF 0.73 0.95 0.92 0.88 0.85 
llrG 0.88 0.95 0.92 0.93 0.85 
llrH 0.6 0.63 0.75 0.92 0.8 
lmrA 1 1.17 1.06 1.03 1.21 
lnbA 1.42 1.1 1.3 1.39 1.04 
lplL 1.24 1.13 1.12 1.16 0.78 
lspA 0.99 0.8 1.04 0.99 0.86 
lysA 1.05 0.92 1.13 1.09 1 
lysP 1.31 1.01 1.18 1.14 1.13 
lysQ 1.15 1.03 1.1 1.04 1 
lysS 1.37 1.31 1.22 1.16 1.18 
mae 0.44 0.42 0.9 0.43 0.43 
malQ 1.14 0.95 1.09 1.13 0.85 
menB 1.2 1.02 1.19 1.18 1.08 
menD 1.15 0.99 1.16 1.12 1.1 
menE 1.14 0.86 1.16 1.11 1.04 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
menF 0.99 0.91 0.94 0.88 0.87 
menX 1.07 0.97 0.99 0.93 0.85 
mesJ 1.16 1.07 1.04 1.02 1.04 
metB1 0.99 0.95 1.13 1.03 0.92 
metB2 1.22 1.08 0.86 1.08 1.01 
metE 1 0.8 0.96 0.98 0.98 
metF 1.12 0.96 0.96 0.93 0.98 
metK 1.21 1.05 1.05 1.1 1.13 
metS 1.26 1 1.17 1.1 1.17 
mgtA 1.15 1.02 1.13 1.08 1.09 
miaA 1.22 1.09 1.12 0.99 1.09 
mleR 0.99 0.82 1.01 0.85 0.96 
mleS 0.9 0.93 0.97 0.8 0.91 
mreC 1.24 1.16 1.12 0.98 1.11 
mreD 1.29 1.04 1.04 1.04 1.21 
mscL 1.14 0.93 0.98 1 1.05 
msmK 1.11 0.94 1.05 1.09 1.02 
mtlD 1.46 1.21 1.25 1.23 1.32 
mtlF 1.11 1 1.2 1.23 1.25 
mtlR 1.21 1.13 1.13 1.03 1.22 
mtsA 1.12 1 1.11 0.98 1.02 
mtsB 1.2 1.05 1.11 0.99 1.08 
mtsC 0.92 0.92 0.9 0.76 0.84 
murA1 1.03 1 1.09 0.85 1 
murA2 1.06 0.99 1 0.85 1.02 
murB 0.7 0.68 0.85 0.76 0.75 
murC 1.34 1.13 1.28 1.11 1.25 
murD 1.04 0.92 0.96 1.02 1 
murE 1.04 0.96 1 1.02 0.99 
murF 1.09 1.03 1.09 1.11 1.08 
murI 1.17 1.03 1.18 1.06 1.11 
mutM 1.05 0.98 0.94 0.96 0.97 
mutS 1.09 1.08 1.06 1.03 1.07 
mutX 0.96 0.96 0.91 0.82 0.91 
mvaA 0.82 0.81 0.9 0.81 0.89 
mycA 1 0.93 1.05 0.91 0.99 
nadE 0.9 0.76 1.02 0.95 0.95 
nadR 1.16 1.14 1.12 1.19 1.1 
nagA 1.05 0.96 0.98 1 1 
nagB 1.27 1.27 1.25 1.33 1.21 
nah 1.2 1.18 1.15 1.22 1.2 
napB 1.02 1.02 0.98 1.01 0.97 
napC 1.22 1.15 1.08 1.03 1 
ndrH 0.86 0.77 0.78 0.79 0.8 
ndrI 0.95 0.9 0.9 0.88 0.9 
nifS 0.96 1.05 1 0.87 0.97 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
nifU 0.84 0.87 0.93 0.81 0.88 
nifZ 0.83 0.94 0.9 0.83 0.81 
noxA 1.11 0.98 1.11 1.04 1.04 
noxB 1.25 1.11 1.13 1.26 1.13 
noxC 1.02 0.95 1.02 1.01 0.98 
noxD 1.03 0.97 1.05 1.13 1.05 
noxE 1.32 1.32 1.18 1.35 1.24 
nrdD 1.06 1.05 0.99 1.05 0.98 
nrdE 0.95 0.92 0.96 0.93 0.93 
nrdF 0.96 0.99 1.01 0.95 0.92 
nrdG 1.03 0.99 0.93 0.9 0.9 
nth 1.03 1.04 1.08 1.01 1.01 
nucA 0.89 0.8 0.98 0.82 0.83 
nusA 0.87 0.92 0.96 0.85 0.85 
nusB 1.33 1.06 1.34 1.35 1.31 
nusG 1.2 1.11 1.15 1.08 1.14 
obgL 1.06 0.94 1.01 1.08 1.05 
ogt 1.31 1.14 1.19 1.25 1.19 
oppA 1.62 1.66 1.44 1.55 1.08 
oppB 2.12 2.07 1.74 1.62 1.92 
oppC 2.18 2.21 1.89 1.86 1.92 
oppD 1.77 1.78 1.7 1.58 1.81 
oppF 2.19 2.28 2.13 1.91 2.16 
optA 1.21 1.22 1.32 1.12 1.14 
optB 1.03 0.97 1.13 0.96 1.02 
optC 1.24 1.27 1.15 1.07 1.25 
optD 1.02 0.89 1.01 0.97 0.97 
optF 1.23 1.02 1.22 1.13 1.02 
optS 1.13 1.1 1.16 1.07 1.07 
osmC 1.04 1.04 1.03 1.06 0.99 
otcA 1.14 1.14 1.08 1.13 1.02 
pabB 0.77 0.84 0.96 0.83 0.75 
pacB 0.87 0.83 0.84 0.79 0.77 
pacL 1.03 0.97 1 0.98 1.01 
panE 0.96 0.87 1.05 0.97 0.87 
papL 0.99 0.95 0.99 0.97 0.92 
parA 1.29 1.13 1.21 1.14 1.17 
parC 0.88 0.85 0.88 0.91 0.87 
parE 1.14 1.05 1.01 1.08 1.06 
pbp1B 1.15 1.09 1.08 1.18 1.07 
pbp2A 0.91 0.95 0.91 0.95 0.89 
pbp2B 1.08 0.98 1.02 0.95 0.94 
pbpX 1.13 1.02 1.11 0.96 0.99 
pbuX 1.11 1.18 1.12 0.96 1.01 
pcaC 0.93 0.96 0.96 0.92 0.9 
pcrA 1.16 1.04 1.17 1.09 1.06 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
pdc 1.14 1.08 1.25 1.13 1.11 
pdhA 0.98 1.13 1.04 1.09 1.19 
pdhB 1.12 1.01 1.13 0.95 1.09 
pdhC 0.92 0.89 0.93 0.98 0.84 
pdhD 1.12 1.08 1.12 1.09 1.04 
pdp 0.97 0.97 0.87 1.01 0.88 
pepC 1.01 1.04 1.01 1.01 0.98 
pepDA 0.96 0.93 1.03 0.86 0.89 
pepDB 1.02 0.98 0.98 0.75 0.85 
pepF 1.41 1.38 1.34 1.07 1.26 
pepM 1.24 1.1 1.2 0.99 1.12 
pepN 1.03 0.96 1.03 0.93 0.92 
pepO 0.86 0.9 0.99 0.87 0.96 
pepP 1.14 1.01 1.1 1.07 1.08 
pepT 1.34 1.34 1.09 1.23 1.19 
pepV 1.07 1.06 1.06 1.14 1.02 
pepXP 1.06 1.13 1.04 0.98 0.88 
pfl 1.06 0.99 1.13 0.88 0.94 
pflA 1.07 1.05 1.06 0.83 0.89 
pfs 1.15 1.07 1.12 0.99 1.03 
pgk 1.1 1.08 1.26 0.97 1.05 
pgmB 0.76 0.81 0.86 0.79 0.84 
pgsA 1.1 1.05 1.1 0.98 1.06 
pheA 1.16 1.17 1.07 1.08 1.07 
pheS 1.34 1.42 1.17 1.31 1.33 
pheT 1.22 1.23 1.04 1.11 1.07 
phnA 1.01 1.03 0.93 0.96 1.01 
phnB 0.95 1.05 0.93 0.93 0.94 
phnC 1.08 1.09 1.07 0.93 0.95 
phnE 1.21 1.1 1.17 1.03 0.98 
phoL 1.02 0.87 1.11 0.92 0.97 
phoU 1.06 0.96 1.02 0.91 0.99 
pi101 0.65 0.66 1.19 0.65 0.65 
pi102 0.45 0.57 0.93 0.58 0.57 
pi103 0.81 0.77 0.97 0.76 0.76 
pi104 0.7 0.7 0.71 0.69 0.7 
pi105 0.81 0.74 1.08 0.76 0.83 
pi106 0.77 0.73 0.87 0.76 0.68 
pi107 0.78 0.87 0.99 0.83 0.81 
pi108 0.45 0.59 1.11 0.38 0.6 
pi109 0.13 0.16 0.92 0.75 0.89 
pi110 0.79 0.61 0.75 0.77 0.75 
pi111 0.4 0.43 0.92 0.41 0.4 
pi113 0.99 0.83 0.98 0.83 0.8 
pi114 0.88 0.51 0.87 0.46 0.48 
pi115 0.83 0.56 1.13 0.9 0.72 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
pi116 0.67 0.7 0.95 0.78 1.08 
pi117 0.86 0.73 0.92 0.94 0.85 
pi118 1.12 0.69 1.05 0.82 0.69 
pi120 0.8 0.6 1.11 0.74 0.91 
pi122 0.55 0.44 1.01 0.43 0.49 
pi123 0.4 0.24 0.98 0.33 0.3 
pi124 0.97 0.64 1.02 0.85 0.82 
pi125 0.62 0.53 0.84 0.76 0.53 
pi127 0.66 0.55 0.84 0.72 0.66 
pi128 0.5 0.59 0.89 0.58 0.57 
pi129 0.55 0.59 1.07 0.59 0.61 
pi130 0.39 0.4 1.2 0.33 0.48 
pi133 0.28 0.29 1.06 1.16 0.48 
pi135 0.79 0.66 0.89 0.97 0.81 
pi137 0.21 0.21 1.02 1.06 0.23 
pi138 0.54 0.58 1.03 0.97 0.58 
pi139 0.58 0.61 1 0.94 0.6 
pi140 0.74 0.77 1 1 0.69 
pi141 0.63 0.65 0.87 0.83 0.63 
pi142 0.37 0.4 1.03 0.96 0.43 
pi143 0.43 0.45 1.07 1.09 0.46 
pi144 0.4 0.38 0.89 0.93 0.49 
pi145 0.14 0.14 1.18 0.11 0.14 
pi205 0.89 0.71 0.79 0.72 0.63 
pi208 0.17 0.2 0.68 0.62 0.58 
pi209 1.42 0.32 0.61 0.71 0.9 
pi210 0.94 1.12 1.67 1 0.9 
pi211 0.3 0.28 1.14 0.26 0.31 
pi215 1.06 1.07 1.67 1.08 1.44 
pi216 0.7 0.65 0.84 0.63 0.67 
pi217 0.68 0.51 0.73 0.52 0.6 
pi218 0.51 0.57 0.8 0.65 0.7 
pi222 0.81 0.6 1.02 0.89 1 
pi223 0.45 0.42 1.34 0.49 0.57 
pi224 0.68 0.74 0.97 0.75 0.72 
pi227 0.6 0.67 0.9 0.72 0.66 
pi228 0.56 0.63 0.95 0.6 0.71 
pi229 0.29 0.33 1.08 0.37 0.35 
pi230 0.46 0.5 0.99 0.43 0.49 
pi231 0.52 0.57 1 0.5 0.5 
pi232 0.45 0.46 1.04 0.43 0.44 
pi233 0.33 0.38 0.94 0.38 0.37 
pi234 0.57 0.6 0.81 0.57 0.63 
pi235 0.51 0.43 1.07 0.47 0.51 
pi236 0.75 0.77 1.15 0.77 0.75 
pi237 0.69 0.64 0.81 0.58 0.71 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
pi238 0.84 0.86 1.12 0.8 0.86 
pi239 0.6 0.63 0.98 0.62 0.6 
pi240 0.51 0.53 0.97 0.55 0.53 
pi241 0.86 0.74 1 0.73 0.78 
pi242 0.41 0.45 1.04 0.44 0.45 
pi243 0.89 0.92 1.09 0.89 0.9 
pi244 0.56 0.64 0.97 0.66 0.59 
pi245 0.63 0.64 0.97 0.69 0.73 
pi246 0.67 0.75 0.92 0.62 0.7 
pi247 0.6 0.57 0.78 0.43 0.6 
pi248 0.58 0.66 1 0.63 0.62 
pi249 0.56 0.46 0.94 0.45 0.46 
pi251 0.69 0.88 1.17 1.04 0.98 
pi301 1.06 0.97 1.08 1.06 1.13 
pi302 1.05 0.93 0.96 0.88 0.92 
pi303 0.64 0.63 0.68 0.61 0.71 
pi307 0.71 0.72 0.75 0.79 0.75 
pi308 0.36 0.41 0.72 0.34 0.81 
pi316 0.69 0.75 0.83 0.74 0.83 
pi317 0.6 0.62 1.01 0.6 0.94 
pi318 0.79 0.83 0.9 0.72 0.83 
pi319 0.72 0.77 0.93 0.77 0.74 
pi320 0.59 0.62 0.76 0.58 0.79 
pi321 0.53 0.59 0.82 0.56 0.8 
pi322 0.6 0.59 0.98 0.57 0.94 
pi323 0.55 0.6 0.91 0.61 0.86 
pi324 0.36 0.46 1.03 0.47 1.07 
pi325 0.41 0.46 0.86 0.44 0.43 
pi326 0.37 0.33 0.9 0.37 0.31 
pi327 0.31 0.35 0.92 0.76 0.84 
pi328 0.79 0.86 0.89 0.94 1.03 
pi329 0.76 0.68 0.82 0.75 1.03 
pi330 0.92 0.99 1.13 0.96 0.9 
pi331 1.06 0.99 1.09 0.91 0.97 
pi333 1.03 0.84 0.91 0.93 0.91 
pi334 0.72 0.73 0.7 0.73 0.94 
pi336 0.77 0.53 0.52 0.51 0.48 
pi337 0.61 0.53 0.62 0.74 0.55 
pi338 0.63 0.6 0.59 0.52 0.61 
pi339 0.41 0.47 0.47 0.78 0.71 
pi341 0.36 0.23 0.6 0.3 0.33 
pi343 0.76 0.65 0.8 0.62 0.87 
pi345 0.77 0.84 0.86 0.83 0.79 
pi347 0.19 0.24 0.22 0.2 0.21 
pi348 0.85 0.84 0.83 0.9 0.93 
pi349 0.83 0.93 0.79 0.86 0.97 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
pi350 0.27 0.34 0.38 0.32 0.88 
pi353 0.48 0.35 0.79 1.06 1.03 
pi354 0.65 0.55 0.67 0.64 0.92 
pi355 0.81 0.75 0.89 0.71 0.75 
pi356 0.76 0.75 0.81 0.89 0.85 
pi357 0.79 0.84 0.71 0.77 0.85 
pi358 0.49 0.7 0.75 0.6 0.74 
pi359 0.42 0.46 0.54 0.67 0.48 
pi360 0.55 0.6 0.63 0.55 0.86 
pip 1.05 1.1 1.15 1.1 0.99 
pknB 0.99 1.03 1.08 1.03 1 
plpA 1.02 1.02 1.12 1.03 1 
plpB 1.06 1.03 1.03 1.11 0.98 
plpC 1.01 1.11 1.04 1.1 1.06 
plpD 0.74 0.92 0.85 0.9 0.87 
plsX 0.97 1.15 1.15 1.07 1.14 
pmg 0.93 1.02 1.01 0.98 0.97 
pmpA 0.93 0.94 1.01 0.93 0.89 
pmrA 0.88 0.93 0.99 0.89 0.87 
pmsR 0.91 0.94 1 0.98 0.89 
pmsX 0.92 0.96 1.01 0.93 0.89 
pnpA 0.97 0.97 0.88 1.04 1.03 
pnuC2 1 0.92 1 0.95 1.01 
polA 1.21 1.25 1.18 1.14 1.2 
polC 0.93 1.03 1.01 0.95 1.01 
ponA 0.93 1.14 1.02 1 1.07 
potA 0.76 0.87 0.92 0.89 0.88 
potB 0.9 0.93 0.96 0.87 0.96 
potC 0.91 0.93 1.02 1 0.92 
potD 0.95 1.12 1.1 1.01 0.98 
poxL 0.74 0.88 0.88 0.85 0.84 
ppiA 1.02 1.04 1.11 1.13 1.04 
ppiB 0.88 0.98 1.04 0.95 0.97 
preA 1.07 1.12 1.17 1.04 1.21 
prfA 0.95 0.88 0.94 0.99 0.9 
prfB 0.98 0.98 1.02 1.01 1 
prfC 0.97 1.07 1.04 0.99 0.99 
prmA 0.81 0.94 0.95 0.94 0.98 
proA 0.83 0.88 0.83 0.89 0.88 
proB 0.86 0.95 0.94 1.01 0.92 
proC 0.68 0.81 0.83 0.78 0.78 
proS 0.98 1.03 1.14 1.11 1.06 
prsA 1.03 1.07 1.16 1.11 1.07 
prsB 1.07 1.15 1.19 1.11 1.09 
ps101 0.75 0.78 0.78 0.72 0.72 
ps102 0.89 0.71 0.89 0.87 0.76 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ps104 0.8 0.68 0.94 0.73 0.81 
ps105 1.13 1.2 1.14 1.04 1.13 
ps106 1.01 1.03 0.96 0.83 1.17 
ps107 0.96 0.94 0.88 0.81 0.99 
ps108 1.08 1.1 0.99 0.6 0.97 
ps109 0.91 0.82 0.84 0.46 0.9 
ps110 0.92 0.93 0.87 0.77 0.97 
ps111 1.09 0.56 1.02 0.5 1.15 
ps112 0.81 0.79 0.81 0.68 0.9 
ps113 0.9 0.81 1.03 0.69 0.98 
ps114 0.5 0.57 0.99 0.56 0.55 
ps115 0.66 0.6 0.97 0.58 0.79 
ps116 0.78 0.77 0.92 0.76 0.79 
ps117 0.88 0.87 1.05 0.85 0.86 
ps118 1 1.2 0.87 0.6 1.08 
ps119 0.96 0.73 1 0.8 1.05 
ps120 0.41 0.29 1.03 0.41 1.18 
ps121 1.24 0.97 1.09 0.6 1.17 
ps122 0.75 0.78 0.8 0.75 0.77 
ps123 0.99 1.01 0.97 0.96 0.98 
ps201 0.79 0.96 1 0.79 0.97 
ps202 0.64 0.84 0.84 0.75 0.75 
ps203 0.39 1.11 1.08 1.08 1.14 
ps205 0.68 0.78 0.85 0.77 0.7 
ps206 0.57 0.9 0.92 0.77 0.71 
ps207 0.73 1.06 0.94 0.59 0.94 
ps209 0.71 0.97 0.93 0.71 0.65 
ps211 0.65 1.04 0.81 0.64 0.94 
ps212 0.85 1.24 1.02 0.82 1.13 
ps213 0.76 0.95 0.93 0.76 0.74 
ps214 0.99 1.06 1.06 0.94 1.07 
ps216 0.6 0.99 0.91 0.63 1.08 
ps218 0.83 1.12 0.94 0.74 0.91 
ps219 0.8 0.89 0.84 0.8 0.84 
ps220 0.72 0.87 0.79 0.68 0.79 
ps301 0.15 0.19 1.18 0.17 0.19 
ps302 0.63 0.65 0.87 0.69 0.65 
ps303 0.9 0.84 1.03 1.01 1.29 
ps304 0.54 0.59 0.87 0.55 0.57 
ps306 0.99 1.08 1.09 1.08 1.1 
ps307 0.75 1.05 1.09 0.94 1.04 
ps308 0.87 0.93 0.9 0.77 0.98 
ps309 0.94 0.74 0.89 0.84 0.59 
ps311 0.98 1.23 1.24 1.11 0.18 
ps312 0.73 0.78 0.94 0.87 0.4 
ps314 0.44 0.79 1.05 0.5 0.44 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ps316 0.23 0.37 1.05 0.94 0.55 
pstA 1.02 1.1 0.97 1.05 0.98 
pstB 1 1.02 1.02 1.06 0.99 
pstC 1.17 1.2 1.18 1.1 1.09 
pstE 1.04 1.29 1 1.12 1.13 
pstF 1.04 1.25 1.03 1.01 1 
pta 0.99 1.09 1.02 1.07 1.08 
ptbA 1.03 1.09 1.13 1.1 1.09 
ptcA 1.21 1.41 1.16 1.22 1.29 
ptcB 0.97 1.03 1.03 1.05 1 
ptcC 1.24 1.28 1.19 1.18 1.24 
ptk 1 1.02 0.86 1 0.95 
ptnAB 0.96 0.97 0.97 1.09 0.94 
ptnC 0.99 0.96 0.96 1 1.01 
ptnD 1.1 1.1 1.12 1.04 1.05 
ptpL 1.07 1.1 1.02 1 1.08 
ptsH 0.93 0.93 0.92 1.01 0.91 
ptsI 0.94 1.08 0.9 1.03 1.01 
ptsK 1.02 1.05 1.08 1.04 1.06 
purB 0.85 0.96 0.96 0.95 0.91 
purC 0.92 1.05 0.97 0.93 0.96 
purD 0.91 0.96 0.97 0.92 0.91 
purE 0.74 0.93 0.91 0.87 0.83 
purF 0.74 0.84 0.72 0.84 0.77 
purH 0.96 1.01 0.98 1.01 0.95 
purK 0.81 0.84 0.88 0.87 0.81 
purL 1.14 1.17 1.05 1.02 1.04 
purM 0.95 0.96 0.88 0.91 0.89 
purN 0.98 1.06 0.99 0.96 0.91 
purR 0.96 1.11 1.16 1.09 1.09 
pycA 0.83 0.97 1.05 0.99 0.89 
pydA 1 0.99 0.95 0.9 0.96 
pydB 0.93 1.08 1 0.95 0.96 
pyk 0.91 1.04 0.95 1.07 0.99 
pyrB 1 1.05 0.96 1.06 1.05 
pyrC 0.81 0.83 0.88 0.88 0.83 
pyrE 1.01 0.88 0.96 0.92 1.02 
pyrF 0.95 0.96 1.03 0.88 0.98 
pyrG 1.07 1.22 1.16 1.11 1.11 
pyrH 0.92 1.09 1.02 0.98 1.02 
pyrR 0.81 0.86 0.93 0.92 0.93 
pyrZ 0.93 1.06 1.11 0.98 1.07 
qor 1.05 1.12 1.15 1.04 1.15 
queA 0.99 1.1 1.09 1.05 1.09 
racD 1.07 1.15 0.96 1.02 1.06 
radA 0.85 0.93 0.83 0.88 0.88 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
radC 0.77 0.79 0.85 0.83 0.86 
rarA 0.82 0.74 0.71 0.7 0.83 
rbfA 1.12 1.12 1.13 1.01 1.03 
rbsA 1.1 1.23 1.11 1.11 1.09 
rbsB 0.98 1.2 1.14 1.09 1.1 
rbsC 0.94 1.04 1.04 1.04 1.13 
rbsD 0.81 0.96 0.97 0.85 0.95 
rbsK 0.91 1.04 1.13 1.05 1.06 
rbsR 0.93 1.05 1.1 0.95 1.04 
rcfA 1.01 1.16 1.06 1 1.13 
rcfB 0.94 1.12 0.92 1.02 1 
rdrA 0.79 0.85 0.83 0.87 0.81 
rdrB 0.68 0.85 0.86 0.9 0.87 
recA 0.86 0.96 0.88 0.79 1.04 
recD 1.16 0.92 1.01 1.15 0.98 
recJ 1.4 1.12 1.24 1.24 1.1 
recM 1.15 0.99 1.07 1.02 0.86 
recN 1.11 0.89 1.09 1.08 0.99 
recQ 1.12 0.91 1.07 1 0.99 
relA 0.98 0.8 0.97 0.91 0.84 
rexA 1.02 0.82 0.98 0.89 0.91 
rexB 0.95 0.94 0.88 0.89 0.92 
rgpA 1.04 0.93 0.87 0.92 0.83 
rgpB 1 0.94 0.79 0.87 0.95 
rgpC 0.67 0.61 0.87 0.67 0.57 
rgpE 0.66 0.7 0.91 0.67 0.59 
rgpF 0.58 0.42 0.92 0.5 0.52 
rgrA 0.88 0.86 0.82 0.94 0.71 
rgrB 0.98 0.8 0.95 1.05 0.81 
rheA 1.02 0.91 1 1 0.96 
rheB 0.99 0.96 1 0.99 0.87 
ribA 0.99 0.86 0.92 0.92 0.88 
ribC 0.94 0.78 0.93 0.82 0.84 
ribH 0.85 0.83 0.78 0.81 0.8 
rimM 0.83 0.76 0.72 0.78 0.76 
rliA 0.95 0.87 0.96 0.91 0.9 
rliB 0.9 0.91 0.79 0.87 0.67 
rliC 1.16 0.94 1.01 0.96 1.04 
rliDB 0.87 0.82 0.89 0.84 0.82 
rlrA 1.03 0.84 0.98 0.96 0.9 
rlrB 1.14 0.94 1.01 1.06 1.09 
rlrC 0.99 0.93 0.95 1.04 0.91 
rlrD 0.98 0.91 1.01 0.96 0.95 
rlrG 0.94 0.85 0.87 0.83 0.86 
rluA 1.14 1.1 1.05 0.97 1.12 
rluB 0.83 0.82 0.82 0.77 0.81 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
rluC 0.85 0.85 0.88 0.72 0.84 
rluD 0.98 0.8 0.97 0.8 0.91 
rmaA 0.81 0.79 0.79 0.67 0.76 
rmaB 1.2 1 1.04 1.07 1.17 
rmaC 0.93 0.76 0.87 0.9 0.85 
rmaD 1.11 0.95 1.07 1.09 1.02 
rmaE 0.89 0.79 0.91 0.9 0.87 
rmaF 0.89 0.88 0.83 0.9 0.89 
rmaG 0.83 0.81 0.81 0.79 0.82 
rmaH 0.94 0.91 0.93 0.85 0.87 
rmaI 0.9 0.78 0.8 0.71 0.84 
rmaJ 0.71 0.83 0.82 0.8 0.83 
rmeA 0.86 0.87 0.9 0.75 0.81 
rmeB 1.07 1.01 1.02 0.94 1.11 
rmeC 0.97 1.07 0.93 0.89 0.82 
rmeD 1.02 0.91 1.01 0.9 1 
rmlA 0.97 0.9 0.89 0.98 0.89 
rmlB 0.95 0.88 0.97 0.9 0.9 
rmlC 0.98 0.92 0.94 0.99 0.92 
rnc 0.88 0.88 0.86 0.89 0.79 
rnhA 0.96 0.94 0.91 0.91 0.9 
rnhB 0.89 0.87 0.87 0.88 0.81 
rnpA 0.87 0.87 0.92 0.89 0.84 
rpe 0.85 0.9 0.94 0.87 0.9 
rpiA 1.07 0.95 1.04 0.9 1.03 
rplA 0.87 0.92 0.85 0.82 0.83 
rplB 1.1 0.9 1.03 0.99 1.08 
rplI 0.95 0.82 0.92 0.94 0.89 
rplM 0.88 0.9 0.84 0.81 0.78 
rplN 0.71 0.75 0.87 0.75 0.77 
rplO 1.1 1.17 1.21 1.05 1.17 
rplQ 0.78 0.88 0.78 0.76 0.7 
rplR 1.11 0.97 1.04 1.03 1.06 
rplS 1.17 1 1.04 1.14 1.1 
rplT 1.08 1.04 1.03 1.03 0.96 
rplU 0.82 0.8 0.89 0.87 0.77 
rplV 1.1 1.08 1.04 1.07 1.02 
rplX 1.2 1.21 1.12 1.2 1.12 
rpmA 1.07 0.94 0.97 1.13 0.99 
rpmB 1.03 0.95 0.95 0.98 1.03 
rpmD 1.15 1.14 1.04 1.12 1.05 
rpmE 0.97 0.93 0.93 0.96 0.9 
rpmF 0.88 0.91 0.87 0.84 0.86 
rpmGA 0.8 0.81 0.89 0.72 0.82 
rpmGB 0.91 0.88 0.92 0.88 0.92 
rpmGC 0.62 0.79 0.74 0.7 0.69 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
rpmH 0.92 0.8 0.84 0.79 0.9 
rpmI 0.86 0.81 0.8 0.87 0.82 
rpmJ 1.12 0.97 1.03 1.06 0.98 
rpoA 1.09 1.09 1.04 0.99 0.99 
rpoB 0.93 0.92 0.92 0.95 0.88 
rpoC 1.09 0.97 1.01 0.98 0.99 
rpoD 0.94 0.98 0.99 0.93 0.98 
rpoE 1.18 0.97 1 1.08 1.03 
rpsA 0.99 0.96 1.03 0.97 0.97 
rpsB 1.26 1.2 1.21 1.21 1.13 
rpsC 0.98 0.98 0.99 0.97 0.92 
rpsD 1.11 1.12 1.03 1.1 0.99 
rpsE 0.99 0.96 0.88 0.93 0.93 
rpsF 0.93 0.87 0.88 0.93 0.84 
rpsG 1.02 1 1.01 0.98 0.95 
rpsH 0.89 0.88 0.8 0.88 0.88 
rpsI 1.18 1.21 1.13 1.18 1.17 
rpsJ 0.91 0.89 0.98 0.89 0.88 
rpsK 0.65 0.79 0.85 0.75 0.84 
rpsL 1.22 1.2 1.05 1.04 1.15 
rpsM 1.04 0.89 0.95 0.97 0.97 
rpsN 1.22 1.22 1.19 1.27 1.23 
rpsN2 1.02 0.94 0.91 1.01 0.94 
rpsO 0.9 0.9 0.9 0.91 0.84 
rpsP 1.14 1.17 1.1 1.1 1.02 
rpsQ 0.94 0.93 0.85 0.9 0.87 
rpsR 0.8 0.87 0.81 0.78 0.82 
rpsS 0.96 0.94 1.06 0.98 0.96 
rpsT 0.81 0.89 0.95 0.86 0.88 
rpsU 0.92 0.81 0.88 0.92 0.89 
rsuA 1.19 1.1 1.18 1.11 1.09 
ruvA 1.18 1.02 1.01 1.06 1.1 
ruvB 1.26 1.26 1.1 1.21 1.14 
sbcC 1.16 1.07 1.03 1.08 0.95 
sbcD 1.08 1.11 1.05 1 1 
scrK 1.1 1.06 1.12 0.99 1.03 
sdaA 1.04 0.97 0.96 0.87 0.92 
sdaB 1.06 1.04 1.05 0.89 0.97 
secA 1.11 1.12 1.21 1.08 1.14 
secE 1.43 1.22 1.36 1.24 1.45 
secG 1.13 0.96 1.06 1.01 0.98 
secY 1.19 1.05 1.12 1.08 1.05 
serA 0.89 0.96 0.85 0.87 0.91 
serB 1.03 0.88 1.09 0.96 0.93 
serC 1.31 1.23 1.26 1.34 1.2 
serS 1.22 1.17 1.11 1.22 1.16 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
sigX 0.97 0.97 0.98 0.93 0.87 
sipL 1.12 1.13 1.14 1.06 1.05 
smc 1.01 0.96 1 0.97 0.92 
smpB 0.83 0.87 0.9 0.79 0.76 
snf 1.15 1.17 1.11 0.96 1.03 
sodA 1.15 1.14 1.17 1.09 1.07 
ssbA 1.03 0.96 1.03 0.94 0.93 
ssbB 0.89 0.88 0.94 0.84 0.91 
sugE 0.73 0.82 0.77 0.83 0.87 
sunL 1.21 1.07 1.23 1.06 1.13 
tag 1.01 0.99 1.04 1.09 0.98 
tagB 1.15 1.08 1.07 1.08 1.07 
tagD1 0.62 0.62 0.97 0.6 0.59 
tagD2 0.86 0.81 0.85 0.81 0.78 
tagF 1.13 1.11 1.11 1.06 1.07 
tagH 1.04 1.04 1.1 0.89 0.94 
tagR 0.94 0.89 0.95 0.77 0.82 
tagX 0.92 0.86 0.93 0.82 0.9 
tagY 0.8 0.76 0.87 0.81 0.78 
tagZ 1.01 0.95 1 0.97 1.05 
tenA 1.16 1.05 1.08 1.07 1.11 
thdF 1.31 1.39 1.19 1.26 1.28 
thgA 1.11 1.04 0.98 1.12 1.06 
thiD1 1.01 1.03 1.02 1 0.96 
thiD2 1.07 1.14 1.08 1 1 
thiE 1.05 1.01 1.11 0.87 0.98 
thiL 0.95 0.96 1.02 0.79 0.8 
thiM 1 0.95 1.05 0.87 0.93 
thrA 1.19 1.05 1.19 1.07 1.12 
thrB 0.83 0.86 0.95 0.88 0.85 
thrC 0.98 0.94 0.85 0.96 1.03 
thrS 1.09 1.08 1.06 0.99 1.06 
thyA 1.14 1.12 1.03 1.16 1.14 
tig 1.28 1.33 1.12 1.31 1.3 
tkt 1.06 1.09 0.95 1.04 1.02 
topA 0.91 1.01 0.95 0.98 0.97 
tpiA 1.01 1.06 1.07 1.01 0.97 
tpx 1.07 1.06 1.15 1.05 0.98 
tra1077B 0.77 0.65 1.9 0.51 0.47 
tra904A 0.65 0.67 1.23 0.4 0.73 
tra905 0.46 0.49 1.08 1.11 0.51 
tra981C 1.32 1.07 1.36 0.6 0.9 
tra983L 0.92 0.96 0.97 0.28 0.31 
trmD 1.17 1.04 1.02 1.18 1.08 
trmU 1.08 1.14 1.02 1.19 1.07 
trpA 0.98 1.01 0.84 0.98 0.91 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
trpB 0.86 0.96 0.92 0.91 0.89 
trpC 1.08 1.14 1.18 1.08 1.02 
trpD 1.04 1.07 1.18 0.99 0.92 
trpE 0.81 0.8 0.85 0.74 0.76 
trpF 0.91 0.87 0.99 0.89 0.9 
trpG 1.06 1.01 1.13 1.05 0.93 
trpS 1.2 1.16 1.13 1.06 1.12 
truA 0.95 0.95 0.88 1.02 1 
truB 1.01 0.91 1.08 1.08 1.05 
trxA 1.19 1.23 1.05 1.27 1.16 
trxB1 1.26 1.24 1.21 1.29 1.22 
trxB2 1.05 1.15 1.04 1.18 1.1 
trxH 1.18 1.35 1.26 1.31 1.24 
tsf 1.07 1.16 1.26 1.21 1.2 
tuf 1.27 1.36 1.38 1.36 1.14 
typA 1.24 1.35 1.33 1.19 1.15 
tyrA 1.37 1.35 1.27 1.26 1.15 
tyrS 1.23 1.13 1.12 1.2 1.17 
udk 1.04 0.94 0.97 1.08 0.94 
udp 1.05 0.96 1.03 0.99 0.99 
umuC 1.28 1.27 1.13 1.28 1.3 
ung 1.02 1.07 0.99 1.07 1.07 
upp 1.26 1.36 1.12 1.33 1.26 
usp45 0.95 1 1.02 1 0.97 
uvrA 0.99 1.21 1.09 1.16 1.08 
uvrB 1.11 1.3 1.29 1.31 1.14 
uvrC 0.98 1 1.09 1.07 0.93 
uxaC 1.01 1.04 1.07 1 0.9 
uxuA 1.01 1.02 1.01 1.09 0.98 
uxuB 0.95 0.9 0.89 0.99 0.89 
uxuT 0.93 0.81 0.9 0.93 0.91 
vacB1 0.83 0.81 0.82 0.82 0.85 
vacB2 1.04 0.95 1.02 1.02 1 
valS 0.93 0.98 0.93 0.98 0.97 
xerD 0.41 0.47 1.22 0.42 0.46 
xpt 1.07 1.16 1.18 1.16 1.16 
xseA 0.93 1.07 1.08 1.09 1.01 
xylA 1 1.09 1.15 1.09 1.02 
xylB 1.11 1.12 1.14 1.05 0.99 
xylH 0.94 0.84 0.84 1.01 0.98 
xylM 1.03 1.06 1.11 1.06 0.99 
xylR 0.99 0.93 0.95 0.94 0.89 
xylT 0.91 0.91 0.93 0.94 0.88 
xylX 0.92 0.9 0.91 1.03 0.88 
xynB 0.87 0.9 0.92 0.96 0.75 
xynD 1.19 1.17 0.94 1.11 1.04 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
xynT 1.03 1.1 1.03 1.09 0.74 
yabA 1.03 1.14 1.21 1.18 1.09 
yabB 0.87 1.01 1.15 1.14 1.17 
yabC 0.96 1.16 1.23 1.15 1.11 
yabD 1 1.12 1.23 1.18 1.04 
yabE 1.02 0.99 1.14 1.01 0.92 
yabF 0.89 0.9 0.94 0.83 0.9 
yacB 0.98 0.93 0.92 0.94 0.87 
yacC 1.09 1.04 1.12 1.1 1.07 
yacG 1.19 1.12 1.05 1.23 1.1 
yacI 0.79 0.8 0.78 0.85 0.87 
yafB 1.28 1.13 1.11 1.09 1.17 
yafC 1.07 1.15 1.14 1.12 1.11 
yafD 1 1.06 1.05 1.1 1 
yafE 1.06 1.16 0.97 1.04 1.09 
yafF 0.88 0.86 0.82 0.92 0.84 
yafJ 0.97 0.9 0.92 0.93 0.94 
yagA 1.03 1.14 1.18 1.06 1.14 
yagB 1.37 1.33 1.32 1.13 1.37 
yagE 1.17 1.17 1.24 1.01 1.08 
yahA 1.02 1.03 1.05 0.96 0.96 
yahB 0.92 0.93 0.98 0.92 0.9 
yahC 1.01 0.96 1 1.03 1.01 
yahD 1 0.98 0.96 0.94 0.99 
yahG 0.8 0.8 0.91 0.93 0.9 
yahI 1.03 0.99 0.97 1.02 1.05 
yaiA 1.09 1.15 1.08 1.1 1.09 
yaiB 0.97 1.13 1.09 1.07 1.06 
yaiE 0.79 0.92 1.33 1.18 0.86 
yaiF 0.38 0.39 1.45 1.2 0.42 
yaiG 0.64 0.6 0.89 0.91 0.75 
yaiI 0.65 0.61 0.93 0.93 0.59 
yajB 0.7 0.75 0.9 0.87 0.9 
yajE 1.17 1.05 1.24 0.85 0.92 
yajH 0.89 0.88 0.91 0.94 0.86 
ybaA 0.97 0.95 0.95 0.96 0.97 
ybaB 0.94 0.91 0.94 0.89 0.85 
ybaC 0.77 0.78 0.82 0.76 0.77 
ybaD 0.92 0.93 0.89 0.93 1.04 
ybaF 1.28 1.3 1.2 1.23 1.13 
ybaG 0.95 1.06 0.98 1.04 1.04 
ybaH 1.12 1.32 1.23 1.19 1.23 
ybaI 1.08 1.33 1.29 1.08 1.2 
ybbA 0.84 0.95 0.94 0.91 1 
ybbB 1.09 1.15 1.16 1.07 1.12 
ybbC 1.21 1.25 1.21 1.15 1.17 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ybbE 0.91 0.99 1.01 0.94 0.93 
ybcC 0.95 1.02 1.01 0.99 1 
ybcG 0.86 0.87 0.92 0.9 0.8 
ybcH 1.07 1.16 1.2 1.15 1.2 
ybdA 0.93 0.91 0.93 0.92 0.92 
ybdC 1.11 1.1 1.08 1.12 1.09 
ybdD 1.1 1.24 1.13 1.16 1.14 
ybdG 0.34 0.39 1 0.98 1.1 
ybdH 0.35 0.31 1.11 0.94 1.04 
ybdI 0.73 0.77 1.13 0.99 1.13 
ybdJ 0.51 0.61 0.95 0.89 0.94 
ybdK 0.6 0.66 1.06 0.4 0.67 
ybdL 0.79 0.78 1.86 0.57 0.6 
ybeA 1.21 1.03 1.16 1.06 1.06 
ybeB 1.05 1.06 1.02 0.97 1.05 
ybeC 0.92 0.96 0.93 0.91 0.91 
ybeD 1.01 1 1.04 1.06 0.94 
ybeF 1.19 1.23 1.3 1.26 1.23 
ybeH 1.08 1.05 1.07 1 1.1 
ybeI 1.1 0.94 1.03 1.03 0.96 
ybeM 0.96 0.77 0.88 0.94 1.05 
ybfA 1.23 1.05 1.18 1.13 1.19 
ybfB 1.22 1.33 1.24 1.15 1.23 
ybfC 0.98 0.99 0.94 1.02 0.98 
ybfD 1.1 1.23 1.13 1.03 1.14 
ybfE 0.94 1.09 1.16 0.99 1.07 
ybgA 1.19 1.1 1.04 1.24 1.09 
ybgD 0.65 0.75 1.03 0.95 0.98 
ybgE 1.08 1.16 1.14 1.06 1.08 
ybhA 0.89 0.92 0.88 0.96 0.95 
ybhB 0.98 1.03 1.01 1.05 0.99 
ybhC 0.84 0.86 1.08 1.02 0.95 
ybhD 1 1.15 1.13 1.16 1.14 
ybhE 0.82 0.92 0.99 0.94 0.97 
ybiB 1.1 1.12 1.09 1.08 1.09 
ybiC 0.97 1.02 1.03 0.99 1 
ybiD 1.12 1.23 1.2 1.13 1.24 
ybiE 1.23 1.46 1.41 1.25 1.45 
ybiG 1.14 1.22 1.26 1.12 1.2 
ybiH 0.97 1.12 1.17 1.1 1.1 
ybiI 1.28 1.31 1.21 1.34 1.29 
ybiJ 1.1 1.02 0.96 1.02 1.02 
ybiK 1.14 1.07 0.98 1.08 1.01 
ybjA 1.18 1.17 1.12 1.19 1.19 
ybjB 0.92 1.1 1 1.09 1.01 
ybjD 1.18 1.16 1.09 0.86 0.97 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ybjJ 1.01 1.05 1.08 1.19 1.13 
ybjK 0.84 0.94 0.97 0.95 0.9 
ycaF 0.36 0.39 1.04 0.38 0.39 
ycaG 0.29 0.33 0.9 0.34 0.33 
ycbA 0.43 0.4 1 0.42 0.43 
ycbB 0.34 0.35 1.17 0.35 0.39 
ycbC 0.51 0.58 1.16 0.53 0.59 
ycbD 0.53 0.55 1.13 0.53 0.56 
ycbF 0.69 0.7 0.69 0.55 0.71 
ycbH 0.2 0.2 1.3 0.21 0.22 
ycbI 0.46 0.48 0.96 0.5 0.49 
ycbJ 0.58 0.65 0.96 0.62 0.59 
yccB 0.57 0.7 0.91 0.64 0.62 
yccE 0.86 0.92 0.91 0.91 0.78 
yccF 0.94 0.95 0.95 0.98 0.98 
yccG 0.99 1.06 1.01 1.06 1.06 
yccH 1.2 1.16 1.12 1.13 1.18 
yccI 1.06 1.22 1.11 1.09 1.14 
yccJ 1.01 1.22 1.13 1.01 1.05 
yccK 1.03 1.12 1.1 1.06 1.13 
yccL 0.99 1.1 1.05 0.99 0.98 
ycdA 0.9 1.02 1.02 1.02 0.94 
ycdB 1.09 1.14 1.07 1.13 1.12 
ycdC 1.04 1.04 1.03 1.05 0.97 
ycdE 0.86 0.87 0.92 0.94 0.85 
ycdF 0.97 1.03 0.91 1.07 1.05 
ycdG 1 0.91 0.83 0.76 0.89 
ycdH 0.96 1.02 0.95 0.93 1.01 
yceA 0.8 0.82 0.84 0.78 0.78 
yceD 1.13 1.13 1.11 0.64 0.67 
yceE 0.9 0.96 0.95 0.87 0.94 
yceG 0.76 0.94 0.91 0.82 0.82 
yceJ 1.04 1.15 1.15 1.06 1.15 
ycfA 1.03 1.12 1.08 1.06 1.07 
ycfB 0.85 0.94 0.8 0.77 0.87 
ycfD 0.95 1.02 0.95 1.08 0.99 
ycfF 0.96 1.03 0.99 1.03 1.03 
ycfG 0.92 0.95 0.89 1.04 0.96 
ycfH 0.63 0.73 0.77 0.76 0.71 
ycfI 0.93 0.93 1.03 1.09 1.04 
ycgA 1.2 1.25 1.25 1.22 1.26 
ycgB 1.01 1.09 1 1.03 1.07 
ycgC 0.83 0.99 0.98 0.96 0.97 
ycgD 0.99 1.19 1.12 1.04 1.19 
ycgE 0.82 0.96 0.9 0.87 0.84 
ycgF 1.03 1.1 1.07 1.06 1.11 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ycgG 0.95 1 0.99 1.1 1.11 
ycgH 1.02 1.06 0.97 1.01 1.04 
ycgI 0.8 0.9 0.86 0.96 0.88 
ycgJ 1.03 0.99 1.04 1 1 
ychC 1.03 1.04 0.96 1.02 1.02 
ychD 0.98 1.06 0.97 1.02 1.03 
ychE 0.9 0.9 0.94 0.84 1 
ychG 1 1.03 1.07 0.93 1.02 
yciA 1.13 1.3 1.19 1.21 1.18 
yciC 1.02 1.18 1.12 1.12 1.19 
yciD 0.84 0.97 1.02 0.93 0.94 
yciF 0.78 0.81 0.82 0.82 0.85 
yciG 1.27 1.37 1.36 1.26 1.21 
ycjA 0.92 0.85 0.95 0.98 1.04 
ycjB 1.07 1.09 1.07 1.11 1.08 
ycjC 1.02 1.12 1.04 1.11 1.03 
ycjD 0.9 0.92 0.78 0.89 0.83 
ycjG 0.99 0.92 0.88 0.93 0.99 
ycjH 0.99 1.04 1 1.06 1.11 
ycjI 1.03 0.89 0.96 0.97 0.99 
ydaE 1 1.1 0.95 1.02 1 
ydaF 1.15 1.34 1.16 1.18 1.15 
ydaG 1.08 1.31 1.17 1.13 1.2 
ydbA 0.91 1.05 1.04 0.97 0.9 
ydbC 1.43 1.26 1.21 1.37 1.33 
ydbD 0.89 1.04 1.07 1.08 0.98 
ydbE 0.81 0.99 0.93 0.95 0.92 
ydbF 0.79 0.89 0.92 0.95 0.83 
ydcB 1.09 1.09 1.02 1.05 1.05 
ydcD 0.8 0.82 0.89 0.88 0.84 
ydcE 0.89 0.85 0.84 0.84 1.02 
ydcF 0.89 1.07 1.19 0.79 1.04 
ydcG 1.12 1.08 1.02 1.1 1.1 
yddA 1.1 1.31 1.18 1.16 1.13 
yddB 1.01 1.23 1.1 1.1 1.12 
yddC 0.91 1.17 1.1 1.07 1.05 
yddD 0.89 0.95 0.92 0.8 0.89 
ydgB 1.2 1.41 1.43 1.3 1.47 
ydgC 1.06 1.09 1.12 1.12 1.13 
ydgD 0.68 0.79 0.82 0.84 0.74 
ydgE 0.75 0.88 0.83 0.89 0.77 
ydgF 0.81 0.87 0.81 0.87 0.86 
ydgG 0.98 1.06 0.95 0.99 1.08 
ydgH 0.77 0.89 0.84 0.85 0.93 
ydgI 1.12 1.24 1.11 1.02 1.14 
ydhB 1.15 1.44 1.44 1.14 1.22 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ydhF 1.01 1.14 1.17 1.1 0.91 
ydiA 1.15 1.27 1.83 1.12 1.26 
ydiB 1.07 1.18 1.23 1.16 1.2 
ydiC 0.97 1.02 1.07 0.93 1.05 
ydiD 0.95 1.04 0.97 1.02 1.06 
ydiE 0.99 1.04 0.85 1 1.01 
ydiF 0.9 0.91 0.91 0.98 0.96 
ydiG 0.87 0.93 0.97 1 0.96 
ydjB 1.04 0.97 1.04 1.14 0.99 
ydjD 0.73 0.69 0.75 0.58 0.82 
yeaA 0.66 0.55 0.86 0.9 0.58 
yeaC 0.78 0.65 0.92 0.74 0.61 
yeaD 0.86 0.69 0.96 0.93 0.76 
yeaF 0.87 0.88 0.84 0.89 0.9 
yeaG 1.08 0.94 0.94 0.95 0.92 
yeaH 0.99 0.94 0.95 0.87 0.91 
yebB 1.24 1.14 1.16 1.05 1.21 
yebE 0.93 0.92 0.89 0.85 0.89 
yebF 1.01 0.91 0.97 0.88 0.88 
yecA 0.98 0.99 0.99 0.88 0.85 
yecD 0.91 0.86 0.78 0.87 0.85 
yecE 0.84 0.65 0.75 0.81 0.77 
yedA 1.04 0.88 0.89 0.96 0.84 
yedE 1.05 0.83 0.95 0.99 0.89 
yedF 0.92 0.76 0.86 0.89 0.85 
yeeC 1.07 0.96 0.98 0.94 0.94 
yeeD 0.79 0.79 0.87 0.8 0.78 
yeeF 1.05 0.94 0.95 0.88 0.96 
yeiD 0.6 1.08 1 0.99 0.67 
yeiE 1.19 1.09 1.2 1.03 1.1 
yeiF 0.98 1.02 1.03 0.89 0.86 
yeiG 1.26 0.96 1.04 1.01 1.13 
yejC 0.95 0.82 0.86 0.83 0.86 
yejD 0.9 0.77 0.84 0.88 0.82 
yejE 0.64 0.83 0.95 0.93 0.91 
yejI 0.68 0.96 0.88 0.85 0.92 
yfaA 0.91 0.88 1.14 0.84 0.82 
yfbB 0.92 1.23 0.99 0.32 0.91 
yfbG 0.87 0.9 1.06 1.27 1.24 
yfbI 1.1 1 1 0.89 0.99 
yfbJ 0.91 0.81 0.85 0.78 0.85 
yfbK 0.55 0.59 1.02 0.66 0.98 
yfbM 1.2 1.05 1.04 0.95 1.1 
yfcB 0.94 0.75 0.81 0.93 0.88 
yfcF 0.91 0.83 0.9 0.89 0.83 
yfcI 0.96 0.87 0.89 0.87 0.94 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
yfdA 1.13 1.03 1.04 0.99 0.99 
yfdB 1.23 1.14 1.11 1.04 1.2 
yfdD 0.8 0.89 0.78 0.85 0.87 
yfdE 1.03 0.98 1.06 0.85 0.92 
yfeA 0.95 0.95 1.06 0.92 0.98 
yffA 0.93 1.07 1.05 0.97 0.81 
yffB 1.22 0.91 1.08 1.01 1.08 
yffD 1.09 0.98 0.97 1.08 1.08 
yfgC 1.17 1.07 1.03 1.06 1.05 
yfgG 0.93 0.96 0.94 0.99 0.91 
yfgH 1.01 0.94 0.92 0.97 0.93 
yfgL 1 0.96 0.95 0.96 0.92 
yfhA 1.27 1.2 1.08 1.12 1.22 
yfhF 0.81 0.9 0.94 0.82 0.83 
yfhH 0.91 0.86 0.85 0.93 0.85 
yfhI 0.41 0.37 1.12 0.43 1.16 
yfhJ 0.51 0.54 0.95 0.66 0.95 
yfhK 0.96 0.87 0.98 0.92 0.97 
yfhL 0.96 0.88 0.9 0.97 0.88 
yfiC 1.11 1.06 0.95 0.98 0.98 
yfiE 0.94 0.96 0.94 0.92 0.91 
yfiG 0.92 0.99 0.98 0.84 0.87 
yfiH 1.02 0.97 1.1 0.95 1.03 
yfiJ 0.98 1.04 0.99 0.96 0.96 
yfiL 1.09 0.9 0.93 0.92 0.97 
yfjA 1.13 1.04 0.98 1.01 1.07 
yfjC 1.18 1.07 1.11 1.17 1.11 
yfjD 1.02 0.95 0.92 1.04 0.94 
yfjF 0.95 0.96 0.87 0.97 0.88 
ygaB 1.3 1.3 1.17 1.15 1.18 
ygaC 0.73 0.75 0.72 0.66 0.74 
ygaD 0.89 0.82 0.97 0.94 0.84 
ygaE 1.31 1.14 1.15 1.32 1.22 
ygaF 0.88 0.84 0.79 0.93 0.84 
ygaI 1.02 1.1 1.1 0.96 1.04 
ygaJ 0.96 0.83 0.92 0.96 0.9 
ygbB 0.92 0.93 0.93 0.95 0.89 
ygbD 1.02 0.96 0.97 1 0.96 
ygbE 1.06 1.11 1 1.16 1.05 
ygbF 0.94 0.94 0.95 0.98 0.9 
ygcA 1.11 1.04 0.94 1.02 0.98 
ygcC 1.09 1.04 0.99 0.99 0.97 
ygdC 0.8 0.86 0.81 0.81 0.82 
ygdD 0.71 0.69 0.77 0.7 0.73 
ygdE 0.98 0.94 1.06 0.98 0.94 
ygdF 0.54 0.57 1.15 0.6 0.56 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ygeB 0.8 0.79 0.91 0.8 0.69 
ygeC 1.03 0.93 0.97 0.88 0.9 
ygeD 0.9 1.01 0.98 0.9 0.92 
ygfA 0.97 0.85 0.99 0.87 0.93 
ygfB 1.09 0.94 1.08 1.15 1.01 
ygfC 1.29 1.12 1.07 1.26 1.16 
ygfE 1.22 1.21 1.09 1.31 1.12 
yggA 1.18 1.12 1.04 1.16 1.03 
yghB 0.98 0.99 0.96 1.01 0.97 
yghC 1.05 1.05 1.07 0.98 0.96 
yghD 0.83 0.82 0.86 0.8 0.75 
yghE 1.02 1.07 1.17 0.89 1.11 
yghG 0.91 0.89 0.9 0.81 0.87 
ygiC 0.79 0.82 0.8 0.79 0.81 
ygiG 0.87 0.88 0.94 0.83 0.87 
ygiI 0.94 0.96 1.02 0.97 0.95 
ygiJ 1.19 1.07 1.16 1.04 1.07 
ygiK 1.17 1.05 1.11 1.17 1.09 
ygjB 1.01 1 0.98 1.06 0.98 
ygjD 1.05 0.99 1.02 1.12 1.1 
yhbE 0.95 1.11 1.04 1.13 1 
yhbH 1.07 1.08 1.06 0.92 0.94 
yhcA 0.74 0.94 0.91 0.81 0.84 
yhcB 0.99 1.01 1.03 0.96 0.94 
yhcC 0.98 0.95 1.04 0.98 0.96 
yhcE 1.18 1.06 1.22 1 1.09 
yhcH 1.07 1.08 1.1 1.04 1.13 
yhcI 1.03 0.92 1.03 0.98 0.99 
yhcK 1.15 1.02 1.02 1.08 1.08 
yhdA 1.12 0.93 1.01 1.08 1.07 
yhdB 1.13 1.16 0.96 1.22 1.07 
yhdC 1.15 1.18 1.1 1.14 1.13 
yheA 1.02 0.97 0.96 0.98 1.01 
yheB 1.03 1.05 1.05 0.96 0.95 
yhfB 0.99 1.04 1.12 0.98 1.01 
yhfC 1.2 1.1 1.13 1.23 1.07 
yhfD 1.07 0.95 1.01 1.05 1 
yhfE 0.86 0.87 0.87 0.96 1.01 
yhfF 1 1.01 0.92 1.06 1.01 
yhgA 1.11 1.17 1.06 1.13 1.02 
yhgB 1.01 1.1 0.95 1 1.04 
yhgC 1.04 1.07 1.03 0.94 0.98 
yhgD 1.06 0.94 1.05 0.91 0.91 
yhgE 0.91 0.89 0.91 0.8 0.81 
yhhA 0.88 0.86 0.91 0.87 0.91 
yhhB 1.08 0.98 1.16 0.98 1.03 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
yhhD 1 0.8 0.95 1.01 1.02 
yhhE 1 1 0.99 0.96 1.02 
yhhG 1.11 1.1 1.11 1.19 1.1 
yhjA 0.95 0.91 0.91 0.97 0.96 
yhjB 1.16 1.16 1.1 1.26 1.2 
yhjC 1.06 1.1 0.84 1.06 0.97 
yhjE 1.22 1.04 0.93 1.07 1.13 
yhjF 1.06 1.11 1.02 1.09 1.11 
yhjG 1.08 1.06 0.94 1.14 1.06 
yiaA 0.89 0.87 0.95 0.95 0.9 
yiaB 0.94 1 1.04 1.05 0.88 
yiaC 0.94 0.87 0.97 0.92 0.83 
yiaD 0.99 0.99 1.06 0.98 0.99 
yibB 0.95 0.88 0.94 0.88 0.94 
yibC 1.05 1 1.13 1.05 1.02 
yibD 0.85 0.92 0.96 0.86 0.95 
yibE 1 0.97 1.04 1.1 1 
yibF 1.08 1.09 1.01 1.11 1.06 
yibG 0.99 1 0.91 1.03 0.92 
yicA 1.08 1.12 0.92 1.1 1.06 
yicB 1.14 1.21 1.09 1.17 1.13 
yicC 0.97 0.97 1 1 0.96 
yicE 1.08 1.04 1.06 1.1 0.93 
yidA 1.11 1.02 1.04 0.98 0.95 
yidB 0.98 0.99 1.08 1.02 0.99 
yidC 1.02 0.93 1.07 0.99 0.92 
yidE 0.88 0.89 0.9 0.82 0.87 
yieF 0.99 0.9 0.9 0.88 0.85 
yieH 0.86 0.91 0.91 0.88 0.87 
yifA 1.06 0.96 1.02 1.08 1.08 
yigC 1.07 1.05 1.03 1.12 1 
yihA 1.13 1.21 1.03 1.18 1.16 
yihB 1.08 1.2 1.1 1.22 1.17 
yihD 0.99 1.29 1.13 1.19 1.17 
yihF 0.97 1.08 1.02 1.11 1.02 
yiiB 0.95 1.03 1.05 1.04 0.92 
yiiD 0.91 0.89 0.91 0.92 0.91 
yiiE 0.79 0.89 0.89 0.83 0.77 
yiiF 1.06 0.99 1.01 0.92 0.89 
yiiG 1.14 1.08 1.07 1 1.04 
yiiH 0.74 0.78 0.86 0.8 0.75 
yiiI 0.84 0.87 0.93 0.86 0.8 
yijB 1.04 0.94 0.98 0.83 0.91 
yijC 1.06 1.06 0.98 1.05 1.02 
yijD 1.03 1.05 1.09 1.13 1.13 
yijE 1.04 1.1 1.05 1.18 1.07 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
yijF 0.9 1.03 0.99 1.04 1.01 
yijG 1.1 1.21 1.26 1.37 1.22 
yijH 1 1 1.01 1.18 0.96 
yjaB 1.05 1.02 1.14 1.15 0.96 
yjaD 1.13 1.1 1.13 1.11 1.02 
yjaE 1.01 1 1.03 1.11 0.91 
yjaF 0.82 0.81 0.92 0.88 0.85 
yjaH 0.87 0.78 1.01 0.9 0.88 
yjaI 0.82 0.87 0.92 0.79 0.75 
yjaJ 1 0.94 0.84 0.84 0.95 
yjbB 1.09 0.88 1 1.02 0.99 
yjbC 0.92 0.93 0.9 1 0.9 
yjbE 1 1.06 1.07 1.12 1.02 
yjbF 1.07 1.11 1.07 1.2 1.15 
yjcA 0.88 1.05 1.05 1.03 1.06 
yjcD 1.19 1.09 1.28 1.32 1.31 
yjcE 1.07 1.14 1.2 1.06 1.04 
yjcF 0.94 0.93 1.02 0.96 0.88 
yjdA 1.03 1.04 1.1 1.03 0.93 
yjdB 1.1 1.01 1.04 1.03 1 
yjdE 0.86 0.85 0.87 0.96 0.88 
yjdI 1.04 0.97 1.07 1.01 0.99 
yjdJ 1.12 1.1 1.1 1.12 1.07 
yjeA 1.12 1.02 0.97 1.07 1.08 
yjeD 1.08 1.13 1.08 1.17 1.13 
yjeF 0.97 1.01 1.03 1.11 1.05 
yjeG 1 1.09 1.07 1.09 1.08 
yjfB 0.89 0.96 1.14 1.14 1.12 
yjfG 0.83 0.82 0.93 0.77 0.85 
yjfI 1 0.98 1.03 0.93 0.91 
yjfJ 0.94 0.94 0.98 0.87 0.9 
yjgB 0.86 0.9 0.88 0.89 0.84 
yjgC 1.04 0.95 1.1 1.06 0.97 
yjgD 1.01 0.95 1.04 1 0.94 
yjgF 1.03 0.99 0.95 0.98 0.96 
yjhA 0.95 0.96 0.93 0.98 0.92 
yjhB 0.94 0.98 0.97 1.07 1 
yjhC 1.01 1.01 1.16 1.05 1.01 
yjhD 0.96 1.12 1.03 1.1 1.12 
yjhF 1.11 1.05 1.18 1.01 1.05 
yjiB 0.96 0.92 0.99 0.98 0.89 
yjiE 0.83 0.86 0.9 0.83 0.79 
yjjA 0.96 1.03 1.15 1.11 1.04 
yjjB 0.83 0.83 0.92 0.83 0.82 
yjjC 1 0.9 0.95 0.97 0.93 
yjjD 0.98 1.01 0.97 1 1.01 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
yjjE 0.88 0.83 0.86 0.95 0.89 
yjjF 0.9 1.05 1.02 1.05 1.09 
yjjH 0.96 0.99 1.12 0.94 0.97 
ykaE 0.89 0.81 0.87 0.83 0.89 
ykaF 0.83 0.89 0.89 0.89 0.85 
ykbA 0.91 0.73 0.84 0.85 0.88 
ykbC 0.91 0.84 1.05 0.88 0.88 
ykbE 1.05 0.93 0.96 1.04 1.08 
ykbF 0.91 0.91 0.96 0.95 0.88 
ykcA 0.98 1 1 1.02 0.98 
ykcB 0.84 0.98 0.96 0.96 0.94 
ykcC 0.95 1.03 0.99 0.88 1.03 
ykcF 0.96 1 1.02 1.01 0.98 
ykcG 0.89 0.99 0.95 0.98 0.94 
ykdA 0.68 0.78 0.8 0.77 0.74 
ykdB 0.85 0.86 0.95 0.92 0.88 
ykhE 0.87 1 1.09 0.99 0.98 
ykhF 1.06 1.02 1.05 0.99 1.04 
ykhG 0.94 0.86 0.94 1.03 0.92 
ykhI 0.92 1.01 0.95 0.95 0.99 
ykhJ 0.89 1.03 1.12 0.97 1.03 
ykhK 0.85 0.87 0.93 0.88 0.97 
ykiC 1 0.94 1 1.05 1.05 
ykiD 0.93 0.82 1.14 0.97 0.91 
ykiF 0.86 0.89 1.15 0.94 0.9 
ykiG 0.97 0.97 1.06 1.06 1 
ykiH 0.92 0.97 1.04 0.97 0.91 
ykjA 0.95 0.84 0.96 0.94 0.91 
ykjB 0.94 0.94 1.1 1 1.01 
ykjC 0.9 0.87 0.89 0.88 0.86 
ykjE 0.87 0.9 1 0.91 0.89 
ykjF 1 1.03 1.06 0.96 1.04 
ykjH 0.88 0.93 0.99 0.94 1.03 
ykjJ 0.93 1.02 1.03 1.01 0.99 
ylaC 1.2 1.11 1.12 1.2 1.18 
ylaE 0.88 0.83 0.96 0.98 0.88 
ylbA 0.9 0.83 0.89 0.99 0.91 
ylbB 0.94 0.97 0.93 1.07 1.06 
ylbD 0.95 0.98 1.04 0.96 1.02 
ylbE 0.9 1.03 1.1 1.03 1.1 
ylcA 0.99 1 1 0.94 1.01 
ylcC 0.99 0.98 0.98 0.91 1 
ylcD 0.88 0.94 0.96 0.96 0.97 
ylcE 0.9 0.97 0.87 0.99 0.94 
ylcF 0.9 0.94 1 1.04 1 
yldA 0.9 0.89 0.96 1 0.94 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
yldC 0.87 0.92 0.9 0.87 0.9 
yldE 0.94 0.92 1.01 1 0.98 
yleB 0.99 1.02 1.11 1.02 1.15 
yleE 1.05 1.04 1.12 1.07 1.17 
yleF 0.93 1.02 1.1 1.09 1.08 
ylfA 0.91 0.91 0.87 0.94 0.9 
ylfB 1 0.97 0.99 1.05 0.93 
ylfC 0.9 0.92 0.96 0.94 0.9 
ylfD 0.96 1 0.94 1.05 0.9 
ylfF 0.84 0.86 0.84 0.86 0.81 
ylfH 0.97 0.91 0.96 0.92 0.95 
ylfI 0.93 0.87 1.02 1.03 0.99 
ylgB 0.95 1.03 1.03 1.11 1.12 
ylgC 0.91 1.04 1.08 1.02 1 
ylgG 0.88 0.96 0.98 0.98 1.12 
ylhB 0.89 0.93 1.01 0.97 0.96 
yliA 0.91 0.91 0.9 0.91 0.85 
yliC 0.78 0.85 0.91 0.94 0.81 
yliD 0.78 0.76 0.77 0.75 0.78 
yliE 0.65 0.65 0.56 0.63 0.68 
yliF 0.83 0.78 0.96 0.93 0.99 
yljB 1 0.95 0.94 0.94 1.05 
yljC 0.87 0.86 0.94 0.88 0.88 
yljD 0.89 0.89 0.82 0.88 0.88 
yljE 0.94 1.09 1.02 1.01 1.07 
yljF 1.02 1.08 1.13 0.98 1.05 
yljG 0.78 0.87 0.96 0.85 0.88 
yljH 0.95 0.93 0.98 0.95 1.01 
yljI 0.97 1.02 1.05 1 1.04 
yljJ 0.9 0.91 0.91 0.91 0.88 
ylqL 0.88 0.9 0.85 0.97 0.88 
ylxQ 0.88 0.94 0.89 0.94 0.92 
ymaB 0.64 0.64 0.81 0.68 0.68 
ymbC 0.75 0.72 0.8 0.64 0.66 
ymbD 0.57 0.51 0.87 0.56 0.5 
ymbG 0.74 0.76 0.82 0.69 0.72 
ymbJ 0.34 0.37 0.99 0.36 0.34 
ymbK 0.45 0.65 1.16 0.44 0.47 
ymcA 0.69 0.72 0.91 0.76 0.73 
ymcB 0.44 0.43 0.98 0.44 0.48 
ymcC 0.52 0.49 0.93 0.44 0.53 
ymcF 0.86 1.01 1.01 0.96 0.99 
ymdC 0.95 0.96 1 0.96 0.95 
ymeB 0.89 0.99 0.97 1 0.93 
ymfD 0.88 0.92 0.89 0.92 0.87 
ymfE 0.87 0.82 0.84 0.77 0.82 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ymgB 0.79 0.82 0.82 0.85 0.87 
ymgC 0.89 0.93 0.96 0.94 0.95 
ymgF 0.85 0.81 0.95 0.9 0.95 
ymgG 1.47 1.21 1.29 1.5 1.5 
ymgH 1.93 1.64 1.68 1.88 2.18 
ymgI 1.57 1.34 1.34 1.47 1.69 
ymgJ 1.61 1.33 1.24 1.52 1.51 
ymgK 1.01 1 1.01 0.95 1 
ymhC 0.91 1.04 1 1 1 
ymhG 0.9 1.03 1 1.01 0.98 
ymiA 0.9 0.98 1 1.01 1.04 
ymjE 0.94 0.99 1.07 1.07 1.01 
ymjF 0.85 0.88 0.86 0.87 0.83 
ynaA 1.18 1.17 1.1 1.24 1.12 
ynaB 0.91 0.97 0.91 0.96 0.91 
ynaC 0.91 0.95 0.94 0.97 0.93 
ynaD 0.84 0.89 0.79 0.91 0.85 
ynaE 0.87 0.89 0.94 0.94 0.94 
ynaG 0.81 0.79 0.81 0.83 0.85 
ynbA 0.8 0.93 0.95 0.92 0.86 
ynbB 0.84 0.95 0.98 0.97 0.91 
ynbC 0.87 0.96 0.9 1.01 1 
ynbD 0.91 1 1.02 0.99 0.99 
ynbE 0.95 0.93 0.83 0.95 0.93 
yncA 0.92 0.95 0.99 0.94 1 
yncB 0.85 0.8 0.87 0.84 0.83 
yndA 0.83 0.86 0.91 1 0.88 
yndB 0.91 0.94 0.81 0.89 0.89 
yndC 0.7 0.79 0.7 0.79 0.71 
yndD 0.78 0.82 0.88 0.9 0.88 
yndE 0.16 0.8 0.85 0.86 1.06 
yndF 0.39 1 1.02 0.63 0.95 
yndG 0.82 0.89 0.88 0.83 0.85 
yneB 0.75 0.91 0.9 0.85 0.87 
yneC 1.11 1.08 1.04 1.19 1.28 
yneE 0.89 1.02 1.03 0.94 0.97 
yneF 0.93 1.08 1.28 1.15 1.26 
yneG 0.69 0.78 0.91 0.8 0.83 
yneH 0.7 0.91 0.96 0.91 0.94 
ynfC 0.76 0.86 0.86 0.93 0.87 
ynfD 1.13 1.08 1.02 1.14 1.1 
ynfG 0.91 0.91 0.9 1.04 0.93 
ynfH 0.67 0.73 0.8 0.83 0.81 
yngA 0.81 0.89 0.8 0.81 0.87 
yngB 0.99 1.02 1.02 0.85 0.93 
yngE 0.89 1.05 1.01 0.93 1.01 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
yngF 0.92 1.17 1.11 1.02 1.05 
ynhA 0.98 0.98 1.01 1.05 1.14 
ynhC 0.9 1.05 1.11 0.99 1.03 
ynhD 0.95 1.02 1.1 1.07 1.08 
ynhH 0.66 0.78 0.84 0.79 0.77 
ynhI 0.72 0.92 0.86 0.92 0.93 
yniC 0.82 0.79 0.93 0.81 0.75 
yniG 0.85 0.87 0.87 0.88 0.86 
yniH 0.83 0.9 0.87 0.93 0.92 
yniI 0.56 0.66 0.72 0.84 0.8 
yniJ 0.83 0.81 0.85 0.76 0.91 
ynjC 0.99 0.75 0.85 0.88 0.85 
ynjD 0.98 0.84 0.91 0.86 0.83 
ynjE 1.22 0.89 0.98 0.92 0.97 
ynjF 0.83 0.73 0.85 0.78 0.76 
ynjG 0.68 0.63 0.93 0.88 0.87 
ynjH 0.95 0.93 0.95 0.72 0.71 
ynjI 0.91 0.85 0.88 0.84 0.83 
ynjJ 0.99 0.83 0.91 0.86 0.85 
yoaD 0.94 0.82 0.92 0.82 0.78 
yoaG 0.96 0.75 0.76 0.87 0.81 
yoaH 1.1 0.82 0.89 0.88 0.79 
yoaI 1.15 0.27 0.99 1.08 0.95 
yobA 0.76 0.53 0.78 0.72 0.75 
yobC 0.94 0.79 0.9 0.83 0.88 
yofM 0.99 0.88 0.87 0.88 0.83 
yogE 0.93 0.89 0.85 0.86 0.86 
yogG 1.11 0.9 1.04 0.99 0.95 
yogI 0.92 0.79 0.87 0.83 0.8 
yogJ 1 0.86 0.99 0.87 0.94 
yogL 0.77 0.71 0.62 0.64 0.7 
yogM 0.87 0.84 0.82 0.84 0.86 
yohC 0.93 0.83 0.93 0.82 0.89 
yohD 0.75 0.83 0.87 0.85 0.86 
yohH 0.85 0.8 0.8 0.74 0.64 
yohJ 0.89 0.72 0.81 0.8 0.8 
yoiB 1.03 0.82 0.87 0.93 0.94 
yoiC 0.86 0.74 0.82 0.81 0.82 
yojB 0.84 0.76 0.79 0.83 0.79 
yojC 0.98 0.94 0.99 0.97 0.97 
ypaA 0.91 0.84 0.87 0.85 0.85 
ypaC 0.8 0.8 0.81 0.79 0.79 
ypaG 0.89 0.85 0.77 0.8 0.81 
ypaH 0.87 0.87 0.88 0.8 0.84 
ypaI 0.95 0.87 0.93 0.84 0.87 
ypbB 0.86 0.87 0.85 0.8 0.83 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ypbC 1.04 0.89 0.88 0.91 0.95 
ypbD 1.09 0.9 0.91 1 0.9 
ypcA 1.02 0.91 0.98 1.02 0.99 
ypcB 1 0.92 0.86 0.91 0.9 
ypcC 0.93 0.9 0.9 0.88 0.88 
ypcD 0.91 0.88 0.85 0.87 0.86 
ypcG 0.95 0.88 0.87 0.84 0.91 
ypcH 1.03 0.98 0.99 0.91 0.96 
ypdA 0.86 0.86 0.92 0.78 0.89 
ypdB 1.01 0.91 0.99 0.92 1 
ypdC 0.82 0.88 0.82 0.84 0.69 
ypdD 0.98 0.81 0.94 0.91 0.93 
ypfD 1.11 0.93 0.97 1.07 1.02 
ypfE 1.05 0.91 0.99 0.99 0.98 
ypfF 1.08 0.93 1.03 1.02 0.98 
ypgB 0.88 0.86 0.86 0.86 0.79 
ypgC 1.11 0.99 0.98 1.2 1.09 
ypgD 0.88 0.87 0.86 0.88 0.83 
yphA 1.01 0.97 0.96 1.02 1.02 
yphC 0.84 0.88 0.83 0.79 0.81 
yphH 0.86 0.75 0.78 0.67 0.83 
yphI 0.96 1.01 1.04 1.04 1.03 
yphJ 0.7 0.8 0.85 0.72 0.76 
yphK 0.9 0.75 0.8 0.87 0.87 
yphL 1.14 1.07 1.02 1.15 1.11 
ypiA 1.01 0.98 0.95 1.02 0.94 
ypiB 0.95 0.9 0.95 1.05 0.95 
ypiE 0.85 0.79 0.74 0.84 0.84 
ypiH 0.96 0.9 0.9 0.56 0.58 
ypiJ 0.68 0.72 0.74 0.58 0.56 
ypiK 1.16 1.06 1.03 0.36 0.3 
ypiL 1.01 0.99 0.97 0.77 0.79 
ypjA 0.63 0.65 0.71 0.6 0.63 
ypjB 0.85 0.79 0.81 0.81 0.91 
ypjC 0.97 0.89 0.94 0.91 0.91 
ypjF 0.84 0.86 0.8 0.81 0.78 
ypjH 0.93 0.9 0.87 0.87 0.92 
ypjI 0.94 0.91 0.88 0.93 0.86 
yqaB 0.92 0.92 0.91 0.95 0.84 
yqaC 1.11 1.14 1 1.16 1.09 
yqaD 0.8 0.82 0.8 0.86 0.78 
yqaG 0.93 0.92 0.81 0.89 0.85 
yqbA 0.99 0.97 0.88 0.98 0.84 
yqbF 1 0.98 0.94 0.84 0.78 
yqbH 0.73 0.82 0.8 0.81 0.71 
yqbI 0.96 0.95 1.03 0.9 0.89 
  
 
 
 
 
 
 
231 
 
Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
yqbJ 0.95 0.75 0.88 0.86 0.91 
yqcB 0.66 0.62 0.9 0.93 0.9 
yqcC 0.66 0.63 0.97 1.03 0.94 
yqcD 0.41 0.41 0.94 1.03 0.91 
yqcE 1.03 0.84 0.83 0.92 1.02 
yqcF 0.81 0.82 0.74 0.91 0.77 
yqcG 1 1.09 0.9 1.12 1.04 
yqdA 0.9 0.86 0.85 0.9 0.85 
yqeA 0.91 0.9 0.83 0.89 0.85 
yqeB 1.05 0.95 0.88 0.86 0.98 
yqeD 0.98 0.92 0.98 0.92 0.89 
yqeH 0.89 0.87 1 0.92 0.93 
yqeL 1 0.85 1.12 0.92 0.88 
yqfA 1.09 0.96 1 1.05 0.97 
yqfC 1.12 0.99 0.93 1.13 1.05 
yqfE 1.12 1.09 1.04 1.24 1.05 
yqfF 0.96 0.98 0.91 0.97 0.9 
yqfG 0.92 0.9 0.93 0.91 0.88 
yqgA 0.89 0.92 0.91 0.84 0.75 
yqgC 0.91 0.9 0.88 0.8 0.82 
yqgE 1.02 0.98 1.06 0.95 1.03 
yqgF 0.85 0.99 0.93 0.96 0.97 
yqgG 0.9 0.88 0.93 0.89 0.85 
yqhA 0.91 0.98 0.97 1.02 0.99 
yqiA 1.21 1.1 1.1 1.03 1.08 
yqjA 1.05 1.12 1.07 1.14 1.08 
yqjB 1 0.95 0.97 1.11 0.98 
yqjD 1.06 0.98 1 1.05 0.98 
yqjE 1.05 1.06 1.05 1.16 1 
yraA 0.93 0.96 0.91 0.95 0.87 
yraB 1.02 0.98 0.98 1.06 1.06 
yraC 1.02 1.04 0.94 0.99 0.95 
yraD 0.97 0.93 0.96 0.87 0.85 
yraE 0.86 0.91 0.84 0.77 0.77 
yraF 0.92 0.97 0.94 1 1.01 
yrbA 0.99 0.92 0.96 0.95 0.95 
yrbB 0.93 0.89 0.98 0.99 0.98 
yrbC 0.8 0.81 0.79 0.78 0.79 
yrbD 1.1 0.98 1.07 0.97 1 
yrbE 1.08 1.03 1.05 1 0.83 
yrbF 0.95 0.91 0.84 0.82 0.9 
yrbH 1.11 1.07 1 1.14 1.06 
yrbI 1.07 1.09 0.86 1.13 0.95 
yrcA 1.06 1.14 1 0.99 1 
yrcB 0.79 0.83 0.79 0.8 0.8 
yreB 1.04 0.99 0.91 0.89 0.9 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
yreD 1 0.96 1 0.92 1.05 
yreE 0.94 0.98 0.97 0.9 0.96 
yrfA 0.83 0.89 1.09 0.86 0.84 
yrfB 1.13 1.03 1.08 1.01 0.95 
yrfC 0.99 1.01 0.96 1.03 0.99 
yrfD 1.06 1.07 0.9 1.12 0.98 
yrfE 1.02 1.13 0.97 1.08 1 
yrgA 1 1.07 0.93 0.96 0.94 
yrgE 0.81 0.83 0.86 0.81 0.82 
yrgF 0.93 0.93 0.95 0.78 0.82 
yrgG 0.93 0.92 0.94 0.79 0.77 
yrgH 0.84 0.83 0.86 0.81 0.81 
yrgI 0.95 0.98 0.99 0.87 0.93 
yrhH 0.94 0.99 1.03 1 0.99 
yriB 1.07 1.09 0.99 1.02 1.03 
yriC 1.2 1.23 1.09 1.24 1.08 
yrjA 1.05 1.13 0.93 1.08 1.06 
yrjB 1.06 1.16 0.99 1.13 1.13 
yrjC 1.05 1.13 1 1.08 1.02 
yrjD 1.07 1.12 0.99 1.07 0.94 
yrjE 0.93 0.92 0.93 0.91 0.82 
yrjF 0.83 0.82 0.86 0.82 0.83 
yrjG 0.84 0.83 0.85 0.88 0.85 
yrjI 0.9 0.87 0.86 0.85 0.84 
ysaA 0.9 0.99 0.96 1 1 
ysaB 1.08 1.06 0.99 1.14 1.09 
ysaC 1.19 1.21 1.06 1.23 1.19 
ysaD 1.27 1.45 1.03 1.33 1.22 
ysbA 1.09 1.13 0.9 1.15 1.1 
ysbB 1.02 1.1 1.01 1.1 1.03 
ysbC 0.99 1.1 1.04 1.08 0.98 
ysbD 0.99 1 0.99 1.01 0.82 
yscA 0.99 0.96 0.91 0.92 0.85 
yscB 0.82 0.84 0.85 0.8 0.83 
yscD 0.86 0.84 0.76 0.77 0.81 
yscE 0.97 1 0.98 1 0.94 
ysdA 1.06 1.02 1.04 1.04 1.09 
ysdB 0.83 0.81 0.82 0.86 0.89 
ysdC 0.83 0.84 0.82 0.83 0.87 
ysdE 1.03 1.08 0.92 1.09 0.97 
yseA 0.98 1.01 0.91 1.02 0.94 
yseC 0.91 1.08 0.97 1.03 1.05 
yseD 0.82 0.91 0.88 0.82 0.81 
yseE 0.96 1.04 1.02 1.05 1 
yseF 1.02 1.05 0.98 1.03 0.91 
yseH 0.9 0.96 0.97 0.94 0.84 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ysfB 1.11 1.05 1.01 1.11 1.06 
ysfC 1 0.94 0.92 1 0.9 
ysfD 0.89 0.87 0.84 0.86 0.83 
ysfG 1.13 1.18 0.95 1.11 1.1 
ysgA 1.02 1.13 1 1.16 1.02 
ysgB 1.04 1.07 1.02 1.13 1 
yshA 1.01 1.2 1.02 1.21 1.06 
yshB 0.88 1.05 1 1.11 0.92 
ysiA 0.97 1.04 1.03 1.07 0.92 
ysiB 1.2 1.22 1.16 1.08 1 
ysiC 0.79 0.88 0.85 0.9 0.78 
ysiD 0.95 0.95 0.96 0.97 0.89 
ysiE 0.9 0.87 0.87 0.97 0.9 
ysiG 1.04 1.06 0.96 0.97 0.96 
ysjA 1.06 0.96 0.92 1 0.99 
ysjC 0.92 0.99 0.87 0.96 0.96 
ysjD 0.91 1.05 0.92 1.08 0.93 
ysjE 0.82 1.01 1.01 1.04 0.96 
ysjF 0.82 0.93 0.93 0.91 0.93 
ysjG 0.94 1.01 0.89 1 0.86 
ysjH 0.72 0.83 0.84 0.77 0.76 
ysxL 0.77 0.81 0.82 0.81 0.77 
ytaA 1.05 1.02 1.02 1.08 0.97 
ytaB 0.92 0.92 0.83 1.03 0.91 
ytaD 0.94 0.9 0.83 0.94 0.86 
ytbA 1.17 1.19 1 1.17 1.19 
ytbB 1.1 1.13 0.98 1.22 1.03 
ytbC 0.84 0.98 0.92 1.03 0.9 
ytbD 0.92 1.07 0.97 1.01 1.01 
ytbE 0.71 0.83 0.83 0.87 0.8 
ytcA 0.71 0.85 0.79 0.79 0.76 
ytcB 0.95 0.94 0.97 1.01 0.9 
ytcC 0.98 1.06 0.99 0.94 0.92 
ytcD 0.87 0.93 0.85 0.94 0.85 
ytcE 0.71 0.76 0.74 0.81 0.73 
ytdA 0.98 0.93 0.77 0.88 1 
ytdB 0.95 0.84 0.81 0.98 0.88 
ytdC 0.76 0.76 0.71 0.81 0.8 
ytdF 1 1.03 0.93 1.09 0.96 
yteA 1.07 1.12 1 1.1 1.08 
yteB 0.96 1.1 0.87 1.03 1.02 
yteC 0.91 1 0.98 0.98 0.99 
yteD 1.1 1.16 1.13 1.03 1.04 
yteE 0.99 0.99 0.95 0.93 0.91 
yteG 0.8 0.88 0.87 0.85 0.8 
ytfA 1.02 1.05 0.94 1.05 1.02 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ytfB 0.74 0.8 0.8 0.75 0.74 
ytgA 0.71 0.71 0.78 0.77 0.69 
ytgB 0.9 0.96 0.83 1.01 0.89 
ytgC 0.76 0.82 0.78 0.8 0.77 
ytgD 0.71 0.74 0.73 0.82 0.73 
ytgE 1.22 1.22 1.04 1.28 1.17 
ytgF 1 1.07 0.9 1.11 0.95 
ytgG 1 1.16 0.97 1.06 1.09 
ytgH 1.01 1.19 1 1.07 1.18 
ythA 0.92 0.98 0.9 0.92 0.96 
ythB 1.11 1.03 0.87 0.95 1.05 
ythC 0.96 1 0.98 0.93 0.95 
ytiA 0.98 0.98 1 0.94 0.91 
ytjA 0.83 0.9 0.84 0.87 0.85 
ytjD 0.95 0.97 0.99 1.03 0.89 
ytjE 1.04 1.04 1.01 1.05 1 
ytjF 1 1 0.98 0.93 0.97 
ytjG 0.95 0.9 0.85 0.95 1.03 
ytjH 1.11 1.07 1.04 1.02 1.04 
yuaA 1.03 1.07 1 1.07 1.02 
yuaB 1.08 1.24 1.1 1.19 1.03 
yuaC 0.98 1.13 1.07 1.05 1.06 
yuaD 0.97 1.14 1 1.02 1.07 
yuaE 0.77 0.94 0.88 0.93 0.96 
yucF 0.84 0.94 0.86 0.83 0.79 
yucG 0.86 1.03 0.94 0.93 0.98 
yudA 0.83 0.92 0.91 0.94 0.93 
yudB 0.82 0.9 0.88 0.88 0.87 
yudD 0.85 0.93 0.99 0.94 0.9 
yudE 0.81 0.91 0.84 0.94 0.83 
yudF 0.9 0.97 0.9 0.93 0.9 
yudG 0.92 0.92 0.81 0.9 0.9 
yudI 0.86 1.06 0.88 0.9 0.99 
yudJ 0.87 1.1 0.96 0.94 1.08 
yudK 0.86 1 0.9 0.95 0.95 
yudL 0.8 0.99 0.86 0.92 0.87 
yueA 1.02 1.07 1.01 1.09 0.88 
yueB 1.03 1.07 1.04 1.07 0.99 
yueC 0.77 0.85 0.83 0.85 0.81 
yueD 1.18 1.12 1.15 1.21 1.06 
yueE 0.93 0.98 1.01 1.02 0.98 
yueF 0.75 0.83 0.9 0.87 0.82 
yufA 0.84 0.83 0.82 0.84 0.83 
yufC 0.98 0.92 0.95 0.96 0.99 
yugA 0.9 0.97 0.92 0.92 0.97 
yugB 1.06 1.09 1.05 0.98 1.11 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
yugC 0.85 1.02 0.94 0.94 0.97 
yugD 0.9 0.99 0.93 0.94 1.01 
yuhA 1.1 0.99 0.93 0.91 0.93 
yuhB 0.94 0.99 0.9 0.92 0.94 
yuhC 1.04 1.08 0.91 0.96 0.98 
yuhD 0.83 0.88 0.83 0.83 0.85 
yuhE 0.85 0.93 0.83 0.9 0.89 
yuhH 0.84 0.88 0.87 0.9 0.83 
yuhI 0.78 0.83 0.82 0.89 0.79 
yuhJ 1.29 1.23 1.25 1.26 1.34 
yuiA 0.78 0.86 0.86 0.88 0.88 
yuiB 0.81 0.84 0.86 0.79 0.89 
yuiC 0.65 0.67 0.6 0.6 0.68 
yuiD 0.99 1.02 0.93 1.12 1.04 
yuiE 0.89 0.96 0.89 0.92 0.95 
yujA 0.99 1.06 1.02 1.02 1.11 
yujB 0.88 1.02 1.06 1.02 1.04 
yujD 0.82 1 0.84 0.96 0.92 
yujE 0.88 1.01 0.85 0.97 0.98 
yujF 0.69 0.83 0.82 0.84 0.83 
yujG 0.86 0.91 0.88 0.95 0.84 
yvaA 1.1 0.97 0.99 1.04 0.92 
yvaB 0.7 0.78 0.8 0.83 0.76 
yvaD 0.72 0.8 0.86 0.81 0.8 
yvcA 0.78 0.82 0.78 0.78 0.82 
yvcC 0.96 0.98 0.98 1 1.03 
yvdB 0.86 1.01 1.01 0.92 0.93 
yvdC 0.95 1.11 1.03 1.03 1.03 
yvdD 0.84 0.92 0.87 0.88 0.91 
yvdE 0.82 0.94 0.87 0.88 0.87 
yvdF 0.82 0.93 0.87 0.88 0.86 
yvdG 1.05 1.1 1.04 1.15 1.09 
yveB 0.91 0.89 0.83 1.01 0.94 
yveC 0.77 0.77 0.72 0.8 0.78 
yveD 0.95 1.02 0.91 0.94 1.02 
yveE 1.06 1.03 0.98 1.05 1.01 
yveF 0.96 1.04 0.89 0.95 1.03 
yveG 0.96 1.19 1.03 1.01 1.09 
yveH 0.93 1.05 0.99 1 1.09 
yveI 1.17 1.26 1.08 1.11 1.19 
yvfA 0.91 0.75 0.69 0.73 0.84 
yvfB 1.5 1.45 1.24 1.33 1.43 
yvhA 0.94 1.02 0.88 1.01 1.02 
yvhB 0.94 1 0.95 1.01 0.99 
yviA 0.96 0.99 0.96 1.04 0.94 
yviC 0.86 1.05 0.95 0.97 0.99 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
yviH 0.96 0.89 0.87 0.93 0.88 
yviI 0.87 0.91 0.8 0.79 0.88 
yviJ 1.03 0.91 0.93 1.01 0.94 
yvjA 0.9 0.86 0.96 0.92 1 
yvjB 1.02 1.07 1.02 1.04 1.16 
ywaB 0.93 1.05 0.96 0.96 0.94 
ywaC 1.02 1.18 1.05 1.01 1.06 
ywaD 0.98 0.94 1 1.04 0.96 
ywaE 1.01 1.09 1.13 1.09 1.12 
ywaF 1.08 1.14 1.13 1.13 1.18 
ywaG 0.86 0.93 0.85 0.89 0.91 
ywaH 0.8 0.84 0.78 0.87 0.76 
ywaI 0.9 0.98 0.92 0.96 0.93 
ywbA 0.77 0.89 0.81 0.84 0.8 
ywbB 1.02 1.06 0.91 1.15 1.08 
ywcC 0.86 0.96 0.99 0.98 0.99 
ywdA 1.1 1.04 0.92 1.05 1.02 
ywdB 0.88 0.82 0.89 0.92 0.88 
ywdC 1.12 1.15 1.1 1.12 1.16 
ywdD 1.01 1.18 1.02 1.08 1.14 
ywdE 0.86 1.04 0.93 0.91 0.93 
ywdF 0.99 1.14 1.04 1 1.09 
yweA 0.95 1.02 0.98 1.01 1.06 
yweB 0.77 0.83 0.9 0.98 0.98 
yweC 1.01 1.1 0.95 1 1 
yweD 0.92 0.99 0.89 1.02 0.99 
yweE 0.88 0.86 0.89 1.02 0.93 
yweF 0.69 0.75 0.76 0.78 0.76 
ywfA 0.96 1.01 0.93 0.97 1 
ywfB 1.22 1.1 1.04 1.1 1.01 
ywfC 0.94 0.9 0.94 0.89 0.94 
ywfD 1.31 1.28 1.19 1.08 1.22 
ywfE 1.23 1.34 1.21 1.17 1.17 
ywfF 0.73 0.92 0.94 0.9 0.84 
ywfH 0.5 0.59 0.97 0.99 0.98 
ywgA 0.69 0.92 0.93 0.93 0.91 
ywhA 0.85 0.95 0.9 0.85 0.91 
ywiA 0.97 1 0.94 1.04 1.02 
ywiB 0.94 1 0.88 0.96 0.96 
ywiC 0.91 0.98 0.96 1.05 0.95 
ywiD 0.82 0.9 0.89 0.9 0.92 
ywiE 1.22 1.26 1.11 1.29 1.12 
ywiH 1.16 1.24 1.16 1.15 1.2 
ywjA 0.84 0.94 0.9 0.91 0.89 
ywjB 0.85 0.96 0.97 0.98 0.98 
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Table D2 (Continued). 
 
CGH ratios between the strains of interest and the IL1403 strain  
(normalization by the intensities of a subset of conserved genes, method C) 
Gene id UCMA5713 LD55 LL08 LL52 S86 
ywjC 1.12 1.18 1.01 1.13 1.12 
ywjD 0.33 0.35 0.95 0.95 0.98 
ywjE 0.38 0.42 1.07 1.08 1.07 
ywjG 0.9 0.99 0.87 0.94 0.96 
yxaB 0.98 1.01 0.96 1.09 1.02 
yxaC 0.96 1.01 0.91 0.99 0.95 
yxaF 0.69 0.84 0.9 0.92 0.93 
yxbA 0.93 0.91 0.88 0.8 1.04 
yxbC 0.97 1.15 1.08 0.69 1.11 
yxbD 1.08 1.14 1.11 1.04 1.1 
yxbE 0.98 1.21 1.1 1.08 1.12 
yxbF 0.81 0.85 0.91 1.02 0.91 
yxcA 0.97 1.23 1.15 1.12 1.15 
yxcB 0.89 1.07 1.04 0.94 0.99 
yxcD 1.06 1.17 1.17 1.11 1.22 
yxdB 0.85 0.99 0.93 0.9 0.96 
yxdC 0.89 1.01 0.91 0.92 0.96 
yxdD 0.94 0.92 0.85 0.95 0.96 
yxdE 0.9 0.98 0.97 1.01 1.05 
yxdF 0.81 0.91 0.8 0.87 0.97 
yxdG 1.03 1.06 1.1 0.97 1.16 
yxeA 1.03 1.12 1.09 1.04 1.04 
yxeB 1.01 1.18 1.2 1.09 1.02 
yxfA 1.71 1.92 1.2 1.78 1.5 
yxfB 0.95 1.06 1.07 1.03 1.07 
yxfC 1.08 1.19 1.2 1.16 1.18 
yyaL 0.87 0.99 1.02 0.9 1.05 
zitP 0.82 1 0.92 0.96 0.95 
zitQ 0.78 0.88 0.82 0.94 0.92 
zitR 0.92 0.96 0.89 0.93 0.99 
zitS 0.92 0.98 0.95 1.08 1.1 
zwf 0.89 0.91 0.93 0.67 1.09 
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